cyclosporine has been researched along with Chronic Disease in 756 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 280 (37.04) | 18.2507 |
2000's | 317 (41.93) | 29.6817 |
2010's | 137 (18.12) | 24.3611 |
2020's | 22 (2.91) | 2.80 |
Authors | Studies |
---|---|
Fu, JJ; Li, FF; Qian, P; Sun, ZM; Wang, YQ; Yan, HX; Yang, L; Zhao, J | 1 |
Balicka, A; Balicki, I; Szadkowski, M; Zwolska, J | 1 |
Chan, TC; Chang, YT; Chen, YJ; Chiu, TM; Cho, YT; Chou, WY; Chu, CY; Hong, CH; Hsiao, PF; Huang, YH; Lan, CC; Lee, CH; Tsai, TF; Tu, WT; Wang, WM; Wu, PY; Yang, CW | 1 |
Alves, F; Calado, R; Gomes, T; Gonçalo, M; Relvas, M | 1 |
Jendoubi, F; Masson Regnault, M; Paul, C; Shourick, J; Tauber, M | 1 |
Arcuri, LJ; Lerner, D; Tavares, RCBDS | 1 |
Krebs, B; Menter, AM; Valdecantos, WC; Weiss, J; Zema, CL | 1 |
Bishnoi, A; Kumaran, MS; Mehta, H; Parsad, D | 1 |
Hsu, JI; Hsu, S | 2 |
Beckmann, KM; Hetzel, U; Martini, F; Rostaher, A | 1 |
Blanchard, I; Kodali, N; Kunamneni, S; Lebwohl, MG | 1 |
Jin, HZ; Wang, HM; Xu, JM | 1 |
Aala, WJF; Chen, PH; Chuang, YR; Hong, YK; Hsu, CK; Jeng, YC; Lin, YC; Yang, CC | 1 |
Beshensky, D; Comis, LE; Cowen, EW; Holtzman, NG; Joe, GO; Magone, MT; Mays, JW; Pavletic, SZ; Pirsl, F; Schulz, E; Steinberg, SM; Waldman, MA | 1 |
Bei, W; Feng, H; Kai, C; Liuqing, C; Qian, J; Ruili, J; Zilu, Q | 1 |
Jang, YJ; Kim, KH; Kim, KJ; Park, EJ; Yoon, JH | 1 |
Alvarez, L; Cardona, R; Sánchez, J | 1 |
Furukawa, K; Ichinose, K; Imadome, KI; Kawakami, A; Okamoto, M; Sato, S | 1 |
Ambrosiani, L; Feltri, M; Gardellini, A; Guidotti, F; Saccà, V; Turrini, M; Zancanella, M | 1 |
Alsharabati, M; King, P; Lu, L; Morgan, MB; Oh, SJ | 1 |
Expósito-Serrano, V; Garbayo-Salmons, P | 1 |
Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E | 1 |
Jerome, D; Kim, WB; Yeung, J | 1 |
Halfwassen, C; Scholz, SL; Steuhl, KP; Thomasen, H; Westekemper, H | 1 |
Chugh, S; Khurana, N; Ranjan, R; Sardana, K | 1 |
Ott, H | 1 |
Holm, JG; Ivyanskiy, I; Thomsen, SF | 1 |
Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
Blaise, D; Blancho, G; Chantepie, S; Chevallier, P; Gaugler, B; Guillaume, T; Labopin, M; Magro, L; Malard, F; Mohty, M; Moreau, P; Tabrizi, R; Vanhove, B; Yakoub-Agha, I | 1 |
Ferrer, M; Madamba, R | 1 |
Kennedy, KK; Koski, R | 1 |
Falk, W; Hauschildt, S; Hoffmann, M; Lehmann, J; Schwertassek, U; Seydel, A; Weber, K | 1 |
Archilla, LR; Curto-Barredo, L; Giménez-Arnau, AM; Pujol, RM; Vives, GR | 1 |
Kaplan, AP | 4 |
Borel, C; Boulinguez, S; Bulai Livideanu, C; Dimeglio, C; Huynh, A; Lepage, B; Marguery, MC; Paul, C; Richet, C | 1 |
Oosterhaven, JAF; Schuttelaar, MLA | 1 |
Ferreira, B; Gonçalo, M; Ramos, L; Santiago, L | 1 |
Akpek, EK; Stern, M; Utine, CA | 1 |
Endo, T; Hayama, K; Ito, M; Izaki, S; Kanegae, K; Nishimori, N; Okayama, Y; Sugai, K; Terui, T; Toyoshima, S | 1 |
Börjesson, C; Guinard, E; Konstantinou, MP; Livideanu, CB; Mazereeuw-Hautier, J; Meyer, N; Paul, C; Tauber, M | 1 |
Hao, P; Huang, Y; Li, Y; Shi, Y; Xiao, X; Xu, M; Zhang, L; Zheng, H; Zheng, Q; Zhou, S | 1 |
Bayaraa, B; Imafuku, S; Ohga, Y | 1 |
Obata, H; Takayama, K; Takeuchi, M | 1 |
D'Ascenzo, G; Feci, L; Fimiani, M; Marotta, G; Murdaca, F; Poggiali, S; Rubegni, P | 1 |
Abu El-Asrar, AM; Al Tamimi, M; Al-Mezaine, HS; Al-Muammar, A; Hemachandran, S; Kangave, D | 1 |
Hashi, S; Kinoshita, R; Masuda, S; Matsubara, K; Ogawa, E; Ogawa, K; Okamoto, S; Shinke, H; Sonoda, M; Sugimoto, M; Takada, N; Taniguchi, R; Uemoto, S; Yoshizawa, A | 1 |
Humphreys, F; Kaur, MR; Raghavendran, RR | 1 |
Albanesi, M; Di Stanislao, C; Franconi, G; Guaragna, MA; Paparo Barbaro, S; Stefani, S | 1 |
Lommer, MJ | 1 |
Chung, BH; Doh, KC; Heo, SB; Jin, L; Kang, SH; Li, C; Lim, SW; Piao, SG; Yang, CW | 1 |
McNeil, C | 1 |
Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS | 1 |
Bart, PA; Bellutti Enders, F; Cavassini, M; Cellerai, C; Faouzi, M; Harari, A; Miconnet, I; Ohmiti, K; Pantaleo, G; Perreau, M; Rozot, V; Savoye, AL; Viganò, S | 1 |
Casco, F; Colmenero, I; Delmiro, A; Fiuza-Luces, C; González-Murillo, A; Lucia, A; Melén, GJ; Morán, M; Palacio, JM; Ramírez, M; Soares-Miranda, L | 1 |
Ganachari, M; Ghobrial, RM; Kloc, M; Li, XC; Sidhu, J; Skelton, TS; Tejpal, N; You, J; Zhang, L | 1 |
Feng, L; Li, CW; Li, SF; Li, YP; Long, D; Lu, J; Luo, L; Shan, J; Xiao, Z | 1 |
Garriga-Companys, S; Labrador-Horrillo, M | 1 |
Chen, HS; Liu, JP; Wang, W; Wu, SN | 1 |
Makris, M; Maurer, M; Zuberbier, T | 1 |
Hirohata, S | 2 |
Grattan, C; Marrouche, N | 1 |
Fukuoka, J; Hasegawa, Y; Kataoka, K; Kimura, T; Kondoh, Y; Nishiyama, O; Ono, K; Sakamoto, K; Taniguchi, H; Watanabe, N | 1 |
Nuttall, T; Reece, D; Roberts, E | 1 |
Bygum, A; Winther, AH | 1 |
Ferreira, MB; Kaplan, AP; Viegas, LP | 1 |
Chung, BH; Doh, KC; Heo, SB; Jin, J; Jin, L; Lim, SW; Piao, SG; Yang, CW | 1 |
Chu, DS; Fang, C; Kim, E; Kim, JS; Kolomeyer, AM; Nayak, NV; Ragam, A | 1 |
Brennan, J; Coulston, J; Kennedy, T; Millen, A | 1 |
Savikko, J; Taskinen, E; Teppo, AM; von Willebrand, E | 1 |
Ardusso, L; Cabrera, H; De Gennaro, M; Fernández Bussy, R; Galimany, J; Galimberti, D; La Forgia, M; Label, M; Máspero, J; Medina, I; Neffen, H; Troielli, P | 1 |
Nakao, S | 1 |
Li, X; Wang, W; Wang, Y; Yin, H; Zhang, X | 1 |
Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
Charron, D; Couture, F; Filion, A; Guillemette, C; Lalancette, M; Laverdière, I; Lévesque, É; Loiseau, P; Peffault de Latour, R; Robin, M; Socié, G; Tamouza, R; Tourancheau, A | 1 |
Chen, YP; Li, M; Rui, HL; Sun, QL | 1 |
Asero, R | 2 |
Cassano, N; Foti, C; Romita, P; Vena, GA; Ventura, MT; Vestita, M | 1 |
Dada, T; Dhiman, R; Saini, M; Tandon, R; Vanathi, M | 1 |
Murata, M | 1 |
Al-Ghareeb, SM; Al-Wedaie, F; El-Agroudy, AE; Farid, E; Tabbara, K | 1 |
Inkpen, H | 1 |
Chung, YR; Lee, ES; Lee, K; Park, JY; Song, JH | 1 |
Akpek, EK; Doroslovacki, P; Karakus, S; O'Donnell, JJ | 1 |
Acir, NO; Cetinkaya, S; Cetinkaya, YF; Dadaci, Z; Mestan, E; Yener, HI | 1 |
Alarcón-Payer, C; García-Martín, P; Jurado, M; López-Fernández, E; Moratalla, L; Ríos, R; Romero, A; Sainz, J | 1 |
Asero, R; Cugno, M; Marra, AM; Marzano, AV; Pinter, E; Tedeschi, A | 1 |
Arora, M; Bejanyan, N; Blazar, BR; Brunstein, CG; DeFor, T; Holtan, S; Lazaryan, A; MacMillan, ML; Wagner, JE; Weisdorf, DJ | 1 |
Anglicheau, D; Babinet, F; Caillard, S; Colosio, C; Deslée, G; Dury, S; Essig, M; Etienne, I; Launois, C; Lebargy, F; Merieau, E; Perotin-Collard, JM; Rieu, P; Rivalan, J; Subra, JF; Thervet, E; Toubas, O | 1 |
Ay, Y; Demirag, B; Ince, D; Karapinar, TH; Koker, SA; Moueminoglou, N; Oymak, Y; Ozcan, E; Toret, E; Vergin, C | 1 |
Lima, F; Mello, ES; Tanigawa, RY; Tannuri, AC; Tannuri, U | 1 |
Chularojanamontri, L; Kulthanan, K; Likitwattananurak, C; Tuchinda, P; Ungaksornpairote, C | 1 |
Jang, JH; Jung, CW; Kim, K; Kim, SJ; Kim, WS; Park, S | 1 |
Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY; Lee, AH; Lee, PP; Liu, AP; Tsoi, WC | 1 |
Deza, G; Giménez-Arnau, AM | 1 |
Arai, M | 1 |
Bellon, H; De Vleeschauwer, S; Heigl, T; Jungraithmayr, W; Somers, J; Van Raemdonck, DE; Vanaudenaerde, BM; Vandermeulen, E; Vaneylen, A; Verbeken, EK; Verleden, GM; Verleden, SE; Vos, R; Yamada, Y | 1 |
Bernstein, JA; Greiwe, J | 1 |
Camarero-Mulas, C; Daudén, E; Martinez-Mera, C; Sanz-Sánchez, T | 1 |
Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
Aoyama, Y; Hamada, T; Iwatsuki, K; Shirafuji, Y | 1 |
Barker, JN; Capon, F; Choon, SE; Lau, BW; Lim, DZ | 1 |
Berbegal-de Gracia, L; de León-Marrero, F; Hispán, P; Marín-Cabañas, I; Silvestre, JF | 1 |
Costa, C; Gonçalo, M | 1 |
Feng, Y; Liu, M; Tan, HB; Wu, YC | 1 |
Hirsch, GM; Jordan, JL; Lee, TD | 1 |
Choi, BS; Ghee, JY; Han, DH; Kim, J; Kim, SH; Kim, WY; Kim, YS; Song, HK; Yang, CW; Yoon, HE | 1 |
Andree, H; Freund, M; Hilgendorf, I; Holzhueter, S; Junghanss, C; Leithaeuser, M; Loddenkemper, C; Steiner, B; Wolff, D | 1 |
Blume, C; Grabensee, B; Helmchen, U; Ivens, K; Marcard, T; Rump, LC; Willers, R | 1 |
Azzari, C; Barni, S; Bernardini, R; Calogero, C; Cianferoni, A; Di Grande, L; Mori, F; Novembre, E; Pucci, N; Vierucci, A | 1 |
Che, W; Chen, H; Sui, W; Xie, S; Yan, Q; Zou, G; Zou, H | 1 |
D'Angelo, S; Olivieri, I; Palazzi, C | 1 |
El-Agroudy, AE; El-Baz, M; El-Dahshan, KF; Ghoneim, MA; Ismail, AM; Mahmoud, K; Shokeir, AA | 1 |
Campanati, A; Ganzetti, G; Giuliodori, K; Marconi, B; Offidani, A; Simonetti, O | 1 |
Choudhary, DR; Kumar, R; Mahapatra, M; Mishra, P; Naithani, R; Saxena, R | 1 |
Cheng, K; Huang, ZF; Ye, QF; Zhao, YJ; Zhu, SH | 1 |
Jeong, HJ; Kim, YS; Kwon, J; Lee, D; Park, J | 1 |
Baumann, M; Heemann, U; Liu, S; Lutz, J; Roos, M; Schmaderer, C; Strobl, M | 1 |
Bartra, J; Dávila, I; del Cuvillo, A; Ferrer, M; Jáuregui, I; Montoro, J; Mullol, J; Sastre, J; Valero, A | 1 |
de Hoon, J; Meersseman, W; Spriet, I; von Winckelmann, S; Willems, L; Wilmer, A | 1 |
Banner, NR; Hamour, IM; Lyster, HS; Omar, F; Palmer, A | 1 |
Nagami, GT; Paige, NM | 1 |
Kuypers, DR; Naesens, M; Sarwal, M | 1 |
Bodaghi, B; Fardeau, C; Labetoulle, M; Lehoang, P; Monin, C; Soubrane, G; Trinh, L | 1 |
Kessel, A; Toubi, E | 3 |
Biagioli, M; Cantarini, L; Cimaz, R; Dal Canto, N; Fanti, F; Galeazzi, M; Martino, S; Miracco, C | 1 |
Hullin, R; Kalangos, A; Mach, F; Pascual, M; Rotman, S; Vogt, P; von Segesser, L; Yerly, P | 1 |
Yang, CW; Yoon, HE | 1 |
Li, J; Xia, J; Xu, L; Zhang, K | 1 |
Denoyer, A; Nochez, Y; Pisella, PJ | 1 |
Beckebaum, S; Cicinnati, VR; Gerken, G; Klein, C; Paul, A; Saner, F; Schmitz, K; Sotiropoulos, GC; Varghese, J | 1 |
Altunbaşak, S; Hergüner, MO; Incecik, F | 1 |
Banner, NR; Hamour, I; Leaver, N; Lyster, H; Palmer, A | 1 |
Byun, YJ; Kim, EK; Kim, SW; Kim, TI; Kwon, SM; Park, WC; Seo, KY | 1 |
Fujinaga, S; Hara, S; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
Arni, S; Hillinger, S; Inci, I; Jungraithmayr, W; Korom, S; Vogt, P; Weder, W | 1 |
Etienne, I; Glotz, D; Hayem, C; Hurault, de LB; Le Meur, Y; Le Pogamp, P; Lebranchu, Y; Meas-Yedid, V; Moulin, B; Olivo Marin, JC; Presne, C; Servais, A; Thervet, E; Thierry, A; Toupance, O | 1 |
Arnold, DM; Chan, H; Heddle, NM; Kelton, JG; Nazi, I; Santos, A; Warkentin, TE | 1 |
Castroagudín, JF; Molina, E; Otero, E; Romero, R; Tomé, S; Varo, E | 1 |
Bajwa, ZH; Najib, U; Ostro, MG; Sheikh, J | 1 |
Tedeschi, A | 1 |
DeBoer, DJ; Favrot, C; Jackson, HA; Mueller, RS; Nuttall, T; Olivry, T; Prélaud, P | 1 |
Ghee, JY; Han, DH; Kim, J; Lee, SY; Piao, SG; Song, HK; Song, JH; Yang, CW; Yoon, HE; Yoon, HJ | 1 |
Avila, S; Carpentier, C; Cermenati, T; Cuchacovich, M; Díaz, G; Gallardo, P; Merino, G; Rojas, B; Sabugo, F; Solanes, F; Stopel, J; Traipe, L; Verdaguer, J; Verdaguer, JI; Villarroel, F; Zanoli, M | 1 |
Duffy, S; Griffin, S; Ingram, JR; Paulden, M; Rodgers, M; Sculpher, M; Slack, R; Woolacott, N | 1 |
Ohtsuka, T | 1 |
Agarwal, SK; Bharti, AC; Bhowmik, DM; Guleria, S; Gupta, N; Kumar, R; Mehra, NK; Panigrahi, A; Sharma, PK; Shukla, S | 1 |
Keränen, MA; Krebs, R; Lemström, KB; Nykänen, AI; Syrjälä, SO; Tammi, M; Tuuminen, R | 1 |
Quan, L; Zhang, W; Zheng, X; Zhou, X; Zuo, YX | 1 |
Bondada, S; Brandon, JA; Bryson, JS; Cohen, DA; Jennings, CD; Kaplan, AM; Perez, J; Sindhava, VJ | 1 |
Appelbaum, FR; Deeg, HJ; Flowers, ME; Maloney, DG; Martin, PJ; Mielcarek, M; Peffer, A; Rotta, M; Sandmaier, BM; Storb, R; Storer, BE; Vernon, MS | 1 |
Ghee, JY; Han, DH; Kim, S; Kobori, H; Kuro-o, M; Ohashi, N; Piao, S; Song, JH; Yang, CW; Yoon, HE | 1 |
Nagano, Y; Nakajima, H; Nakajima, K; Sano, S; Takahashi, M; Takahashi, Y; Tarutani, M; Yamamoto, M | 1 |
Abraham, G; Chandramohan, V; Matthew, M; Mullassery, A; Thirumoorthy, K | 1 |
Choi, BS; Ghee, JY; Han, DH; Ishikawa, N; Kim, J; Kim, SH; Nishijima, F; Obara, K; Piao, S; Song, JH; Yang, CW; Yoon, HE | 1 |
Samudre, S; Scoper, SV; Sheppard, JD | 1 |
Baba, HA; Brand, M; Di Marco, GS; Grabner, A; Jacobi, AM; Kentrup, D; Pavenstädt, H; Reuter, S; Tiemann, K; Ting, L | 1 |
Huang, QM; Liu, JF; Wu, YB | 1 |
Aksu, K; Emmungil, H; Kalfa, M; Karabulut, G; Keser, G; Sen, S; Zihni, FY | 1 |
Boubouka, CD; Charissi, C; Kalogeromitros, D; Katsarou, A; Kouimintzis, D; Stavropoulos, PG | 1 |
Koskinen, PK; Rintala, JM; Rintala, SE; Savikko, J; von Willebrand, E | 1 |
Bertocchio, JP; Jaisser, F; Warnock, DG | 1 |
Alcubierre, R; Arias, L; Lorenzo, D | 1 |
Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 1 |
de Mello Souza, CH; Headrick, J; Millis, DL; Weigel, JP | 1 |
Chen, J; Han, F; He, Q; Huang, H; Wang, H; Wang, S; Wang, Y; Wu, J; Zhang, X | 1 |
Inagaki, J; Nagatoshi, Y; Nomura, Y; Okamura, J; Sakiyama, M; Teranishi, H; Yanai, F | 1 |
Antin, JH | 1 |
Morozumi, K; Takeda, A | 1 |
Komiya, T; Muso, E | 1 |
Gesser, C; Kaulfers, PM; Loderstädt, U; Meyer-Rüsenberg, B; Richard, G | 1 |
Fourie, J; McEachen, SC; van Heerden, WF; van Zyl, A | 1 |
Intong, LR; Murrell, DF | 1 |
Bocian, K; Duszota, A; Górski, A; Korczak-Kowalska, G; Korecka-Polak, A; Kłosowska, D; Niemczyk, M; Paczek, L; Wierzbicki, P | 1 |
Hollander, SM; Joo, SS; Wedner, HJ | 1 |
Cao, YM; Liu, S; Qiao, JY; Wang, M; Wang, XG; Yang, J; Zhao, XM; Zhou, YJ | 1 |
Ardelean, E; Bräutigam, M; Krause, K; Maurer, M; Schoepke, N; Weller, K | 1 |
Goto, T; Koike, K; Kurokawa, M; Yamamoto, G; Yoshimi, A | 1 |
Choi, BS; Chung, BH; Ghee, JY; Hwang, HS; Kim, J; Kim, JY; Lim, SW; Piao, SG; Yang, CW; Yoon, HE | 1 |
Djamali, A; Hafez, O; Huang, L; Jacobson, L; Kolehmainen, C; Reese, S; Swain, W; Torrealba, JR; Vidyasagar, A; Wilson, NA | 1 |
Khan, DA; Trojan, TD | 1 |
Abuchar, A; Dehesa, L; Kerdel, FA; Nuno-Gonzalez, A; Vitiello, M | 1 |
Arai, A; Fujiwara, S; Imadome, K; Kurata, M; Miura, O; Murakami, N; Nogami, A | 1 |
Awadain, W; el-Agroudy, A; El-Deeb, S; Fouda, A; Gheith, O; Ghoneim, MA; Hassan, A; Hassan, N | 1 |
Heiligenhaus, A; Heinz, C; Hennig, M; Rammrath, D; Roesel, M; Zurek-Imhoff, B | 1 |
Auyanet, I; Batista, F; Oppenheimer, F; Torregrosa, JV | 1 |
Koskinen, PK; Palin, NK; Savikko, J | 1 |
Jin, J; Wei, J; Xu, H; Zhang, J; Zhang, Y | 1 |
Abboud, HE; Andoh, TF; Bagby, GC; Bennett, WM; Christianson, TA; Faulkner, GR; Jin, DC; Wahba, IM; Yang, CW | 1 |
Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W | 1 |
Hershberger, RE; Ni, H; Toy, W; Vossler, MR | 1 |
Arias, M; Cotorruelo, JG; de Francisco, AL; Escallada, R; Fernández-Fresnedo, G; Herráez, I; Piñera, C; Rodrigo, E; Ruiz, JC; Zubimendi, JA | 1 |
Alamanos, Y; Bougias, DV; Drosos, AA; Georgiadis, AN; Temekonidis, TI; Voulgari, PV | 1 |
Berardinelli, L; Edefonti, A; Ferraresso, M; Garavaglia, R; Ghio, L | 1 |
Billerey, C; Bresson-Vautrin, C; Chalopin, JM; Ducloux, D; Motte, G; Rebibou, JM; Saint-Hillier, Y; Vautrin, P | 1 |
Durlik, M; Elhasade, A; Gaciong, Z; Gałazka, Z; Lao, M; Perkowska, A; Placha, G | 1 |
Hayward, C; Keogh, AM; Kusano, K; Macdonald, PS; Savdie, E; Spratt, PM; Tedoriya, T; Wilson, M | 1 |
Alvarellos, T; De Boccardo, G; Giraudo, C; Mas, V; Massari, P | 1 |
Asai, T; Iwao, H; Kim, S; Kishimoto, T; Miura, K; Nakao, T; Nakatani, T; Okamura, M; Tamada, S; Tashiro, K; Yamanaka, S | 1 |
Paul, LC | 1 |
Murata, R; Sakai, K; Ueda, M; Yamaguchi, M | 1 |
Anagnostopoulos, A; Beguelin, GZ; Champlin, R; Couriel, DR; De Lima, M; Giralt, S; Hosing, C; Kharfan-Dabaja, MA | 1 |
Bakran, A; Hammad, A; Rustom, R; Sells, RA; Sharma, AK; Sinha, S; Smith, D | 1 |
Dambara, T; Fukuchi, Y; Ohwada, A; Yoshioka, Y | 1 |
Bernaudin, F; Blatt, J; Brichard, B; Brochstein, JA; Ertem, M; Garnier, F; Giorgiani, G; Gluckman, E; Grafakos, S; Haut, PR; Ionescu, I; Kurtzberg, J; Li, X; Locatelli, F; Lubin, BH; Lutz, P; Miniero, R; Nagler, A; Nugent, DJ; Raja, T; Reed, W; Roberts, I; Rocha, V; Rubin, CM; Tannoia, N; Vermylen, C; Walters, MC; Will, AM; Woodard, P; Yaniv, I | 1 |
Doebis, C; Filantenkov, A; Jurisch, A; Neuhaus, P; Pratschke, J; Reutzel-Selke, A; Schmidt, H; Seifert, M; Tullius, SG; Volk, HD | 1 |
Chen, X; Hou, M; Ji, C; Li, W; Liu, C; Liu, D; Peng, J; Ren, C; Wang, Z; Xing, N; Xu, C; Zhang, M | 1 |
Aihara, Y; Ito, S; Kawamoto, M; Nakamura, T; Nezu, A; Yokota, S | 1 |
Aletaha, D; Smolen, JS | 1 |
Bobadilla, NA; Feria, I; Gamba, G; García-Torres, R; González, MA; Juárez, P; López-Casillas, F; Pichardo, I; Ramírez, V; Uribe, N | 1 |
Newstead, CG; Stoves, J | 1 |
Bang, BK; Bennett, WM; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW | 1 |
Klaus, A; Klima, G; Margreiter, R; Offner, FA; Pernthaler, H | 1 |
Jha, S; Karetskaya, L; Ledbetter, S; Li, X; Ling, H; Pratt, B; Wang, W | 1 |
Chiba, T; Fukai, K; Imazeki, F; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
Qiao, BP; Ruan, Q; Tang, XD | 1 |
Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA | 1 |
Chan, HW; Lee, W; Tong, KL; Tsang, WK; Yeung, S | 1 |
Abbate, M; Caruso, R; Cattaneo, D; Ferrari, S; Gaspari, F; Gotti, E; Marchetti, G; Perico, N; Perna, A; Remuzzi, G; Stucchi, N | 1 |
Carpenter, PA; Sanders, JE | 1 |
Adler, KR; Bisaccia, E; Goldberg, SL; Gonzalez, J; Palangio, M; Rowley, SD | 1 |
Andoh, TF; Bennett, WM; Isaac, J; Shihab, FS; Yi, H | 1 |
Urbano-Ispìzua, A | 1 |
Arcese, W; Cerilli, L; Cerretti, R; De Felice, L; De Propris, MS; Fenu, S; Girelli, G; Iori, AP; Mengarelli, A; Moleti, ML; Romano, A | 1 |
Bicknell, GR; Nicholson, ML; Saunders, RN | 1 |
Amendola, G; Conte, ML; d'Urzo, G; Locatelli, F; Nobili, B; Perrotta, S; Rossi, F | 1 |
Bailey, RJ; Lam, EC | 1 |
Airaghi, L; Asero, R; Lorini, M; Tedeschi, A | 1 |
Amberger, A; Candinas, D; Margreiter, R; Mark, W; Offner, F; Schneeberger, S; Seiler, R; Stroka, DM | 1 |
Koshiba, T; Pirenne, J; Rutgeerts, O; Van Damme, B; Waer, M | 1 |
Battaglia, M; Di Paolo, S; Gesualdo, L; Grandaliano, G; Infante, B; Schena, A; Schena, FP; Stallone, G | 1 |
Asai, T; Iwao, H; Kim, S; Komiya, T; Kuwabara, N; Miura, K; Nakao, T; Nakatani, T; Okamura, M; Tamada, S; Tashiro, K; Yamanaka, S | 1 |
Moreno, AJ; Oliveira, PJ; Palmeira, CM; Rolo, AP; Santos, MS; Seiça, R | 1 |
Fujisaki, C; Hirokawa, K; Kitagawa, M; Kuroda, Y; Seidler, H; Utsuyama, M; Watanabe, A; Watanabe, S | 1 |
Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ | 1 |
Harada, H; Rothstein, DM; Sayegh, MH; Sho, M | 1 |
Savikko, J; Taskinen, E; Von Willebrand, E | 1 |
Bamberger, E; Kessel, A; Toubi, E | 1 |
Braun, WE | 1 |
Ducloux, D | 1 |
Bruijn, JA; Claas, FH; de Fijter, JW; Doxiadis, II; Paul, LC; Sijpkens, YW; van Kemenade, FJ; Zwinderman, AH | 1 |
Bain, V; Barkun, J; Erb, S; Ghent, C; Grant, D; Greig, P; Kneteman, N; Lilly, L; Marleau, D; Marotta, P; McAlister, V; Peltekian, K; Roy, A; Scudamore, C; Tchervenkov, J; Wall, W; Yoshida, E | 1 |
Atra, A; Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Meller, S; Ortin, M; Pinkerton, CR; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J | 1 |
Cusmai, A; Dammacco, R; Frassanito, MA; Fusaro, T; Guerriero, S; Sborgia, C | 1 |
Bajema, IM; Bakker, RC; Bruijn, JA; De Heer, E; Eikmans, M; Koop, K; Paul, LC; Sijpkens, YW | 1 |
Dupont, LJ; Van Raemdonck, D; Vanhaecke, J; Verleden, GM | 1 |
Bakker, RC; Bruijn, JA; de Fijter, JW; Hollander, AA; Mallat, MJ; Paul, LC | 1 |
Bos, JD; Bossuyt, PM; de Borgie, CA; de Rie, MA; Goldschmidt, WF; Heydendael, VM; Opmeer, BC; Reitsma, JB; Spuls, PI | 1 |
Dymecki, D; Gruca, Z; Głowacki, J; Lachinski, A; Stefaniak, T | 1 |
Arias, M; Campistol, JM; Castro, A; García, J; Gómez, JM; Grynió, JM; Gutiérrez, JA; Morales, JM; Mota, A; Prats, D; Ruiz, JC | 1 |
Akpek, EK; Green, WR; Ilhan-Sarac, O | 1 |
Andoh, TF; Bennett, WM; Burdmann, EA; Yu, L | 1 |
Goto, M; Inui, K; Kiuchi, T; Kodawara, T; Masuda, S; Saito, H; Tanaka, K; Uemoto, S | 1 |
Boratyńska, M; Falkiewicz, K; Klinger, M; Radwan-Oczko, M; Szyber, P | 1 |
Androudi, S; Brazitikos, P; Christen, W; Fiore, T; Foster, CS; Iaccheri, B; Meniconi, M | 1 |
Alsina, J; Andres, E; Bover, J; Castelao, AM; Gilvernet, S; Gonzalez, C; Griño, JM; Sabate, I; Seron, D | 1 |
Buckels, JA; Dousset, B; Elias, E; Gunson, BK; Hubscher, SG; Mayer, AD; McMaster, P; Neuberger, JM; Padbury, RT | 1 |
Ehrich, JH; Henne, T; Latta, K; Offner, G; Pape, L; Strehlau, J | 1 |
Russell, JH; Tripp, CS; Yu, JJ | 1 |
Gürer, MA; Oztas, P | 1 |
Cohen, EJ; Laibson, PR; Nagra, PK; Rapuano, CJ | 1 |
Kamm, MA | 1 |
Kahan, BD | 2 |
Abe, Y; Choi, I; Inaba, S; Matsushima, T; Muta, K; Nagasawa, E; Nawata, H; Nishimura, J; Ohtsuka, R; Tachikawa, Y | 1 |
Alonso, A; Gómez, JA; Malagelada, JR; Molero, X; Salas, A; Vaquero, E | 1 |
Dorta, S; Escoda, M; Fagundo, E; García-Bustínduy, M; García-Montelongo, R; Guimerá, FJ; Noda-Cabrera, A; Sáez, M; Sánchez-González, R | 1 |
Ponticelli, C | 1 |
Hoffmann, U; Krämer, BK; Pietrzyk, M | 1 |
Fellström, B | 1 |
Busauschina, A; Schnuelle, P; van der Woude, FJ | 1 |
Cattaneo, D; Gaspari, F; Perico, N; Remuzzi, G | 1 |
Mihatsch, MJ; Morozumi, K; Takeda, A; Uchida, K | 1 |
Burdelski, MM | 1 |
Parekh, K; Patterson, GA; Trulock, E | 1 |
Aubert, JD; Auterith, A; Böttcher, H; Chaparro, C; Corris, P; Estenne, M; Gerbase, MW; Glanville, A; Klepetko, W; Knoop, C; Levvey, B; Niedermayer, J; Reichenspurner, H; Sarahrudi, K; Venuta, F; Verleden, G | 1 |
Finlay, AY; Lewis, JJ; Salek, MS; Sumner, MI | 1 |
Aschan, J; Larsson, K; Ljungman, P; Remberger, M; Ringdén, O; Winiarski, J | 1 |
Cardoni, RL; Ferraris, JR; Prigoshin, N; Tambutti, ML | 1 |
Bardy, P; Doherty, K; Grigg, A; Heatley, S; Hughes, T; Mullighan, C; Schwarer, A; Szabo, F; Szer, J; Tait, B; To, B | 1 |
Andoh, TF; Bennett, WM; Choi, SO; Shihab, FS; Yi, H | 1 |
Bérard, F; Hequet, O; Kaiserlian, D; Nicolas, JF; Saint-Mézard, P; Vocanson, M | 1 |
Baczkowski, AJ; Hammad, AQ; Newstead, CG; Owens, G; Paraoan, M; Stoves, J | 1 |
Huang, YG; Jie, YL; Liu, CZ; Tan, JX; Wang, Y | 1 |
Baskan, EB; Saricaoglu, H; Tunali, S; Turker, T | 1 |
Atsuta, Y; Emi, N; Hamajima, N; Hirabayashi, N; Hiraoka, A; Iwato, K; Kanda, Y; Kato, S; Naoe, T; Okamoto, S; Sakamaki, H; Takahashi, S; Tanimoto, M; Tanosaki, R; Yanada, M | 1 |
Bonvoisin, SC; Cenni, JC; Descos, L; Flourié, B; Moussata, D; Nancey, S | 1 |
Ejiri, M; Hara, S; Harima, A; Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
Aroldi, A; Banfi, G; Campise, MR; Cesana, BM; Montagnino, G; Passerini, P; Ponticelli, C | 1 |
Natarajan, S; Sinha, A; Velangi, S | 1 |
Baelde, HJ; Bruijn, JA; de Heer, E; Eikmans, M; Ijpelaar, DH | 1 |
Baelde, HJ; Bakker, RC; Bruijn, JA; de Heer, E; Eikmans, M; Koop, K; Paul, LC | 1 |
Chen, Y; Chiang, YJ; Chu, SH; Lai, WJ | 1 |
Arias, M; Campistol, JM; García, J; Gómez, JM; Grinyó, JM; Gutiérrez, JA; Henriques, AC; Morales, JM; Mota, A; Pinto, JR; Prats, D; Ruiz, JC | 1 |
Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M | 1 |
Caruso, M; Codreanu, I; Perico, N; Remuzzi, G | 1 |
Cho, WY; Jo, SK; Kim, HK; Lee, SY; Won, NH | 1 |
Bodian, CA; Griepp, RB; Haldenwang, PL; Spielvogel, D; Strauch, JT; Tatton, NA; Weisz, D; Zhang, N | 1 |
Li, C; Lim, SW; Sun, BK; Yang, CW | 1 |
Enosawa, S; Fukuchi, K; Hakamata, Y; Iwanami, S; Kaneko, T; Kishi, T; Kobayashi, E; Kudou, S; Kuriyama, K; Matsumoto, K; Morishita, Y; Murakami, T; Shimizu, H; Takahashi, M; Takeyoshi, I; Yasue, T | 1 |
Coombes, JD; Couser, WG; Pippin, JW; Rangan, GK | 1 |
Blancho, G; Cantarovich, D; Dantal, J; Giral-Classe, M; Hourmant, M; Karam, G; Megnigbeto, A; Renou, M; Soulillou, JP | 1 |
Pleyer, U; Schmidt, S | 1 |
Bédard, EL; Buelow, R; Chakrabarti, S; Garcia, B; Jiang, J; Kim, P; Liu, W; Parry, N; Wang, H; Zhong, R | 1 |
Chang, CT; Hung, CC; Wu, MS | 1 |
Pleyer, U | 1 |
Bogunia-Kubik, K; Lange, A; Mlynarczewska, A; Wysoczanska, B | 1 |
Griffiths, CE; Naldi, L | 1 |
Becker, B; Djamali, A; Holzmacher, R; Jaffery, J; Kendziorski, C; Michael Hofman, R | 1 |
Legendre, Ch; Mourad, G; Rostaing, L | 1 |
Cleven, HA; Genden, EM; Moran, TM | 1 |
Lindley, KJ; Milla, PJ; Ramsay, AD; Shah, N; Thapar, N | 1 |
Joseph, K; Kaplan, AP; Marsland, AM; Soundararajan, S | 1 |
Daniel, V; Dietrich, H; Ernst, W; Feuring, E; Kamali-Ernst, S; Opelz, G; Padberg, W; Pelzl, S; Renner, F; Staak, A; Streller, S; Süsal, C; Weimer, R; Yildiz, S | 1 |
Chuhjo, T; Shiobara, S | 1 |
Bernier, C | 1 |
Bumbea, V; Durand, D; Esposito, L; Guitard, J; Kamar, N; Modesto, A; Nasou, G; Ribes, D; Rostaing, L | 1 |
de Las Heras-Castaño, G; Domínguez-Diez, A; Fernández-Fernández, F; Fernández-González, MD; García-de la Paz, AM; García-Unzueta, MT; Mayorga-Fernández, M | 1 |
Hirata, K; Odaka, M; Susuki, K; Tatsumoto, M; Yuki, N | 1 |
Brunet, S; Caballero, MD; Carreras, E; de León, A; del Cañizo, MC; Díez-Campelo, M; López-Fidalgo, J; Martino, R; Pérez-Simón, JA; San Miguel, JF; Sierra, J; Urbano, A; Valcárcel, D | 1 |
Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE | 1 |
Adam, RL; Alborghetti, MR; Cintra, ML; Coracin, FL; Corrêa, ME; de Souza, CA; Metze, K | 1 |
Clark, G; Kerecuk, L; Taylor, J | 1 |
Becker, BN; Hullett, DA; Laeseke, PF; Malin, G; Nessel, R; Sollinger, HW | 1 |
Dong, X; Lin, P; Shi, W; Wang, S; Xie, L; Yuan, G | 1 |
Asselman, M; D'Haese, PC; De Broe, ME; De Naeyer, S; Gwinner, W; Mengel, M; Verhulst, A; Verkoelen, CF; Vervaet, BA | 1 |
Ahn, C; Ahn, KO; Kim, J; Lee, JR; Li, C; Lim, SW; Moon, IS; Yang, CW | 1 |
Latham, CW; Margolin, SB; Visner, GA; Zander, DS; Zhou, H | 1 |
Ashra, SY; Bowley, L; Imtiaz, S; Jain, S; Nicholson, ML; Pawluczyk, IZ; Yang, B | 1 |
Clausen, JT; Funding, AT; Iversen, L; Kragballe, K; Noerby, PL; Otkjaer, K; Steiniche, T | 1 |
Anthuber, M; Farkas, S; Geissler, EK; Guba, M; Herfarth, H; Hornung, M; Sattler, C; Schlitt, HJ; Steinbauer, M | 1 |
Aplenc, R; Bunin, N; Grupp, S; Monos, D; Pierson, G | 1 |
Hashmi, K | 1 |
Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ | 1 |
Burckart, GJ; Corcoran, TE; Dauber, JH; Fung, JJ; Grgurich, WF; Griffith, BP; Iacono, AT; Johnson, BA; McCurry, KR; Seiler, DA; Smaldone, GC; Yousem, SA; Youssef, JG; Zeevi, A | 1 |
DeCamp, MM | 1 |
Ekberg, H; Hedner, U; Osterholm, C; Simanaitis, M; Veress, B | 1 |
Imai, M; Sabbah, HN; Sharov, VG; Todor, AV | 1 |
Fricke, L; Jabs, WJ; Meier, M; Nitschke, M; Steinhoff, J; Suefke, S; Weidtmann, B; Wong, W | 1 |
Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT | 1 |
Al-Aly, Z; Bastani, B; Philoctete Ashley, JM; Sachdeva, A | 1 |
Fujinaga, S; Kaneko, K; Murakami, H; Muto, T; Ohtomo, Y; Yamashiro, Y | 1 |
Cernelc, P; Zupan, IP; Zver, S | 1 |
Atanackovic, D; Ayuk, F; Kröger, N; Renges, H; Schieder, H; Zabelina, T; Zander, A | 1 |
Chapman, JR; Nankivell, BJ | 1 |
Jin, J; Su, AL; Xu, YL; Zhang, L; Zhang, XQ; Zhang, XZ | 1 |
Daudén, E; Delgado-Jiménez, Y; García-Díez, A; García-Río, I; Pedraz, J | 1 |
Chan, KW; Chan, TM; Ho, YW; Lai, KN; Lam, MF; Leung, CY; Li, CS; Tang, CS; Tang, SC; Tong, MK; Tse, KC | 1 |
Da Cruz, CA; Do Nascimento, JL; Salgado, CG; Sena, CB; Tavares, CM; Xavier, MB | 1 |
Andoh, TF; Bennett, WM; Shihab, FS; Yi, H | 3 |
Wieczorek, D | 1 |
Cao, G; Gao, R; Li, X; Li, Y; Lu, Y; Teng, D; Wang, J; Wang, L; Xin, Y | 1 |
Cassano, N; Colombo, D; Peruzzi, E; Pigatto, P; Vena, GA | 1 |
Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S | 1 |
Barkholt, L; Hassan, Z; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Sairafi, D; Uzunel, M | 1 |
Perry, HD; Wilson, SE | 1 |
Ertl, HC; Lederman, MM; Margolis, DM; Medvik, K; Pollard, R; Pu, M; Rodriguez, B; Sevin, A; Sieg, SF; Smeaton, L; Smith, KY; Tebas, P; Valdez, H; Wang, H | 1 |
Altuntas, F; Cetin, M; Eser, B; Fen, T; Ferahbas, A; Kocyigit, I; Ozturk, A; Sari, I; Sisman, Y; Unal, A | 1 |
Chalermsanyakorn, P; Changsirikulchai, S; Lothuvachai, T; Sumethkul, V | 1 |
Buzyn, A; Combe, C; Delmas, Y; Fakhouri, F; Glowacki, F; Hummel, A; Knebelmann, B; Lesavre, P; Maillard, N; Noël, LH; Nusbaum, S; Patey-Mariaud de Serre, N; Presne, C; Radford, I; Terrier, B | 1 |
Alò, D; Bosc, LV; de Frutos, S; Spangler, R | 1 |
Fukaya, T; Harigaya, H; Iwata, A; Matsubara, K; Nigami, H; Nozaki, H; Tanaka, T; Yura, K | 1 |
Crosson, JT | 1 |
Trivedi, HL; Vanikar, AV | 1 |
Holler, E | 1 |
Kawa, K; Kimura, M; Nakayama, M; Sakata, N; Takemura, T; Toguchi, N | 1 |
Moussatou, V; Papadakis, P; Rallis, E; Sambaziotis, D; Verros, C | 1 |
Jurgutis, M; Kriukelyte, I; Priluckiene, J; Trociukas, I | 1 |
Gu, M; Liu, M; Lv, Q; Xu, D; Yin, C; Zhang, W; Zhang, WY | 1 |
Lipozencić, J; Ljubojević, S | 1 |
Mostafavi-Pour, Z; Vessal, M; Zal, F | 1 |
Gu, M; Liu, M; Wu, Y; Yin, C; Zhang, W; Zhu, P | 1 |
Inagaki, K; Koyanagi, T; Mochly-Rosen, D; Noguchi, K; Ootani, A; Robbins, RC | 1 |
Gottlieb, AB; Lozano, AM; Magliocco, MA; Schuler, KW; Van Saders, C | 1 |
Warren, JW | 1 |
Brown, SM | 1 |
Limat, S; Raymond, S; Woronoff-Lemsi, MC | 1 |
Avgoustinaki, N; Chaidemenos, GC; Karakatsanis, G; Katsambas, A; Mourellou, O; Papakonstantinou, M | 1 |
Bellisai, F; Galeazzi, M; Giannitti, C; Manganelli, S; Morozzi, G; Sebastiani, GD | 1 |
Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T | 1 |
Dogru, M; Fujishima, H; Igarashi, A; Kawai, M; Kujira, A; Ogawa, Y; Okada, N; Okamoto, S; Shimazaki, J; Tatematsu, Y; Tsubota, K; Uchino, M; Wang, Y | 1 |
Abbate, M; Casiraghi, F; Cattaneo, D; Conti, S; Cravedi, P; Cugini, D; D'Agati, V; Gagliardini, E; Gaspari, F; Gotti, E; Noris, M; Perico, N; Remuzzi, G; Ruggenenti, P; Todeschini, M | 1 |
de Hertogh, G; Dewit, S; Geboes, K; Tack, J | 1 |
Azordegan, N; Fischer, G; Jassal, DS; Le, K; Moghadasian, MH; Othman, RA; Riediger, N; Suh, M | 1 |
De Paiva, CS; Pflugfelder, SC; Stern, ME; Villarreal, AL | 1 |
Deuse, T; Hoyt, G; Koyanagi, T; Robbins, RC; Schrepfer, S | 1 |
Birnbaum, F; Böhringer, D; Reinhard, T | 1 |
Jansson, L; Karlsson, A; Karlsson, L; Melgar, S; Michaëlsson, E; Rehnström, E; Utkovic, H | 1 |
Akcali, C; Kirtak, N; Ozturk, S; Serhat Inaloz, H; Tarakcioglu, M | 1 |
Al-Hazzouri, A; Burns, LJ; Cao, Q; Majhail, NS; Weisdorf, DJ | 1 |
He, F; Luo, ZM; Ma, L; Tong, JR; Wang, Y | 1 |
Bang, BK; Chang, YS; Kim, YS; Koh, YB; Yang, CW; Yoon, SA; Yoon, YS | 1 |
Jindal, RM; Popescu, I | 1 |
Krasnova, TN; Miroshnichenko, NG; Mukhin, NA; Shilov, EM; Tareeva, IE | 2 |
Busuttil, RW; Klintmalm, GB; McDiarmid, SV | 1 |
Brinkmann, C; Buhr, T; Jost, U; Melter, M; Pichlmayr, R; Ringe, B; Rodeck, B; Winkler, M | 1 |
Banner, B; Demetris, AJ; Langrehr, JM; Lee, KK; Lee, TK; Müller, AR; Schraut, WH; Thalmann, U | 1 |
Calmus, Y | 1 |
Bechstein, WO; Blumhardt, G; Lobeck, H; Mueller, AR; Neuhaus, P; Platz, KP; Zytowski, M | 1 |
Fukata, Y; Okudaira, H; Suehiro, S; Yago, H; Yamamoto, K; Yanagihara, Y; Yoshii, H | 1 |
Bolman, RM | 1 |
Alpers, CE; Andoh, T; Bennett, WM; Burdmann, EA; Couser, WG; Johnson, RJ; Young, BA | 1 |
Blume, KG; Chao, N; Forman, SJ; Kashyap, A; Long, GD; Margolin, K; Molina, A; Nademanee, A; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Planas, I; Schmidt, GM; Smith, EP; Snyder, DS; Somlo, G; Spielberger, R; Stein, AS; Stepan, DE; Wilsman, K; Zwingenberger, K | 1 |
Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
Asakawa, J; Fukuda, T; Makino, S; Motojima, S | 1 |
Beneyto, I; Crespo, J; Pallardó, LM; Puig, N; Rochera, A; Ros, F; Sánchez, J; Sánchez, P | 1 |
Feutren, G; Modigliani, R; Peña, AS; Smith, PR; Stange, EF; Wood, AJ | 1 |
Gajardo, J; Villaseca, J | 1 |
Ali, NM; Allende, MC; Bacher, J; Berenguer, J; Garrett, K; Lee, JW; Lyman, C; Pizzo, PA; Walsh, TJ | 1 |
Castillo Palma, MJ; Chinchón Lara, I; Ocaña Medina, C; Sánchez Román, J; Segura Ayestarán, DI; Wichmann, I | 1 |
Backman, L; Gibbs, JF; Goldstein, RM; Gonwa, TA; Holman, MJ; Husberg, BS; Klintmalm, GB; Levy, M; McMillan, R; Morris, C | 1 |
Ascher, NL; Goldstein, R; Gonwa, T; Klintmalm, GB; Krom, RA; Lake, J; Roberts, JW; Shaw, BW; Stratta, R; Wiesner, RH | 2 |
Backman, L; Gibbs, JF; Goldstein, RM; Gonwa, TA; Holman, MJ; Husberg, BS; Klintmalm, GB; Levy, M; McMillan, R | 1 |
Jost, U; Pichlmayr, R; Ringe, B; Rodeck, B; Winkler, M | 1 |
Enomoto, N; Hirata, R; Ishiwata, N; Koyama, N; Marumo, F; Noguchi, O; Sakamoto, H; Sato, C; Tanaka, Y | 1 |
Castillo Palma, MJ; Ocaña Medina, C; Rodríguez Cañas, T; Sánchez Román, J | 1 |
Gallo, R; Guarrera, M; Parodi, A; Rebora, A | 1 |
Baron, E; Duffaut, M; Durand, D; Izopet, J; Puel, J; Rostaing, L | 1 |
Belghiti, J; Benhamou, JP; Bernuau, JR; Degott, C; Durand, F; Erlinger, S; Gadano, AC; Marcellin, P; Martinot-Peignoux, M; Mosnier, JF | 1 |
Langendijk, PN; Nieboer, C; Schulten, EA; van der Waal, I; Voûte, AB | 1 |
Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G | 1 |
De Caterina, R | 1 |
Cherqui, D; Dhumeaux, D; Duvoux, C; Fagniez, PL; Julien, M; Lauzet, JY; Metreau, JM; Salvat, A | 1 |
Azuma, H; Hancock, WW; Heemann, UW; Pradham, P; Tilney, NL; Tullius, SG | 1 |
Bailey, RR; Gardner, J; Yuan, ZF | 1 |
Ellis, J; Seymour, RA; Thomason, JM | 1 |
Almond, MK; Cunningham, J; Kelsey, SM; Tailor, D | 1 |
Battaglia, D; Fahmy, H; Solez, K; Trpkov, K | 1 |
Malinowska, J | 1 |
Bolman, RM; Hertz, MI; Kubo, SH; Matas, AJ; Reinsmoen, NL | 1 |
Benediktsson, H; Chea, R; Davidoff, A; Paul, LC | 1 |
Byer, B; Cerilli, GJ; Kremer, M; McKenna, BA; Pabico, RC; Yarger, J | 1 |
Binetti, G; Ferrazzi, P; Fiocchi, R; Gamba, A; Mamprin, F; Merlo, M; Motta, T; Parma, A; Senni, M; Troise, G | 1 |
Alberti, A; Bellati, G; Belli, LS; De Carlis, L; Fesce, E; Ideo, G; Romani, F; Rondinara, GF; Sansalone, CV; Zavaglia, C | 1 |
Antin, JH; Bierer, BE; Fruman, DA; Leong, T; McGarigle, C; Neuberg, D; Pai, SY; Rosano, TG | 1 |
Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K | 1 |
Beelen, DW; Liedtke, W; Quabeck, K; Schaefer, UW; Straeten, V | 1 |
Komorowski, R; McManus, RP; O'Hair, DP | 1 |
Jones, AR; Poon, MC; Ruether, BA; Russell, JA; Woodman, RC | 1 |
Bagot, M; Binderup, L; Charue, D; Dubertret, L; Grossman, R; Pamphile, R; Revuz, J | 1 |
Barkworth, E; Cope, GH; el Nahas, A; Raftery, AT; Shehata, M | 1 |
Bitter-Suermann, H; Lee, T; MacAuley, MA; MacDonald, AS; McAlister, VC; Sabr, K | 1 |
Brock, J; Chadimová, M; Havlícková, J; Lácha, J; Lehmann, M | 1 |
Brenchley, PE; Coupes, BM; Newstead, CG; Short, CD | 1 |
Luke, RG | 1 |
Solez, K | 1 |
Azuma, H; Brenner, BM; Heemann, UW; Mackenzie, HS; Tilney, NL; Tullius, SG | 1 |
Choi, IJ; Jeong, HJ; Kim, YS; Oh, CK; Park, K | 1 |
Bartucci, MR | 1 |
DeLaat, C; Desantes, K; Friedman, DJ; Kohli-Kumar, M; Masterson, M; Morris, C; Mueller, R; Sambrano, J; Shahidi, NT; Yanik, G | 1 |
Johnson, RB; Odlum, O; Pylypas, SP; Zebrowski, EJ | 1 |
Gajardo, J | 1 |
Duncan, JI; Ormerod, AD; Thomson, AW; Wakeel, RA; Winfield, AJ | 1 |
Feldmann, R; Masgrau-Peya, E; Mesheit, J; Salomon, D; Saurat, JH | 1 |
Auchincloss, H; Bazari, H; Cosimi, AB; Delmonico, FL; Fang, LT; Farrell, ML; Tolkoff-Rubin, N; Williams, WW | 1 |
Andolina, M; Arcese, W; Dini, G; Locatelli, F; Messina, C; Miniero, R; Porta, F; Rovelli, A; Uderzo, C; Zecca, M | 1 |
Abeywickrama, KH; Abi-Rached, J; Dubertret, L; Grossman, R; Laburte, C | 1 |
Friedmann, PS; Levell, NJ; Munro, CS; Shuster, S | 1 |
Cattran, D; Katz, A; Murphy, GF; Pei, Y; Schachter, R; Scholey, JW | 1 |
Burke, JF; DeVault, GA; Matas, AJ; Monaco, A; Pirsch, JD | 1 |
Aresu, G; Barca, L; Frongia, T; Pascalis, L; Pia, G | 1 |
Parkman, R | 1 |
Holzer, H; Horina, JH; Kenner, L; Krejs, GJ; Wirnsberger, GH | 1 |
Anutrakulchai, S; Fornell, LC; John, EG; Jonasson, O; Radhakrishnan, J | 1 |
Granlund, H; Reitamo, S | 1 |
Masouyé, I; Salomon, D; Saurat, JH | 1 |
Aikawa, A; Bakran, A; Davies, HM; Johnson, PM; McDicken, IW; McLaughlin, PJ; Sells, RA; Southern, SA | 1 |
Bungey, J; Cross, NC; Feng, L; Ferrant, A; Goldman, JM; Hughes, TP; Marks, DI; Martiat, P; O'Shea, P | 1 |
Dopfer, R; Meier, F; Rassner, G; Schaumburg-Lever, G; Sönnichsen, K | 1 |
Cooper, HS; Ibrahim, SA; Murthy, SN; Sedergran, DJ; Shah, RS; Shim, H | 1 |
Gijbels, MJ; HogenEsch, H; Offerman, E; van Bekkum, DW; van Hooft, J; Zurcher, C | 1 |
Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
Casadevall, N; Lacombe, C; Varet, B | 1 |
Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
Batchelor, JR; Braun, MY; McCormack, A; Webb, G | 1 |
Belitsky, P; Gulanikar, A; Gupta, R; He, G | 1 |
Magnussen, H | 1 |
Williams, D | 1 |
Noble, B; Ren, K; Van Liew, JB | 1 |
Gudat, F; Mihatsch, MJ; Ryffel, B | 1 |
Beckingham, IJ; Bishop, MC; Burden, RP; Dennis, MJ; Innes, A; Morgan, AG | 1 |
Beckingham, IJ; Blamey, RW; Dennis, MJ | 1 |
Almond, PS; Dunn, DL; Gillingham, K; Gores, P; Gruessner, R; Matas, A; Najarian, JS; Payne, WD | 1 |
Lauricella, M; Riarte, A; Segura, EL; Sinagra, A | 1 |
Ishibashi, M; Kameoka, H; Kokado, Y; Moutabarrik, A; Okuyama, A; Sonoda, T; Takahara, S; Takano, Y; Zaid, D | 1 |
Cacciarelli, TV; Daskalakis, P; Georgi, B; Goldberg, K; Hong, JH; Miles, AM; Sommer, BG; Sumrani, N | 1 |
Kaan, G; Ozden, O | 1 |
Häyry, P; Kallio, E; Rapola, J; Yilmaz, A; Yilmaz, S | 1 |
de Bruin, R; Dowling, J; Jablonski, P; Stein-Oakley, A; Thomson, N | 1 |
Bedard, C; Bredfeldt, J; Brentnall, T; Gelfand, M; Greene, M; Justus, P; Kozarek, R; Patterson, D; Putnam, W; Sandford, R | 1 |
Barnett, KC; Read, RA; Sansom, J | 1 |
Foster, CS; Rodriguez, A; Vitale, AT | 1 |
Alberti, D; de Ville de Goyet, J; Falchetti, D; Otte, JB; Panzali, A; Reding, R; Rigamonti, W; Sokal, E; Wallemacq, P | 1 |
Burckart, GJ; Dauber, JH; Delgado, E; Duncan, SR; Grgurich, WF; Griffith, BP; Iacono, AT; Keenan, RJ; O'Riordan, TG; Ohori, NP; Paradis, IL; Smaldone, GC; Yousem, SA; Zeevi, A; Zendarsky, MM | 1 |
Bechstein, WO; Bismuth, H; Calne, R; Ericzon, BG; McMaster, P; Neuhaus, P; Otto, G; Pichlmayr, R; Williams, R | 1 |
Conway, P; Madras, PN; Monaco, AP; Shaffer, D; Simpson, MA; Washburn, WK | 1 |
Hullett, DA; Little, DM; Sollinger, HW; Stoltenberg, RL | 1 |
Jordan, SC; Kass, RM; Koerner, SK; Nathan, SD; Ross, DJ | 1 |
Bible, KC; Tefferi, A | 1 |
Benediktsson, H; Cavallo, T; Croker, B; Demetris, AJ; Drachenberg, C; Emancipator, S; Furness, PN; Gaber, LW; Gibson, IW; Gough, J; Gupta, R; Halloran, P; Häyry, P; Kashgarian, M; Marcussen, N; Massy, ZA; Mihatsch, MJ; Morozumi, K; Noronha, I; Olsen, S; Papadimitriou, J; Paul, LC; Picken, M; Racusen, LC; Ramos, EL; Randhawa, P; Rayner, DC; Rush, D; Sanfilippo, F; Solez, K; Taskinen, E; Trpkov, K; Truong, L; Yamaguchi, Y; Yilmaz, S | 1 |
Häyry, P; Isoniemi, H; Taskinen, E; Yilmaz, S | 1 |
Endo, T; Irie, A; Koshiba, K; Kumano, K; Mashimo, S | 1 |
Akiyama, T; Kanda, H; Kurita, T; Nagano, T; Uemura, T | 1 |
Joo, I; Kim, HC; Kwon, JK; Park, SB; Suk, J | 1 |
Esato, K; Fujimura, Y; Gohra, H; Hamano, K; Ito, H; Katoh, T; Shirasawa, B; Suzuki, K; Tsuboi, H | 1 |
Andoh, TF; Bennett, WM; Border, WA; Franceschini, N; Noble, NA; Shihab, FS; Tanner, AM | 1 |
Hoey, AJ; Smitherman, P; Williams, DL | 1 |
Beckmann, N; Bruttel, K; Joergensen, J; Rudin, M; Schuurman, HJ | 1 |
Ishikawa, O; Miyachi, Y; Okada, K | 1 |
Kim, JY; Suh, KS | 1 |
Andoh, T; Barry, JM; Bennett, WM; DeMattos, A; Meyer, MM | 1 |
First, MR; Hariharan, S; Schroeder, TJ; Shah, M | 1 |
Andoh, TF; Bennett, WM; Franceschini, N; Lindsley, J | 1 |
Guijarro, C; Kasiske, BL; Ma, JZ; Massy, ZA; Wiederkehr, MR | 1 |
Kahan, BD; Katz, SM; Rutzky, LP; Schoenberg, L; Urbauer, DL; Van Buren, CT; Welsh, M | 1 |
Bruggeman, CA; Häyry, PJ; Kallio, E; Koskinen, PK; Lemström, KB; Yilmaz, S | 1 |
Takahashi, K; Tanabe, K; Toma, H | 1 |
Berth-Jones, J | 1 |
Gerrits, PO; Lijnema, TH; Loof, JG; Minderhoud, JM; Nieuwenhuis, P; Teelken, AW; Trooster, WJ | 1 |
Eriksson, E; Erkko, P; Granlund, H; Reitamo, S | 1 |
Derouin, F; Garin, YJ; Sumyuen, MH | 1 |
Flechner, SM; Goldfarb, DA; Goormastic, M; Mastroianni, B; Modlin, CS; Novick, AC; Papajcik, D; Serrano, DP | 1 |
Bennett, WM | 2 |
Balk, AH; Claas, FH; Knoop, CJ; Mochtar, B; Vaessen, LM; van Besouw, NM; Weimar, W | 1 |
Bechstein, WO; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Nüssler, N; Platz, KP; Schumacher, G; Tullius, SG | 1 |
André, JL; Bensman, A; Bouissou, F; Cochat, P; Fischbach, M; Foulard, M; Guignard, JP; Guyot, C; Janssen, F; Loirat, C; Nguyen, JM; Nivet, H; Van Damme-Lombaerts, R | 1 |
Koskinen, PK; Lemström, KB | 1 |
Ho, V; Lui, H; Shapiro, J; Tron, V | 1 |
Chiba, S; Haseyama, K; Katoh, S; Kudoh, T; Oda, T; Suzuki, N; Watanabe, J | 1 |
Erkko, P; Granlund, H; Reitamo, S | 1 |
Farriaux, JP; Gottrand, F; Launay, V; Masy, E; Michaud, L; Turck, D | 1 |
Fujikawa, H; Kako, M; Miyakawa, H; Nagai, K | 1 |
de Smet, MD; Nussenblatt, RB; Ramadan, AM | 1 |
Chandraker, A; Glysing-Jensen, T; Russell, ME; Sayegh, MH; Willett, TA | 1 |
Abhyankar, SH; Armstrong, W; Godder, K; Henslee-Downey, PJ; Lamb, LS; Pati, AR | 1 |
Beckingham, IJ; Bishop, MC; Hinwood, M; O'Rourke, JS; Rigg, KM; Stubington, SR | 1 |
Blant, A; Golan, TD; Kessel, A; Toubi, E | 1 |
Berth-Jones, J; Boffa, MJ; Chalmers, RJ; Dowd, PM; Friedmann, PS; Graham-Brown, RA; Henderson, CA; Marks, R; Munro, CS; Norris, PG; Rogers, S; Sumner, MJ | 1 |
Choi, YS; Kim, DH; Kim, DO; Kim, KW; Kim, YS; Lee, BK; Lee, JC; Park, JN; Rim, H | 1 |
Kim, YJ; Moon, HK; Park, YH | 1 |
Alexander, JW; First, MR; Hariharan, S; Ogle, CK; Peddi, VR; Schroeder, TJ; Valente, JF | 1 |
Harrison, D; Holland, BK; Holman, MJ; Ippolito, T; Koneru, B; Leevy, CB; Rizwan, M | 1 |
Cadranel, JF; Di Martino, V; Erlinger, S | 1 |
Herout, V; Konecný, K; Kovác, A; Lánská, V; Matl, I; Matousovic, K; Roland, R; Rychlík, I; Sobotová, D; Zdichyncová, I | 2 |
Buelow, R; Hancock, WW; Kim, KS; Murphy, B; Sayegh, MH | 1 |
Ahonen, JP; Isoniemi, HM; Lehtonen, SR; Salmela, KT; Taskinen, EI; von Willebrand, EO; vWillebrand, EO | 1 |
Bechstein, WO; Graser, E; Jonas, S; Neuhaus, P; Nieminen, M; Pratschke, J; Steinmüller, T; Tullius, SG; Volk, HD; Zeilinger, K | 2 |
Aranzasti, C; Eder, F; Mendicute, J; Ostolaza, JI; Salaberria, M | 1 |
Heemann, U; Schmid, C; Tilney, NL | 1 |
Ahonen, J; Bruggeman, C; Kauppinen, H; Krogerus, L; Lautenschlager, I; Saarinen, O; Soots, A | 1 |
Hishida, A; Matsushima, H | 1 |
Iida, S; Kagami, Y; Miura, K; Morishima, Y; Nakamura, S; Ogura, M; Seto, M; Suzuki, R; Taji, H; Yatabe, Y | 1 |
Baumhefner, RW; Ellison, GW; Ke, D; Myers, LW; Syndulko, K; Tourtellotte, WW | 1 |
Agostini, HT; Baumhefner, RW; Ryschkewitsch, CF; Stoner, GL; Tourtellotte, WW | 1 |
Billingham, ME; Hoyt, EG; Pollard, J; Poston, RS; Robbins, RC | 1 |
Ghandour, FZ; Hricik, DE; Knauss, TC; Mulligan, DC; Schulak, JA | 1 |
Aquino, A; Carr, J; Currier, CB; Ghasemian, SR; Light, JA; Rees, J; Sasaki, T; Ward, W | 1 |
Ahonen, J; Krogerus, L; Lautenschlager, I; Saarinen, O; Soots, A | 1 |
Aguilar, M; Andujar, M; Arrebola, F; del Moral, RG; García-Chicano, MJ; Gómez-Morales, M; Guillén, M; Masseroli, M; Nogales, FF; O'Valle, F; Olmo, A; Ramírez, C | 1 |
Haridas, V; Kamat, RS | 1 |
Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S | 1 |
Anderson, L; Bartlett, ST; Cangro, CB; Fink, JC; Gabregiorgish, K; Hoehn-Saric, E; Johnson, LB; Klassen, DK; Kuo, PC; Lim, JY; Schweitzer, EJ; Weir, MR | 1 |
Chikkappa, G; DaSilva, K; Lansing, L; Pasquale, D; Tsan, MF; Vidhya, R | 1 |
Ashton, P; Cousins, SW; Gallemore, RP; Jaffe, GJ; Wang, XC; Yang, CS | 1 |
Azim, M; Dick, AD; Forrester, JV | 1 |
Davis, JH; Hand, JP; Lawlor, ER; Yong, CK | 1 |
Andrade, SG; Andrade, ZA; Carneiro Filho, A; de Lima, ES; de Souza, AJ | 1 |
Mimran, A; Mourad, G; Ribstein, J; Vela, C | 1 |
Barnett, MH; Davies, L; McLeod, JG; Pollard, JD | 1 |
Badia, P; Gil, R; Giraud, C; Hauet, T; Pourrat, O; Robert, R | 1 |
Choi, KS; Chung, IJ; Hwang, TJ; Kim, HJ; Kook, H; Lee, JJ; Park, MR; Seo, JS | 1 |
La Manna, A; Marte, A; Papale, MR; Polito, C; Rocco, CE | 1 |
Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
Krajewska-Kułak, E; Niczyporuk, W | 1 |
Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
Albrecht, KH; Becker, G; Delfs, M; Heemann, U; Müller, V; Philipp, T | 1 |
Bakalska, M; Deleva, D; Filchev, N; Zaprianova, E | 1 |
Andoh, TF; Bennett, WM | 1 |
Poston, RS; Reitz, BA; Robbins, RC; Teranishi, K | 1 |
Bechstein, WO; Jonas, S; Neuhaus, P; Nieminen, M; Qun, Y; Rayes, N; Tullius, SG; Volk, HD | 1 |
Vanrenterghem, Y | 1 |
Adham, M; Aljuaid, N; Baulieux, J; Berthoux, N; Bizollon, T; Chevallier, M; Delaroche, E; Ducerf, C; Taibi, A | 1 |
Akan, H; Anadolu, R; Arat, M; Beksaç, M; Demirer, T; Dilek, I; Erdi, H; Ilhan, O; Koç, H; Ozcan, M; Ustün, C | 1 |
Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kirsten, D; Römer, E; Rudolphi, M; Sanchez, H | 1 |
Flowers, ME; Longton, G; Schubert, M; Storb, R; Sullivan, KM; Wagner, JL | 1 |
Glicklich, D; Greenstein, SM; Gupta, B; Schechner, RS; Schurter-Frey, G; Tellis, VA | 1 |
Bechstein, WO; Egermann, F; Jonas, S; Neuhaus, P; Nieminen, M; Pratschke, J; Qun, Y; Reutzer-Selke, A; Tullius, SG; Volk, HD | 1 |
Campbell, A; Ditkoff, BA; Estabrook, A; Kurtz, E; Moazami, N; Schnabel, F | 1 |
Dauwe, SE; De Broe, ME; Deng, JT; Duymelinck, C; Verpooten, GA | 1 |
Brenot, R; Charvre, P; David, M; Eicher, JC; Gomes, MC; Tatou, E | 1 |
Koo, J | 1 |
Blinder, L; Chong, AS; Foster, P; Huang, W; Jensik, S; Liu, W; McChesney, L; Mital, D; Sankary, H; Shen, J; Williams, JW; Xiao, F | 1 |
Boulland, ML; Calmus, Y; Chereau, C; Conti, F; Dousset, B; Leroy-Viard, K; Soubrane, O; Weill, B | 1 |
De Laey, JJ; Demeulemeester, C; Hanssens, M; Meire, F | 1 |
Deleva, D; Filchev, A; Zaprianova, E | 1 |
Cosimi, AB; Ingelfinger, JR; Pascual, M; Swinford, RD; Tolkoff-Rubin, N; Williams, WW | 1 |
Aschan, J; Carlens, S; Hägglund, H; Klaesson, S; Ljungman, P; Lönnqvist, B; Mattsson, J; Remberger, M; Ringdén, O; Svahn, BM; Winiarski, J | 1 |
Chiewsilp, P; Jirasiritham, S; Kochakarn, W; Leenanupunth, C; Mavichak, V; Sumethkul, V | 1 |
Ando, Y; Beck, Y; Kikuchi, K; Meigata, K; Nishimura, Y; Nomura, Y; Tomikawa, S | 1 |
Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Rudolphi, M; Sanchez, H | 1 |
Krivoshchapov, LG; Pal'tseva, EM | 1 |
Dick, AD; Forrester, JV; Kilmartin, DJ | 1 |
Detry, O; Honoré, P; Jacquet, N; Meurisse, M | 1 |
Esato, K; Fujimura, Y; Hamano, K; Ito, H; Suzuki, K | 1 |
Akkoca, MA; Gürer, MA; Ilter, N | 1 |
Archimbaud, E; Belhabri, A; Fière, D; Guyotat, D; Michallet, M; Molina, L; Nicolini, F; Perrin, MC; Sotto, JJ; Tigaud, JD | 1 |
Kogure, K; Matsumoto, Y; Shin, T; Tanuma, N | 1 |
Eichler, HG; Fuchs, C; Koller-Strametz, J; Laufer, G; Mensik, C; Putz, D; Schmetterer, L; Wisser, W; Wolzt, M | 1 |
Balfour-Lynn, I | 1 |
Berquist, W; Cao, S; Castillo, RO; Concepcion, W; Cox, KL; Esquivel, CO; Frerker, M; Hammes, GB; Hayashi, M; Monge, H; Ojogho, OK; So, SK | 1 |
Seikaly, MG | 1 |
Hamar, P; Heemann, U; Müller, V; Philipp, T; Szabo, A; Vogelsang, M | 1 |
Calmus, Y; Conti, F; Gaulard, P; Houssin, D; Louvel, A; Rouer, E; Zafrani, ES | 1 |
Alekseeva, EI; Shakhbazian, IE | 1 |
Steer, ML | 1 |
Briegel, J; Deutsch, O; Fürst, H; Kur, F; Meiser, BM; Müller, C; Reichart, B; Reichenspurner, H; Schwaiblmair, M; Treede, H; Vogelmeier, C; Welz, A | 1 |
Carreño, MA; Cuchacovich, M; Gatica, H; Verdaguer, J; Verdaguer, JI; Villarroel, F | 1 |
Elpern, S; McFarland, H; Roca, CA; Rubinow, DR; Su, TP | 1 |
Allen, BR; Barker, JN; Chalmers, RJ; Clark, CM; Davison, S; Emerson, R; Griffiths, CE; Kirby, B; Morris, AD; Saihan, EM; Zaki, I | 1 |
Andres, A; Campistol, JM; Gomez de la Camara, A; Herrero, JC; Martinez, MA; Mazuecos, A; Morales, JM; Oppenheimer, F; Osuna, A; Segura, J | 1 |
Alonso, O; Gómez, R; González-Pinto, I; Loinaz, C; Moreno-González, E; Paseiro, G; Pérez-Saborido, B; Rodríguez, F; Rodríguez-Cañete, A | 1 |
Aavik, E; Buchdunger, E; Kallio, EA; Koskinen, PK; Lemström, KB | 1 |
Kimoto, K; Matsumoto, CS; Nakatsuka, K; Yatsuka, H | 1 |
Boran, M; Cetin, S; Gönenç, F | 1 |
Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
Aküyrek, LM; Backman, U; Fellström, B; Jonsson, C; Larsson, E; Tufveson, G; Wahlberg, J | 1 |
Imaizumi, M; Maseki, T; Teranishi, K; Usui, A; Watanabe, T; Yasuura, K | 2 |
Fuchinoue, S; Harano, M; Inui, M; Ishikawa, N; Kanematsu, A; Manu, MA; Oshima, T; Otsubo, S; Shinmura, H; Tanabe, K; Tokumoto, T; Toma, H | 1 |
Barthélemy, H; Bressieux, JM; Jan, V; Legoux, A; Reigneau, O; Steiner, HG; Vaillant, L | 1 |
Andoh, TF; Bennett, WM; Shihab, FS; Tanner, AM; Yi, H | 1 |
Anastopoulos, H; Sakoulas, G | 1 |
Csizmadia, V; Gao, W; Gerard, CJ; Hancock, WW; King, JA; Lu, B; Smiley, ST; Topham, PS | 1 |
Bennett, WM; de Mattos, AM; Olyaei, AJ | 1 |
de Bruin, RW; Dowling, J; Jablonski, P; Jin, XJ; Kouwenhoven, EA; Maguire, JA; Stein-Oakley, AN; Thomson, NM | 1 |
Fujinami, T; Koyama, K; Morozumi, K; Oikawa, T; Takeda, A; Takeuchi, O; Uchida, K | 1 |
Baker, CJ; Barr, ML; McLaughlin, SN; Rose, EA; Schenkel, FA; Starnes, VA; Stouch, BC | 1 |
Boyne, MS; Dye, KR | 1 |
Hamar, P; Heemann, U; Liu, S; Múller, V; Szabó, A; Viklický, O | 1 |
Belitsky, P | 1 |
Hatsumi, N; Karasawa, M; Matsushima, T; Miyawaki, S; Saito, T; Sakura, T; Takada, S; Tamura, J | 1 |
Boyle, TM; Hensler, H; Hosenpud, JD; Khanna, AK; Sanford, G | 1 |
Cicoira, L; Martinelli, V; Pane, F; Rotoli, B; Volpicelli, M | 1 |
Fiejka, E; Małdyk, J; Mizerska-Wasiak, M; Roszkowska-Blaim, M; Weglarska, J | 1 |
Foster, CS; Gion, N; Stavrou, P | 1 |
Benatuil, L; Parra, G; Quiroz, Y; Rincón, J; Rodríguez-Iturbe, B | 1 |
Baltzan, M; George, D; Shoker, A; Yang, H | 1 |
Barlow, RJ; Francis, DM; Grattan, CE; Greaves, MW; Kobza Black, A; Niimi, N; O'Donnell, BF; Seed, PT | 1 |
Bishay, E; Cook, DJ; Dennis, V; El Fettouh, HA; Flechner, S; Goldfarb, D; Modlin, C; Novick, AC | 1 |
Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
Brown, H; Fahmy, H; Halloran, PF; Iványi, B; Solez, K; Szenohradszky, P | 1 |
Benedetto, BJ; Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shaughnessy, J; O'Shea, MH | 1 |
Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Koc, S; Leisenring, W; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 2 |
Flowers, ME; Margolis, DA; McDonald, GB; Prumbaum, M; Reddy, R; Seropian, SE; Shulman, HM; Strasser, SI | 1 |
Hamahira, K; Iijima, K; Kobayashi, A; Nakamura, H; Yoshikawa, N | 1 |
Havlíèková, J; Lácha, J; Lodererová, A; Rossmann, P; Vítko, S | 1 |
Chalermsanyakorn, P; Jirasiritham, S; Mavichak, V; Sumethkul, V | 1 |
Chubachi, S; Doi, H; Haga, I; Kawagishi, N; Kikuchi, H; Koyamada, N; Nakajima, N; Oguma, S; Ohkohchi, N; Orii, T; Satomi, S; Sekiguchi, S | 1 |
Fan, ST; Lai, CL; Lam, BK; Lau, GK; Liu, CL; Lo, CM; Ng, IO; Wong, J; Yong, BH | 1 |
Han, DJ; Jang, HJ; Kim, SC | 1 |
Inman, RD; Stone, M | 1 |
Anasetti, C; Carnevale-Schianca, F; Deeg, J; Flowers, M; Furlong, T; Gooley, T; Martin, P; McSweeney, P; Nash, RA; Storb, R; Sullivan, K | 1 |
Van Gossum, A | 1 |
Kyo, M; Morozumi, K; Ota, K; Takahara, S; Takahashi, K; Uchida, K; Wang, JD | 1 |
Shao, Z; Zhang, Y; Zheng, Y | 1 |
Bartlett, ST; Blahut, SA; Cangro, CB; Fink, JC; Klassen, DK; Ward, MT; Weir, MR | 1 |
Marx, W; Megahed, M; Reinhard, T; Sundmacher, R | 1 |
Dubey, D; Gupta, A; Kumar, A; Mandhani, A; Sharma, AP; Sharma, RK; Srivastava, A | 1 |
Azuma, H; Heemann, U; Tilney, NL; Tullius, SG | 1 |
Devlin, J; Gane, E; Portmann, B; Ramage, J; Williams, R; Wong, P | 1 |
Tejani, A | 1 |
Contrucci, S; Demetris, AJ; Fung, JJ; Lunz, JG; Murase, N; Ruppert, K; Starzl, TE | 1 |
Birsan, T; Klepetko, W; Meiser, B; Reichenspurner, H; Reichert, B; Treede, H; Wisser, W; Zuckermann, A | 1 |
Gordon, KL; Hughes, J; Jefferson, JA; Johnson, RJ; Kang, DH; Kim, YG; Kivlighn, SD; Lan, HY; Mazzali, M; Suga, S | 1 |
Arita, S; Hamaguchi, K; Hatakeyama, E; Nakajima, K; Nishimura, M; Otsuka, M; Sakamaki, T; Sakamoto, K; Tanabe, K; Yamada, K | 1 |
Anioł-Borkowska, M; Bilińska-Pietraszek, E; Mrówka-Kata, K; Namysłowski, G; Scierski, W | 1 |
Finlay, AY; Hakkaart-Van Roijen, L; Paul, C; Rutten, FF; Touw, CR; Verboom, P | 1 |
Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
Hamar, P; Heemann, U; Müller, V; Szabó, A | 1 |
McGrath, JS; Shehata, M | 1 |
Bechstein, WO; Jonas, S; Klupp, J; Langrehr, JM; Lohmann, R; Neuhaus, P; Neuhaus, R; Raakow, R | 1 |
Boots, JM; Christiaans, MH; Kooman, JP; Leunissen, KM; van Der Sande, FM; van Hooff, JP | 1 |
Magalhães, MC; Mendes, AA; Oliveira, JG; Pestana, M; Ramos, JP; Sampaio, S; Xavier, P | 1 |
Arora, M; Blazar, BR; Davies, SM; Defor, T; Enright, H; Miller, WJ; Wagner, JE; Weisdorf, DF | 1 |
Fontaine, J; Olivry, T | 1 |
Chandy, M; Danda, D; George, B; Mathews, V; Srivastava, A | 1 |
Cavallo, E; D'Oronzio, L; Dambra, PP; Ferrannini, A; Loria, MP; Nettis, E; Pannofino, A; Tursi, A | 1 |
Geiger, H; Hauser, IA; Koziolek, MJ; Riess, R; Thévenod, F | 1 |
Hakkaart-van Roijen, L; Redekop, WK; Rutten, FF; Touw, KR; Verboom, P | 1 |
Back, WE; Braun, C; Fang, L; Herr, D; Laux, V; Rohmeiss, P; Schaub, M; Schnuelle, P; Schultz, M; van der Woude, FJ | 1 |
Cole, O; Rigg, K; Shehata, M | 1 |
Azzollini, N; Benigni, A; Gagliardini, E; Marchetti, G; Mister, M; Noris, M; Perico, N; Pezzotta, A; Remuzzi, G | 1 |
Chen, MG; Gastineau, DA; Gertz, MA; Harmsen, WS; Inwards, DJ; Kumar, S; Lacy, MQ; Litzow, MR; Tefferi, A | 1 |
Day, CP; Hudson, M; Manas, D; Stewart, SF; Talbot, D | 1 |
Domingues-Martins, M; França, CM; Pallotta Filho, RS; Soares de Araújo, N; Volpe, A | 1 |
Kreis, HA; Ponticelli, C | 1 |
Ameen, M; Barker, JN; Smith, HR | 1 |
Amersi, F; Busuttil, RW; Coito, AJ; Fishbein, MC; Gao, F; Ghobrial, RM; Kupiec-Weglinski, JW; Mhoyan, A; Reemtsen, BL; Shen, XD; Singer, JS; Zhao, D | 1 |
Ferrant, A; Straetmans, N; Triffet, A | 1 |
Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Gooley, T; Kansu, E; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 1 |
Ivanyi, B; Kemeny, E; Marofka, F; Szederkenyi, E; Szenohradszky, P | 1 |
Gao, R; Jin, J; Lin, S; Luo, X; Shen, Y; Yu, R; Zhou, Y; Zhu, N | 1 |
Kallio, EA; Savikko, J; Taskinen, E; von Willebrand, E | 1 |
Jacobsohn, DA; Vogelsang, GB | 1 |
Danovitch, GM | 1 |
Dittmer, ID; Pilmore, HL | 1 |
Barenbrock, M; Hausberg, M; Hohage, H; Kisters, K; Kosch, M; Rahn, KH; Suwelack, B | 1 |
Benjamin, CD; Chandraker, A; Coito, AJ; Dong, VM; Salama, AD; Sayegh, MH; Waaga, AM; Yuan, X | 1 |
Abraham, AM; Jacob, CK; John, GT; Mathews, MS; Shankar, V; Thomas, PP | 1 |
Borja Segade, J; Feo Brito, F; Galindo Bonilla, PA; Gómez Torrijos, E | 1 |
Chowdrey, HS; Knight, RA; Lightman, SL; Sarlis, NJ; Stephanou, A | 1 |
Alexander, AG; Barnes, NC; Kay, AB | 1 |
Menné, T; Petersen, CS | 1 |
Abu-Elmagd, K; Alessiani, M; Demetris, AJ; Fung, JJ; Jain, A; McCauley, J; Starzl, TE; Takaya, S; Todo, S; Van Thiel, DH | 2 |
Baxter, K; Jablonski, P; Marshall, VC; Stein-Oakley, AN; Thomson, NM; Tzanidis, A | 1 |
Goto, H; Hoshino, H; Ohara, A; Ozawa, T; Sugiyama, S; Tsukamoto, Y | 1 |
Dick, AD; Forrester, JV; Towler, HM; Whiting, P | 1 |
Amon, U; Wolff, HH | 1 |
Kalinin, NN; Mikhaĭlova, EA; Pashinin, AN; Pustovoĭt, LA; Savchenko, VG; Ustinova, EN | 1 |
Barr, ML; Cohen, DJ; Hardy, M; Ho, E; Marboe, CC; Reed, E; Rose, EA; Suciu-Foca, N | 1 |
Ahonen, J; Eklund, B; Häyry, P; Höckerstedt, K; Isoniemi, H; Krogerus, L; Salmela, K | 1 |
Arregui, MA; Diáz-Pérez, JL; Gardeazábal, J; Gil, N; Landa, N; Ratón, JA | 1 |
Baldwin, B; Cote, PJ; Gerin, JL; Hornbuckle, WE; Korba, BE; Tennant, BC | 1 |
Aroldi, A; Cesana, B; Montagnino, G; Paparella, M; Ponticelli, C; Rumi, MG; Tarantino, A | 1 |
Belohradsky, BM; Janka-Schaub, GE; Raghavachar, A; Rister, M | 1 |
McCombe, PA; Pender, MP; van der Kreek, SA | 1 |
Borel, JF; Chabannes, D; Ryffel, B | 1 |
Donovan, J; Langnas, A; Markin, R; Shaw, BW; Sorrell, M; Stratta, R | 1 |
Kakishita, E; Kanamaru, A; Masaoka, T; Moriyama, Y; Shibata, H; Takemoto, Y | 1 |
Abrams, KL; Morgan, RV | 1 |
Buoncompagni, A; Ciccone, O; Cordone, G; De Langlade, E; Fasce, L; Minetti, C; Scribanis, R | 1 |
Ellis, CN; Fradin, MS; Goldfarb, MT; Voorhees, JJ | 1 |
Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
Halimi, JM; Mimran, A; Mion, C; Mourad, G; Ribstein, J | 1 |
Azar, N; Cabrol, A; Cadranel, JF; Desruennes, M; Grippon, P; Leger, P; Lunel, F; Moussalli, J; Pauwels, A; Salmon, P | 1 |
Barnes, NC; Brown, PH; Corrigan, CJ; Frew, AJ; Kay, AB; Tsai, JJ | 1 |
95 review(s) available for cyclosporine and Chronic Disease
Article | Year |
---|---|
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
Topics: Chronic Disease; Cyclosporine; Humans; Interleukin-17; Interleukin-23; Methotrexate; Psoriasis; Recurrence; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2022 |
Current management of generalized pustular psoriasis.
Topics: Acute Disease; CARD Signaling Adaptor Proteins; Chronic Disease; Cyclosporine; Female; Guanylate Cyclase; Humans; Interleukins; Membrane Proteins; Methotrexate; Psoriasis; Retinoids; Skin Diseases, Vesiculobullous | 2023 |
An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations.
Topics: Acitretin; Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Psoriasis | 2023 |
Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
Topics: Anti-Allergic Agents; Azathioprine; Chronic Disease; Chronic Urticaria; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Glycosides; Histamine Antagonists; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Omalizumab; Randomized Controlled Trials as Topic; Treatment Outcome; Urticaria | 2023 |
Autoimmune pancytopenia following chronic immune thrombocytopenia: Case report and literature review.
Topics: Aged; Benzoates; Bone Marrow; Chronic Disease; Cyclosporine; Humans; Hydrazines; Immunologic Factors; Immunosuppressive Agents; Male; Pancytopenia; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Rituximab | 2020 |
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Diagnosis and management of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Biological Factors; Cholecalciferol; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Phototherapy; Psoriasis; Severity of Illness Index | 2017 |
[Ocular graft versus host disease : Corneal complications].
Topics: Adrenal Cortex Hormones; Chronic Disease; Combined Modality Therapy; Corneal Diseases; Corneal Ulcer; Cyclosporine; Diagnosis, Differential; Eye Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Keratoplasty, Penetrating; Limbus Corneae; Ophthalmic Solutions; Tacrolimus | 2017 |
[Chronic urticaria in childhood : Rational diagnostics and treatment].
Topics: Acetates; Angioedema; Child; Child, Preschool; Chronic Disease; Cyclopropanes; Cyclosporine; Diagnosis, Differential; Guideline Adherence; Histamine Antagonists; Humans; Infant; Long-Term Care; Omalizumab; Quinolines; Skin; Sulfides; Urticaria | 2017 |
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.
Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Dapsone; Databases, Factual; Drug Resistance; Histamine Antagonists; Humans; Immunoglobulins, Intravenous; Plasmapheresis; Ultraviolet Therapy; Urticaria | 2018 |
Biologics in chronic urticaria.
Topics: Animals; Antibodies, Monoclonal; B-Lymphocytes; Biological Therapy; Chronic Disease; Cyclosporine; Humans; Immunoglobulin E; Omalizumab; Rituximab; Tumor Necrosis Factor-alpha; Urticaria | 2017 |
Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.
Topics: Autoantibodies; Basophils; Chronic Disease; Cyclosporine; Edema; Histamine H1 Antagonists; Humans; Mast Cells; Omalizumab; Receptors, IgE; Skin; Urticaria | 2018 |
Systematic reviews of pharmacological and nonpharmacological treatments for patients with chronic urticaria: An umbrella systematic review.
Topics: Acupuncture Therapy; Anti-Allergic Agents; Chronic Disease; Cyclosporine; Decision Making; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Male; Medicine, Chinese Traditional; Omalizumab; Quality Improvement; Treatment Outcome; Urticaria | 2019 |
Interventions to improve chronic cyclosporine A nephrotoxicity through inhibiting renal cell apoptosis: a systematic review.
Topics: Animals; Apoptosis; Chronic Disease; Cyclosporine; fas Receptor; Humans; Immunosuppressive Agents; Kidney; Mitochondria; Nitric Oxide; Signal Transduction | 2013 |
[Chronic spontaneous urticaria].
Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Chronic Disease; Cyclosporine; Disease Management; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Male; Omalizumab; Prevalence; Tacrolimus; Urticaria | 2014 |
Corticosteroids for viral myocarditis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Chronic Disease; Cyclosporine; Humans; Myocarditis; Prednisone; Randomized Controlled Trials as Topic; Virus Diseases | 2013 |
Pharmacotherapy of chronic spontaneous urticaria.
Topics: Acetates; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclopropanes; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Histamine H1 Antagonists; Histamine Release; Humans; Omalizumab; Practice Guidelines as Topic; Quinolines; Sulfides; Treatment Outcome; Urticaria | 2013 |
[Recent aspects of Neuro-Behcet's disease].
Topics: Antibodies, Monoclonal; Behcet Syndrome; Chronic Disease; Cyclosporine; Disease Progression; Humans; Infliximab; Interleukin-6 | 2013 |
Update and insights into treatment options for chronic spontaneous urticaria.
Topics: Angioedema; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Drug Resistance; Histamine H1 Antagonists, Non-Sedating; Humans; Immunotherapy; Omalizumab; Pruritus; Skin; Urticaria | 2014 |
Therapy of chronic urticaria: a simple, modern approach.
Topics: Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Omalizumab; Urticaria | 2014 |
Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.
Topics: Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Immunosuppressive Agents; Safety; Treatment Outcome | 2014 |
The maddening itch: an approach to chronic urticaria.
Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Omalizumab; Pruritus; Urticaria | 2014 |
[Recent progress in the management of aplastic anemia].
Topics: Acute Disease; Anemia, Aplastic; Antilymphocyte Serum; Benzoates; Chronic Disease; Cyclosporine; Disease Progression; Hematopoiesis; Humans; Hydrazines; Immunosuppressive Agents; Pyrazoles | 2014 |
Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.
Topics: Acute Disease; Bone Marrow Transplantation; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Japan; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2015 |
Current challenges and controversies in the management of chronic spontaneous urticaria.
Topics: Adrenal Cortex Hormones; Animals; Chronic Disease; Cyclosporine; Humans; Omalizumab; Prevalence; Recurrence; Treatment Failure; Urticaria | 2015 |
Itch in Urticaria Management.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Chronic Disease; Cyclosporine; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Omalizumab; Pruritus; Urticaria | 2016 |
Therapy of antihistamine-resistant chronic spontaneous urticaria.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Drug Resistance; Histamine Antagonists; Humans; Omalizumab; Prevalence; Quality of Life; Skin; Urticaria | 2017 |
Urticaria and urticaria related skin condition/disease in children.
Topics: Autoantibodies; Child; Chronic Disease; Cyclosporine; Epinephrine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Receptors, IgE; Tacrolimus; Urticaria | 2008 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rheumatoid; Chronic Disease; Cryoglobulinemia; Cyclooxygenase 2 Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Hydroxychloroquine; Interferon-alpha; Methotrexate; Penicillamine; Purpura | 2008 |
Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.
Topics: Acute Disease; Analgesics, Opioid; Anti-Bacterial Agents; Anticonvulsants; Benzodiazepines; Catecholamines; Chronic Disease; Critical Care; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Intensive Care Units; Midazolam; Tacrolimus | 2009 |
Calcineurin inhibitor nephrotoxicity.
Topics: Acute Disease; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Risk Assessment; Risk Factors; Tacrolimus | 2009 |
[Monitoring and adjustment of immunosuppression after heart transplantation].
Topics: Chronic Disease; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Graft Rejection; Graft Survival; Heart Failure; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Meta-Analysis as Topic; Monitoring, Immunologic; Mycophenolic Acid; Protein Kinases; Randomized Controlled Trials as Topic; Sirolimus; Survival Analysis; T-Lymphocytes; Tacrolimus; TOR Serine-Threonine Kinases; Treatment Outcome | 2009 |
Established and newly proposed mechanisms of chronic cyclosporine nephropathy.
Topics: Animals; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Risk Factors; Signal Transduction | 2009 |
Alitretinoin for the treatment of severe chronic hand eczema.
Topics: Algorithms; Alitretinoin; Azathioprine; Chronic Disease; Cyclosporine; Dermatologic Agents; Eczema; Hand Dermatoses; Humans; Immunosuppressive Agents; Psychometrics; PUVA Therapy; Quality of Life; Quality-Adjusted Life Years; Tretinoin | 2010 |
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
Topics: Aldosterone; Animals; Chronic Disease; Cyclosporine; Diabetic Nephropathies; Humans; Kidney Diseases; Kidney Failure, Chronic; Mineralocorticoid Receptor Antagonists; Proteinuria; Receptors, Mineralocorticoid; Renin-Angiotensin System | 2011 |
[Calcineurin inhibitor nephrotoxicity in renal allografts].
Topics: Acute Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Renin-Angiotensin System; Tacrolimus; Transplantation, Homologous | 2011 |
[Ischemic tubulointerstitial injury].
Topics: Acute Disease; Antiphospholipid Syndrome; Arteriosclerosis; Calcineurin Inhibitors; Chronic Disease; Contrast Media; Cyclosporine; Humans; Infarction; Ischemia; Kidney Cortex Necrosis; Kidney Diseases; Renal Artery | 2011 |
Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.
Topics: Adenovirus Infections, Human; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Disease Notification; Disinfection; Epidemics; Germany; Hand Disinfection; Humans; Immunosuppressive Agents; Incidence; Keratoconjunctivitis; Ophthalmic Solutions; Randomized Controlled Trials as Topic | 2011 |
Chronic ulcerative stomatitis: a distinct clinical entity?
Topics: Adult; Antirheumatic Agents; Chronic Disease; Cyclosporine; Diagnosis, Differential; Female; Gingivitis, Necrotizing Ulcerative; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus, Oral; Mouth Mucosa; Skin Ulcer; South Africa | 2011 |
Management of epidermolysis bullosa acquisita.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoimmune Diseases; Chronic Disease; Colchicine; Collagen Type VII; Cyclosporine; Dapsone; Dermatologic Agents; Epidermolysis Bullosa Acquisita; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Photochemotherapy; Plasmapheresis; Rituximab; Sulfapyridine; Sulfasalazine | 2011 |
Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Embolization, Therapeutic; Esophageal and Gastric Varices; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Postoperative Complications; Prednisolone | 2012 |
Calcineurin inhibitors in chronic urticaria.
Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Tacrolimus; Time Factors; Urticaria | 2012 |
The use of cyclosporine in dermatology.
Topics: Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatomyositis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Prurigo; Psoriasis; Pyoderma Gangrenosum; Skin Diseases; Sweet Syndrome; Urticaria | 2012 |
[Central nervous system involvement in Behçet's disease].
Topics: Acute Disease; Behcet Syndrome; Biomarkers; Chronic Disease; Cyclosporine; HLA-B Antigens; HLA-B51 Antigen; Humans; Interleukin-6; Magnetic Resonance Imaging; Methotrexate | 2001 |
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Polymyositis; Tacrolimus; Transplantation, Homologous | 2002 |
Steroid-refractory graft-vs.-host disease: past, present and future.
Topics: Acute Disease; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Chronic Disease; Cyclosporine; Daclizumab; Glucocorticoids; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Mycophenolic Acid; Photopheresis; Prednisone; Prodrugs; Sirolimus; Tacrolimus | 2003 |
Chronic urticaria: a role for newer immunomodulatory drugs?
Topics: Adjuvants, Immunologic; Chronic Disease; Cyclosporine; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Methylprednisolone; Skin Tests; Urticaria | 2003 |
Long-term renal transplantation. Recent successes and new problems.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Forecasting; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Time Factors | 2003 |
Is cyclosporine withdrawal a therapeutic option in renal transplant recipients with chronic allograft dysfunction?
Topics: Calcineurin Inhibitors; Chemical and Drug Induced Liver Injury; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation | 2003 |
Cyclosporine nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Kidney Diseases | 2003 |
Cyclosporine nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Kidney; Mycophenolic Acid; Transplantation Immunology | 2004 |
Cyclosporine nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2004 |
Nephrotoxic aspects of cyclosporine.
Topics: Chronic Disease; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Renin-Angiotensin System | 2004 |
Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
Topics: Arterioles; Chronic Disease; Cyclosporine; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Renal Artery; Treatment Failure; Treatment Outcome | 2004 |
Use of cyclosporine in lung transplantation.
Topics: Acute Disease; Calcineurin Inhibitors; Chemistry, Pharmaceutical; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Infections; Lung Transplantation; Neoplasms; Postoperative Complications | 2004 |
Chronic urticaria: pathogenesis and treatment.
Topics: Autoantibodies; Autoimmune Diseases; Chronic Disease; Cyclosporine; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Steroids; Urticaria | 2004 |
The use of extracellular matrix probes and extracellular matrix-related probes for assessing diagnosis and prognosis in renal diseases.
Topics: Biomarkers; Chronic Disease; Cyclosporine; Cytokines; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Extracellular Matrix; Gene Expression; Graft Rejection; Humans; Kidney Diseases; Metalloproteases; Predictive Value of Tests; Tissue Inhibitor of Metalloproteinases | 2004 |
Hyperuricemia in kidney transplantation.
Topics: Chronic Disease; Cyclosporine; Graft Rejection; Humans; Hyperuricemia; Kidney Transplantation | 2005 |
Chronic cyclosporine nephrotoxicity: new insights and preventive strategies.
Topics: Animals; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases; Organ Transplantation | 2004 |
Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Topics: Administration, Oral; Chronic Disease; Cyclosporine; Dermatologic Agents; Ficusin; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Photosensitizing Agents; Psoriasis; PUVA Therapy; Retinoids; Risk Assessment; Ultraviolet Therapy | 2005 |
[Chronic graft-versus-host disease].
Topics: Animals; Autoimmunity; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppressive Agents; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; PUVA Therapy; Risk Factors; Severity of Illness Index; Th2 Cells; Tissue Donors | 2005 |
[How should severe and chronic atopic dermatitis be managed in children?].
Topics: Azathioprine; Child; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Humans; Immunologic Factors; Immunosuppressive Agents; PUVA Therapy; Severity of Illness Index | 2005 |
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Topics: Acute Disease; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Postoperative Complications; Sirolimus; Tacrolimus | 2006 |
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Risk Assessment; T-Lymphocytes; Tacrolimus | 2007 |
Generalized purpuric lichen nitidus. Report of a case and review of the literature.
Topics: Adult; Biopsy, Needle; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Immunohistochemistry; Lichen Nitidus; Male; Severity of Illness Index; Treatment Outcome | 2007 |
Interstitial cystitis/painful bladder syndrome.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Counseling; Cyclosporine; Cystitis, Interstitial; Diagnosis, Differential; Dimethyl Sulfoxide; Food; Humans; Hydroxyzine; Immunosuppressive Agents; Instillation, Drug; Nocturia; Nurse's Role; Nursing Assessment; Pain; Pentosan Sulfuric Polyester; Quality of Life; Referral and Consultation; Risk Factors; United States; Urology | 2007 |
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
Topics: Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Hepatitis C; Humans; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 2007 |
Renal dysfunction associated with liver transplantation.
Topics: Chronic Disease; Cyclosporine; Hepatitis C; Hepatorenal Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Failure; Liver Transplantation; Prostaglandins; Renal Dialysis; Renal Insufficiency; Tacrolimus | 1995 |
Omega 3 fatty acids in renal diseases.
Topics: Chronic Disease; Cyclosporine; Fatty Acids, Omega-3; Glomerulonephritis, IGA; Humans; Hyperlipidemias; Kidney Diseases; Kidney Glomerulus; Lupus Nephritis | 1994 |
The periodontal problems and management of the renal transplant patient.
Topics: Chronic Disease; Cyclosporine; Female; Gingival Hypertrophy; Humans; Kidney Transplantation; Male; Periodontal Diseases; Postoperative Complications; Uremia | 1994 |
Pathology of kidney transplant rejection.
Topics: Biopsy, Needle; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Kidney; Kidney Transplantation | 1993 |
Chronic rejection.
Topics: Chronic Disease; Cyclosporine; Graft Rejection; HLA Antigens; Humans; Immune Tolerance; Kidney Transplantation; Models, Biological; Risk Factors | 1994 |
Is chronic graft versus host disease an autoimmune disease?
Topics: Animals; Autoimmune Diseases; Autoimmunity; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Humans; Mice | 1993 |
Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
Topics: Biopsy; Chronic Disease; Cyclosporine; Diagnosis, Differential; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Transplantation, Homologous | 1996 |
Chronic cyclosporine nephropathy in renal transplantation.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Transplantation, Homologous | 1996 |
Insights into chronic cyclosporine nephrotoxicity.
Topics: Animals; Chronic Disease; Cyclosporine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Kidney Diseases; Rats | 1996 |
[Nephrotic syndrome related to chronic graft versus host disease after allogeneic bone marrow transplantation in a patient with malignant lymphoma].
Topics: Adolescent; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Lymphoma, T-Cell; Male; Nephrotic Syndrome | 1996 |
[Changes of serum GBV-C RNA levels under administration of interferon and cyclosporine for patients with GBV infected hepatitis].
Topics: Adult; Biomarkers; Chronic Disease; Cyclosporine; Flaviviridae; Hepatitis C; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Interferons; RNA, Viral | 1997 |
[Cyclosporin in the treatment of chronic diseases of the liver (excluding transplantation)].
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Liver Diseases | 1997 |
[Cyclosporine nephrotoxicity (chronic arteriolopathy, glomerulopathy)].
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Glomerulus; Vascular Diseases | 1997 |
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A.
Topics: Chronic Disease; Cyclosporine; Drug Monitoring; Glucocorticoids; Humans; Immunosuppressive Agents; Practice Guidelines as Topic; Uveitis, Posterior | 1997 |
Chronic cyclosporine nephrotoxicity.
Topics: Autoimmune Diseases; Chronic Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation | 1998 |
The nephrotoxicity of new and old immunosuppressive drugs.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Prognosis; Sirolimus; Tacrolimus | 1998 |
Difficult asthma: beyond the guidelines.
Topics: Asthma; Budesonide; Child; Chronic Disease; Cyclosporine; Drug Administration Routes; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Leukotriene Antagonists; Methotrexate; Patient Compliance; Patient Education as Topic; Terbutaline; Treatment Failure | 1999 |
Mycophenolate mofetil--is it worth the cost? The in-favor opinion.
Topics: Acute Disease; Azathioprine; Child; Chronic Disease; Cost of Illness; Cyclosporine; Drug Costs; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Technology Assessment, Biomedical; Treatment Outcome | 1999 |
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.
Topics: Acute Disease; Chronic Disease; Costs and Cost Analysis; Cyclosporine; Diagnosis, Differential; Forecasting; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Monitoring, Physiologic; Risk Factors; Tacrolimus; Time Factors | 2000 |
Crohn's colitis and idiopathic thrombocytopenic purpura.
Topics: Adolescent; Chronic Disease; Crohn Disease; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2000 |
Neoral use in the renal transplant recipient.
Topics: Chronic Disease; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Transplantation | 2000 |
Recent developments in the therapy of spondyloarthropathies.
Topics: Alleles; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Reactive; Chronic Disease; Ciprofloxacin; Cyclosporine; Double-Blind Method; Drug Combinations; Follow-Up Studies; Forecasting; Glucosamine; Humans; Immunosuppressive Agents; Lymecycline; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Placebos; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Spondylarthropathies; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
Topics: Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Transplantation, Homologous | 2001 |
Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Drug Synergism; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Sirolimus | 2001 |
Bone marrow aplasia after pipobroman: an immune-mediated mechanism?
Topics: Aged; Aged, 80 and over; Anemia, Aplastic; Antineoplastic Agents, Alkylating; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Pipobroman; Thrombocythemia, Essential | 2001 |
Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carbamates; Chronic Disease; Combined Modality Therapy; Cyclosporine; Daclizumab; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin-11; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; T-Lymphocytes; Tacrolimus | 2002 |
How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?
Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Renal Insufficiency; Sirolimus; Tacrolimus | 2002 |
Antihypertensive treatment in renal transplant patients--is there a role for ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular System; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Postoperative Care | 2001 |
123 trial(s) available for cyclosporine and Chronic Disease
Article | Year |
---|---|
Clinical study on the application of dexamethasone and cyclosporine/dimethyl sulfoxide combination eye drops in the initial therapy of chronic superficial keratitis in dogs.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Dexamethasone; Dimethyl Sulfoxide; Dog Diseases; Dogs; Drug Combinations; Drug Therapy, Combination; Female; Free Radical Scavengers; Immunosuppressive Agents; Keratitis; Male | 2021 |
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study.
Topics: Adrenal Cortex Hormones; Adult; B-Lymphocytes; B7-H1 Antigen; Chronic Disease; Cyclosporine; Drug Combinations; Graft vs Host Disease; Humans; Lymphocyte Count; Middle Aged; Rituximab; Stem Cell Transplantation; Survival Rate; T-Lymphocytes, Helper-Inducer; Transplantation, Homologous; Young Adult | 2017 |
Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
Topics: Adolescent; Adult; Aged; Alitretinoin; Chronic Disease; Cyclosporine; Dermatologic Agents; Eczema; Female; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Patient Reported Outcome Measures; Pregnancy; Prospective Studies; Psychometrics; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index; Young Adult | 2018 |
Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Immunoglobulin E; Male; Middle Aged; Skin Tests; Treatment Outcome; Urticaria; Young Adult | 2019 |
Chronic urticaria with high IgE levels: first results on oral cyclosporine A treatment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Middle Aged; Urticaria; Young Adult | 2013 |
Efficacy of cyclosporine for chronic, refractory stomatitis in cats: A randomized, placebo-controlled, double-blinded clinical study.
Topics: Administration, Oral; Animals; Body Weight; Cat Diseases; Cats; Chronic Disease; Cross-Over Studies; Cyclosporine; Dental Prophylaxis; Dental Scaling; Double-Blind Method; Follow-Up Studies; Gingivitis; Immunosuppressive Agents; Placebos; Remission Induction; Stomatitis; Tooth Extraction; Treatment Outcome | 2013 |
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2013 |
Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2008 |
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus.
Topics: Adult; Biopsy; Chronic Disease; Cyclosporine; Female; Fibrosis; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2009 |
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2010 |
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Topics: Adult; Aged; Biomarkers; Calcineurin Inhibitors; Chronic Disease; Creatinine; Cyclosporine; Drug Administration Schedule; Everolimus; Feasibility Studies; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2009 |
Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Prospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2010 |
Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up.
Topics: Adolescent; Adult; Aged; Autoantibodies; Autoimmune Diseases; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Urticaria; Young Adult | 2011 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
The use of cyclosporine-A in dogs with chronic osteoarthritis: a pilot study.
Topics: Animals; Chronic Disease; Cyclosporine; Dog Diseases; Dogs; Immunosuppressive Agents; Osteoarthritis; Pilot Projects | 2011 |
Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study.
Topics: Adult; Biomarkers; Chi-Square Distribution; China; Chronic Disease; Creatinine; Cyclosporine; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kaplan-Meier Estimate; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2011 |
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
Topics: Adult; Chronic Disease; Cyclosporine; Everolimus; Female; Flow Cytometry; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Photometry; Pilot Projects; Prospective Studies; Recurrence; Sirolimus; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2013 |
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infliximab; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome | 2002 |
Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
Topics: Adolescent; Child; Chronic Disease; Cyclosporine; Diabetes Complications; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Tacrolimus | 2002 |
Renal transplantation: can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings.
Topics: Adult; Azathioprine; Biopsy; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Prednisone; Proteinuria; Renal Circulation; Treatment Outcome | 2003 |
The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy.
Topics: Adult; Chronic Disease; Coloring Agents; Cyclosporine; Drug Therapy, Combination; Female; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Matrix Metalloproteinase 2; Middle Aged; Prospective Studies; Sirolimus; Staining and Labeling; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transplantation, Homologous | 2003 |
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura.
Topics: Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Mycoses; Platelet Count; Purpura, Thrombotic Thrombocytopenic | 2003 |
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2003 |
Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Canada; Child; Chronic Disease; Cyclosporine; Emulsions; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus | 2003 |
Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
Topics: Adult; Breath Tests; Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Female; Forced Expiratory Volume; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Nitric Oxide; Prospective Studies; Tacrolimus | 2003 |
Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Cardiovascular Diseases; Cause of Death; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Neoplasms; Patient Compliance; Proteinuria; Risk Factors; Survival Analysis; Time Factors; Transplantation, Homologous | 2003 |
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Methotrexate; Psoriasis; Quality of Life; Severity of Illness Index | 2003 |
Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Topics: Biopsy; Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Observer Variation; Sirolimus; Transplantation, Homologous | 2003 |
Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Reoperation; Time Factors; Tissue Donors | 1992 |
Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses.
Topics: Adolescent; Antibody Formation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Cytokines; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Retreatment; Tacrolimus | 2004 |
A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy.
Topics: Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2004 |
Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.
Topics: Adult; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Severity of Illness Index; Skin Tests; Treatment Outcome; Urticaria | 2004 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Disease Progression; Female; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Sirolimus; Transplantation, Homologous | 2004 |
[Cyclosporine monitoring in patients with chronic uveitis].
Topics: Adolescent; Adult; Biological Availability; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Uveitis | 2005 |
[Intraocular inflammations. A diagnostic and therapeutic challenge].
Topics: Antiviral Agents; Behcet Syndrome; Chronic Disease; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Prognosis; Recombinant Proteins; Uveitis; Vision, Low | 2005 |
Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids, and anti-IL2R antibodies: 12-month results of a randomized, multicentre, open, p
Topics: Acute Disease; Adrenal Cortex Hormones; Cadaver; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Living Donors; Postoperative Complications; Survival Analysis; Tissue Donors; Treatment Failure | 2005 |
Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias.
Topics: Adolescent; Adult; Antigens, CD34; CD3 Complex; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Donor Selection; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2006 |
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
Topics: Acute Disease; Administration, Inhalation; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Survival Analysis | 2006 |
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Transplantation, Homologous | 2006 |
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity | 2006 |
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; CD3 Complex; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Herpes Zoster; Humans; Leukopenia; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Pyrazines; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Transplantation, Homologous | 2006 |
Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Psoriasis | 2006 |
[Extended cyclosporine-A--treatment for severe chronic urticaria].
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Middle Aged; Prednisone; Treatment Outcome; Urticaria | 2006 |
Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
Topics: Adolescent; Adult; Aged; Chronic Disease; Creatinine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus | 2006 |
Cyclosporine A treatment of leprosy patients with chronic neuritis is associated with pain control and reduction in antibodies against nerve growth factor.
Topics: Animals; Antibodies; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Leprosy; Nerve Growth Factor; Neuritis; Pain Measurement; PC12 Cells; Prospective Studies; Rats; Reflex; Severity of Illness Index; Treatment Outcome | 2006 |
Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Urticaria | 2006 |
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.
Topics: Adult; Anti-Retroviral Agents; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Receptors, Chemokine; T-Lymphocytes; Treatment Outcome | 2006 |
Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
Protective effects of sirolimus by attenuating connective tissue growth factor expression in human chronic allograft nephropathy.
Topics: Adolescent; Adult; Biopsy; Chronic Disease; Connective Tissue Growth Factor; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Transplantation; Male; Sirolimus; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2007 |
An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefacept.
Topics: Adolescent; Adult; Aged; Alefacept; CD4 Lymphocyte Count; Chronic Disease; Combined Modality Therapy; Common Cold; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Focal Infection, Dental; Humans; Middle Aged; Pilot Projects; Psoriasis; Quality of Life; Recombinant Fusion Proteins; Retreatment; Suicide, Attempted; Treatment Outcome; Ultraviolet Rays | 2007 |
Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2007 |
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Chronic Disease; Conjunctiva; Cornea; Cyclosporine; Dry Eye Syndromes; Female; Goblet Cells; Graft vs Host Disease; Humans; Male; Middle Aged; Mucin 5AC; Mucins; Ophthalmic Solutions; Patient Satisfaction; Pilot Projects; Tears; Treatment Outcome | 2008 |
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; CD4 Lymphocyte Count; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Sirolimus; T-Lymphocytes, Regulatory; Treatment Outcome | 2007 |
Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation.
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunosuppressive Agents; Male; Prospective Studies; Treatment Outcome; Urticaria | 2008 |
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Incidence; Infections; Liver Transplantation; Male; Middle Aged; Survival Rate; Tacrolimus | 1994 |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Liver Transplantation; Muromonab-CD3; Steroids; Tacrolimus | 1995 |
Thalidomide as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chronic Disease; Constipation; Cyclosporine; Drug Eruptions; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Neuritis; Neutropenia; Prednisone; Remission Induction; Salvage Therapy; Survival Rate; Thalidomide; Treatment Outcome | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma.
Topics: Adrenal Cortex Hormones; Adult; Asthma; Chronic Disease; Cyclosporine; Female; Humans; Lymphocyte Activation; Male; Middle Aged; Peak Expiratory Flow Rate; Respiratory System; T-Lymphocytes | 1995 |
European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group.
Topics: Adolescent; Adult; Chronic Disease; Cohort Studies; Crohn Disease; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Europe; Female; Humans; Male; Middle Aged; Prednisone; Prospective Studies; Remission Induction | 1995 |
[Psoriasis and cyclosporine: an attempt at topical treatment].
Topics: Administration, Topical; Adult; Chronic Disease; Cyclosporine; Dimethyl Sulfoxide; Double-Blind Method; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis | 1994 |
[The efficacy of cyclosporin in the treatment of myositis].
Topics: Adult; Aged; Child; Chronic Disease; Cyclosporine; Female; Humans; Male; Middle Aged; Muscles; Myositis; Remission Induction; Time Factors | 1995 |
Outcome analysis of FK 506 therapy for acute and chronic rejection.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Male; Tacrolimus; Time Factors; Treatment Outcome | 1993 |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Topics: Acute Disease; Acute Kidney Injury; Adrenal Cortex Hormones; Bilirubin; Chronic Disease; Communicable Diseases; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Liver Function Tests; Liver Transplantation; Male; Muromonab-CD3; Renal Dialysis; Survival Analysis; Tacrolimus; Time Factors | 1993 |
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Topics: Adult; Aged; Alanine Transaminase; Azathioprine; Base Sequence; Biopsy; Chronic Disease; Creatinine; Cyclosporine; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Histocompatibility Testing; Humans; Interferon Type I; Kidney; Kidney Transplantation; Liver; Male; Middle Aged; Molecular Sequence Data; Prospective Studies; Recombinant Proteins; RNA, Viral | 1995 |
Cyclosporin A in an adhesive base for treatment of recalcitrant oral lichen planus. An open trial.
Topics: Administration, Topical; Adult; Chronic Disease; Cyclosporine; Female; Humans; Lichen Planus, Oral; Male; Middle Aged; Ointments; Pain Measurement | 1994 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Etretinate; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Recurrence; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 1995 |
High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Topics: Acute Disease; Azathioprine; Bilirubin; Biopsy, Needle; Chronic Disease; Creatinine; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Kidney; Kidney Transplantation; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Prospective Studies; Steroids; Time Factors | 1995 |
Cyclosporin in renal transplantation: a 9 year experience.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome | 1995 |
Effects of cyclosporine A on chronic renal transplant rejection.
Topics: Adolescent; Adult; Azathioprine; Blood Pressure; Child; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Hypertension; Kidney Transplantation; Male; Prednisone; Time Factors | 1994 |
Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Steroids; Survival Rate | 1994 |
Additive effects of calcipotriol and cyclosporine A: from in vitro experiments to in vivo applications in the treatment of severe psoriasis.
Topics: Adult; Calcitriol; Cell Division; Chronic Disease; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Female; Humans; In Vitro Techniques; Lymphocyte Culture Test, Mixed; Lymphocytes; Male; Psoriasis | 1994 |
Immunomodulation of psoriasis with a topical cyclosporin A formulation.
Topics: Administration, Cutaneous; Adult; Aged; Antigens, CD; CD3 Complex; Cell Adhesion Molecules; Chronic Disease; Cyclosporine; Double-Blind Method; HLA-DR Antigens; Humans; Immune Tolerance; Intercellular Adhesion Molecule-1; Keratinocytes; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Receptors, Interleukin-2; Skin | 1993 |
Management of the renal allograft recipient: immunosuppressive protocols for long-term success.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisone | 1994 |
Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Neoplasms; Psoriasis; Remission Induction; Treatment Outcome | 1994 |
Maintenance treatment with cyclosporin in atopic eczema.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Remission Induction | 1994 |
Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.
Topics: Adult; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Psoriasis; Renal Plasma Flow; Risk Factors | 1994 |
Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.
Topics: Adolescent; Adult; Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Methotrexate; Middle Aged; Uveitis; Visual Acuity | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Survival Rate; Tacrolimus; Time Factors; Treatment Failure | 1996 |
Comparison of topical cyclosporin and dexamethasone for the treatment of chronic superficial keratitis in dogs.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Cross-Over Studies; Cyclosporine; Dexamethasone; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Keratitis; Male; Time Factors; Treatment Outcome | 1995 |
Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection.
Topics: Administration, Oral; Adult; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Rejection; Humans; Immunosuppressive Agents; Individuality; Kidney Transplantation; Male; Middle Aged; Prednisone; Risk Factors | 1996 |
Clinical aspects: preliminary experience with a novel oral formulation of cyclosporin (Neoral).
Topics: Chemistry, Pharmaceutical; Chronic Disease; Cyclosporine; Dermatologic Agents; Emulsions; Follow-Up Studies; Humans; Psoriasis; Recurrence | 1996 |
Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Creatinine; Cyclosporine; Double-Blind Method; Drug Tolerance; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Recurrence; Treatment Outcome | 1996 |
Risk factors for chronic rejection in pediatric renal allograft recipients.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Chronic Disease; Computer Communication Networks; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Risk Factors; Tissue Donors; Treatment Outcome | 1996 |
Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Cyclosporine; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Male; Middle Aged; Quality of Life | 1997 |
Long-term follow-up of patients with chronic uveitis affecting the posterior pole treated with combination cyclosporine and ketoconazole.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Ketoconazole; Longitudinal Studies; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; Uveitis | 1997 |
Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 1997 |
[A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis].
Topics: Adult; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Male; Prospective Studies | 1997 |
[Controlled clinical study of Consupren versus cyclophosphamide in chronic glomerulonephritis. II. Adverse effects].
Topics: Chronic Disease; Cyclophosphamide; Cyclosporine; Glomerulonephritis; Humans; Immunosuppressive Agents | 1997 |
Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study Group.
Topics: Activities of Daily Living; Chronic Disease; Cyclosporine; Double-Blind Method; Evaluation Studies as Topic; Humans; Immunosuppressive Agents; Multiple Sclerosis; Neurologic Examination; Psychomotor Performance; Reproducibility of Results; Treatment Outcome | 1996 |
Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Demyelinating Diseases; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neurologic Examination; Polyradiculoneuropathy; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 1998 |
A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.
Topics: Adolescent; Adult; Aged; Chemistry, Pharmaceutical; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Humans; Immunosuppressive Agents; Middle Aged; Prospective Studies; Psoriasis | 1998 |
Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
Topics: Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Time Factors | 1998 |
Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Prednisolone; Ribonucleosides | 1998 |
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Mycophenolic Acid; Nuclear Family; Prednisolone | 1998 |
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Survival Rate; Transplantation, Homologous | 1999 |
Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
Topics: Aged; Arginine; Blood Pressure; Chronic Disease; Cohort Studies; Cyclosporine; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney; Kidney Diseases; Male; Middle Aged; Nitric Oxide; Nitroprusside; Renal Circulation; Vasodilator Agents | 1999 |
[Sandimmun-Neoral--a new quality of life for patients with severe systemic juvenile rheumatoid arthritis].
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Chronic Disease; Cyclosporine; Humans; Quality of Life; Surveys and Questionnaires; Time Factors | 1999 |
[Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin A].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Eye Diseases; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Prednisone; Prospective Studies; Radioimmunodetection | 1999 |
Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.
Topics: Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Regression Analysis; Time Factors | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation.
Topics: Adolescent; Adult; Antibodies; Azathioprine; Chronic Disease; Coronary Disease; Coronary Vessels; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; HLA Antigens; Humans; Hyperplasia; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Photopheresis; Pilot Projects; Prednisone; Prospective Studies; Safety; Tunica Intima | 2000 |
Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.
Topics: Adult; Aged; Algorithms; Basophils; Chronic Disease; Cyclosporine; Dermatologic Agents; Double-Blind Method; Female; Follow-Up Studies; Histamine Release; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome; Urticaria | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Topics: Actuarial Analysis; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Graft vs Host Disease; Humans; Hypesthesia; Neutropenia; Prednisone; Thalidomide | 2000 |
The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Time Factors; Tissue Donors | 2000 |
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Salvage Therapy; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
Topics: Acute Disease; Adult; Aged; Bronchiolitis Obliterans; Chronic Disease; Creatinine; Cyclosporine; Drug Combinations; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 2001 |
Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.
Topics: Adult; Chronic Disease; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Multivariate Analysis; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2001 |
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infections; Prednisone; Prognosis; Risk Factors; Salvage Therapy; Survival Analysis; Thalidomide; Transplantation, Homologous; Treatment Outcome | 2001 |
Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; B-Lymphocyte Subsets; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Killer Cells, Natural; Male; Middle Aged; Prednisone; T-Lymphocyte Subsets; Urticaria | 2001 |
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.
Topics: Administration, Oral; Adult; Chronic Disease; Cost-Benefit Analysis; Cyclosporine; Dermatologic Agents; Direct Service Costs; Drug Administration Schedule; Economics, Pharmaceutical; Female; Humans; Male; Multicenter Studies as Topic; Psoriasis; Treatment Outcome | 2001 |
Mycophenolate mofetil monotherapy in liver transplantation.
Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Liver Transplantation; Mycophenolic Acid; Renal Insufficiency; Tacrolimus | 2001 |
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Topics: Adult; Biopsy; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Prospective Studies; Risk Factors; Skin; Survival Rate; Time Factors; Transplantation, Homologous | 2001 |
[The combination of cyclosporin A and androgen in the treatment of chronic aplastic anemia].
Topics: Adolescent; Adult; Aged; Androgens; Anemia, Aplastic; Blood Cell Count; Child; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Treatment Outcome; Young Adult | 2001 |
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Survival Analysis; Thrombocytopenia; Transplantation, Homologous | 2002 |
Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.
Topics: Adult; Asthma; Chronic Disease; Cyclosporine; Double-Blind Method; Female; Humans; Male; Maximal Expiratory Flow Rate; Middle Aged; Peak Expiratory Flow Rate; Prednisolone | 1992 |
Chronic rejection of renal allografts with four immunosuppressive regimens.
Topics: Azathioprine; Biopsy; Cadaver; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Kidney Transplantation; Methylprednisolone; Postoperative Complications | 1992 |
Phase II study of FK 506 for allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Diarrhea; Drug Evaluation; Female; Graft vs Host Disease; Humans; Male; Tacrolimus; Transplantation, Homologous | 1991 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
538 other study(ies) available for cyclosporine and Chronic Disease
Article | Year |
---|---|
[Metabolite changes in the greasy tongue coating of patients with chronic gastritis].
Topics: Case-Control Studies; Chronic Disease; Discriminant Analysis; Gastritis; Humans; Lactose; Principal Component Analysis; Tongue | 2012 |
Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: A 2021 update.
Topics: Aged; Child; Chronic Disease; Consensus; Cyclosporine; Female; Humans; Omalizumab; Pregnancy; Urticaria | 2022 |
Short courses of ciclosporin can induce long remissions in chronic spontaneous urticaria.
Topics: Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Urticaria | 2022 |
Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell tran
Topics: Acute Disease; Adolescent; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2022 |
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
Topics: Acute Disease; Adult; Chronic Disease; Cohort Studies; Cyclosporine; Electronic Health Records; Female; Humans; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Skin Diseases, Vesiculobullous; Tacrolimus | 2022 |
Clinical and laboratory parameters associated with treatment response to third-line therapies in chronic refractory urticaria: A real world study from northern India.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Immunoglobulin E; Omalizumab; Retrospective Studies; Treatment Outcome; Urticaria | 2022 |
Chronic Urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Urticaria | 2022 |
Chronic Urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Urticaria | 2022 |
Cyclosporine induced generalized hyperkeratosis in a dog.
Topics: Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Hyperplasia; Immunosuppressive Agents; Papilloma | 2023 |
Transcriptomic responses of peripheral blood mononuclear cells to cyclosporin and etanercept in a female infant with juvenile generalized pustular psoriasis.
Topics: Acute Disease; CARD Signaling Adaptor Proteins; Chronic Disease; Cyclosporine; Etanercept; Female; Guanylate Cyclase; Humans; Infant; Interleukins; Leukocytes, Mononuclear; Membrane Proteins; Psoriasis; Transcriptome; Tumor Necrosis Factor Inhibitors | 2023 |
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.
Topics: Bronchiolitis Obliterans Syndrome; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney | 2023 |
Efficacy and Safety of Treatment with Oral Alitretinoin and Oral Cyclosporine for Chronic Hand Eczema: A Retrospective Review of 118 Cases.
Topics: Administration, Oral; Alitretinoin; Chronic Disease; Cyclosporine; Dermatologic Agents; Eczema; Hand Dermatoses; Humans; Patient Safety; Retrospective Studies; Skin; Time Factors; Treatment Outcome | 2020 |
Cyclosporine and omalizumab together: A new option for chronic refractory urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Omalizumab; Treatment Outcome; Urticaria | 2020 |
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosus.
Topics: Antibodies, Viral; Chronic Disease; Cyclosporine; Diverticulitis; DNA, Viral; Drainage; Epstein-Barr Virus Infections; Female; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Intraepithelial Lymphocytes; Leukemia, Large Granular Lymphocytic; Leukopenia; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Lymphocyte Count; Middle Aged; Prednisolone; Red-Cell Aplasia, Pure; Skin Diseases, Infectious; Spondylitis | 2020 |
Chronic inflammatory axonal polyneuropathy.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases of the Nervous System; Axons; Azathioprine; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Inflammation; Male; Middle Aged; Mycophenolic Acid; Neural Conduction; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve; Young Adult | 2020 |
Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Methotrexate; Omalizumab; Treatment Outcome; Urticaria | 2020 |
Lupus miliaris disseminatus faciei: A resistant case with response to cyclosporine.
Topics: Chronic Disease; Cyclosporine; Dermatologic Agents; Facial Dermatoses; Female; Granuloma; Humans; Middle Aged | 2017 |
Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Humans; Immunoglobulin E; Immunosuppressive Agents; Omalizumab; Urticaria | 2017 |
A refined and translationally relevant model of chronic DSS colitis in BALB/c mice.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Thioguanine | 2018 |
Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment.
Topics: Adult; Age of Onset; Aged; Chronic Disease; Cyclosporine; Disease Progression; Drug Resistance; Female; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Male; Middle Aged; Omalizumab; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Failure; Urticaria | 2018 |
Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Mycophenolic Acid; Photopheresis; Prednisone; Sclerosis; Skin; Tacrolimus | 2018 |
IgE levels are negatively correlated with clinical response to ciclosporin in chronic spontaneous urticaria.
Topics: Adult; Biomarkers; Chronic Disease; Cyclosporine; Humans; Immunoglobulin E; Immunosuppressive Agents; Middle Aged; Omalizumab; Retrospective Studies; Treatment Outcome; Urticaria | 2019 |
Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
Topics: Administration, Topical; Adult; Biomarkers; Biopsy; Chronic Disease; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Female; Follow-Up Studies; HLA-DR Antigens; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Interleukin-33; Keratoconjunctivitis; Male; Middle Aged; Severity of Illness Index; Young Adult | 2019 |
Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
Topics: Administration, Cutaneous; Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Compounding; Drug Substitution; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Remission Induction; Skin; Time Factors; Treatment Outcome | 2019 |
Therapeutic options and prognosis of chronic idiopathic erythroderma in older adults.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Chronic Disease; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Female; Humans; Male; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Ultraviolet Therapy | 2019 |
Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents; Central Serous Chorioretinopathy; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Immunosuppressive Agents; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2020 |
Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Topics: Acute Disease; Adult; Allografts; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Photopheresis; Retrospective Studies; Stem Cell Transplantation; Steroids; Transplantation Conditioning | 2013 |
Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2013 |
Effectiveness of sirolimus in combination with cyclosporine against chronic rejection in a pediatric liver transplant patient.
Topics: Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Sirolimus; Treatment Outcome | 2013 |
Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Mycophenolic Acid; Treatment Outcome; Urticaria | 2014 |
Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Animals; Antioxidants; Apoptosis; Chronic Disease; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression; Glucuronidase; Immunosuppressive Agents; Kidney Diseases; Klotho Proteins; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction; Superoxide Dismutase | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.
Topics: Anti-Retroviral Agents; Antibodies, Viral; Antibody Affinity; CD8-Positive T-Lymphocytes; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Disease Progression; Epitope Mapping; HIV; HIV Infections; Humans; Immunity, Cellular; Immunosuppressive Agents; Longitudinal Studies; Receptors, Antigen, T-Cell; Up-Regulation; Viremia; Virus Replication | 2013 |
Exercise benefits in chronic graft versus host disease: a murine model study.
Topics: Adaptation, Physiological; Animals; Biomarkers; CD4 Lymphocyte Count; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Interleukin-4; Kaplan-Meier Estimate; Leukocyte Common Antigens; Lymphocytes; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Physical Conditioning, Animal; Physical Fitness; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2013 |
Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carrier Proteins; Chronic Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Histocompatibility Antigens; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Phosphoproteins; rac1 GTP-Binding Protein; Rapamycin-Insensitive Companion of mTOR Protein; Rats; Rats, Inbred ACI; Rats, Wistar; Regulatory-Associated Protein of mTOR; Signal Transduction; Sirolimus; T-Lymphocytes; Time Factors; TOR Serine-Threonine Kinases | 2013 |
Efficacy of combined therapy with cyclosporin and low-dose prednisolone in interstitial pneumonia associated with connective tissue disease.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Biopsy; Chronic Disease; Connective Tissue Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Exercise Tolerance; Female; Humans; Japan; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Quality of Life; Respiratory Function Tests; Retrospective Studies; Treatment Outcome | 2014 |
Can median nail dystrophy be an adverse effect of alitretinoin treatment?
Topics: Alitretinoin; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Substitution; Eczema; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Nail Diseases; Nails, Malformed; Time Factors; Treatment Outcome; Tretinoin | 2014 |
Ginseng treatment attenuates autophagic cell death in chronic cyclosporine nephropathy.
Topics: Animals; Autophagy; Chronic Disease; Cyclosporine; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Panax; Phytotherapy; Plant Extracts | 2014 |
Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Young Adult | 2014 |
The use of immunosuppressive agents in the management of recalcitrant lower limb ulcers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Hospitals, University; Humans; Immunomodulation; Immunosuppressive Agents; Leg Ulcer; Lower Extremity; Male; Middle Aged; Tertiary Care Centers; Treatment Outcome; Vascular Diseases; Wound Healing | 2014 |
Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
Topics: Animals; Cells, Cultured; Chronic Disease; Cyclosporine; Fibrosis; Gene Expression Regulation; Graft Rejection; Immunosuppression Therapy; Kidney; Kidney Transplantation; Macrophages; Male; Platelet-Derived Growth Factor; Rats; Rats, Inbred WF; Tacrolimus; Transplantation, Homologous | 2014 |
[Argentine guidelines for urticaria and angioedema].
Topics: Algorithms; Angioedema; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Argentina; Autoimmune Diseases; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Diagnosis, Differential; Evidence-Based Medicine; Histamine Antagonists; Humans; Immunoglobulin E; Leukotriene Antagonists; Omalizumab; Quality of Life; Urticaria | 2014 |
[Risk factors for chronic allograft failure in renal transplant recipients].
Topics: Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Kidney; Kidney Transplantation; Male; Multivariate Analysis; Proteinuria; Risk Factors; Transplant Recipients; Transplantation, Homologous | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Biomarkers, Tumor; Canada; Chronic Disease; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult | 2015 |
Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Topics: Adrenalectomy; Aldosterone; Animals; Chronic Disease; Cyclosporine; Cytochrome P-450 CYP11B2; Disease Models, Animal; Electrolytes; Eplerenone; Fibrosis; Kidney; Kidney Diseases; Male; Potassium; Rats, Sprague-Dawley; RNA, Messenger; Sodium; Spironolactone | 2015 |
Plasma D-dimer levels and clinical response to ciclosporin in severe chronic spontaneous urticaria.
Topics: Chronic Disease; Cyclosporine; Fibrin Fibrinogen Degradation Products; Humans; Immunosuppressive Agents; Severity of Illness Index; Treatment Outcome; Urticaria | 2015 |
Management of chronic spontaneous urticaria in the elderly.
Topics: Aged; Chronic Disease; Cyclosporine; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Quality of Life; Urticaria | 2015 |
Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Chronic Disease; Cornea; Cyclosporine; Drug Combinations; Female; Glaucoma; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Microscopy, Confocal; Middle Aged; Nerve Fibers; Ophthalmic Solutions; Prospective Studies; Trigeminal Nerve; Trigeminal Nerve Diseases; Visual Acuity; Young Adult | 2015 |
T-regulatory cells in chronic rejection versus stable grafts.
Topics: Adolescent; Adult; Aged; Biopsy; Calcineurin Inhibitors; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunity, Cellular; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lymphocyte Count; Male; Middle Aged; Prospective Studies; Risk Factors; Sirolimus; T-Lymphocytes, Regulatory; Transplantation Tolerance; Treatment Outcome; Young Adult | 2015 |
Chronic progressive polyarthritis in a domestic shorthair cat.
Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Buprenorphine; Cat Diseases; Cats; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclosporine; Gabapentin; gamma-Aminobutyric Acid; Immunosuppressive Agents; Male; Pain; Prednisolone; Retroviridae Infections; Spumavirus | 2015 |
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Topics: Adult; Behcet Syndrome; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Recurrence; Remission Induction; Treatment Outcome; Turkey; Uveitis; Visual Acuity | 2015 |
Sarcoidosis Presenting with Cicatrizing Conjunctivitis.
Topics: Administration, Oral; Administration, Topical; Adult; Biopsy; Chronic Disease; Cicatrix; Conjunctivitis; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2015 |
The course of dry eye after phacoemulsification surgery.
Topics: Aged; Aged, 80 and over; Chronic Disease; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Staining and Labeling; Tears | 2015 |
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
Topics: Acute Disease; Adult; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Recurrence; Retrospective Studies; Salvage Therapy; Sirolimus; Thrombotic Microangiopathies | 2015 |
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Siblings; Tissue Donors | 2016 |
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Azathioprine; Bronchiectasis; Chronic Disease; Cough; Cyclosporine; Everolimus; Female; Forced Expiratory Volume; Graft Rejection; Haemophilus Infections; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Rituximab; Sirolimus; Tacrolimus; Tomography, X-Ray Computed; Vital Capacity; Young Adult | 2015 |
Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Topics: Adolescent; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Splenectomy; Treatment Outcome | 2016 |
Prognostic factors for the evolution and reversibility of chronic rejection in pediatric liver transplantation.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Diseases; Liver Transplantation; Male; Multivariate Analysis; Mycophenolic Acid; Prognosis; Remission Induction; Survival Rate; Tacrolimus | 2016 |
Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.
Topics: Adult; Anti-Allergic Agents; Antibodies, Monoclonal, Humanized; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Omalizumab; Prednisolone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Urticaria | 2017 |
Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Biomarkers; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk; Survival Analysis; Transplantation, Homologous; Young Adult | 2016 |
Cyclosporin A for persistent or chronic immune thrombocytopenia in children.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Evaluation; Female; Hirsutism; Humans; Immunosuppressive Agents; Infant; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Retrospective Studies | 2016 |
A case of intravenous immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy of pure motor form responsive to mycophenolate mofetil therapy.
Topics: Aged; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Kidney Diseases; Male; Mycophenolic Acid; Recurrence; Secondary Prevention; Time Factors; Treatment Outcome | 2016 |
The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Humans; Interleukin-17; Lung Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Steroids; Transplant Recipients; Transplantation, Homologous | 2016 |
Combination therapy of infliximab and ciclosporin in the treatment of recalcitrant psoriasis: a case series.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infliximab; Infusions, Intravenous; Male; Middle Aged; Psoriasis; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
Phenotypic analysis of circulating T-cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Aged; Aged, 80 and over; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Chronic Disease; Cyclosporine; Dermatitis, Exfoliative; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Male; Middle Aged; Photosensitivity Disorders; Severity of Illness Index; Sunscreening Agents; Tacrolimus; Ultraviolet Rays | 2017 |
Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.
Topics: Acitretin; Acute Disease; Adolescent; Adult; Age of Onset; CARD Signaling Adaptor Proteins; Child; Child, Preschool; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Guanylate Cyclase; Humans; Interleukins; Keratolytic Agents; Malaysia; Male; Membrane Proteins; Pregnancy; Pregnancy Complications; Psoriasis; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Steroids; Stress, Psychological; Tertiary Care Centers; Vaccination; Young Adult | 2017 |
Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines.
Topics: Adrenal Cortex Hormones; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Chronic Disease; Comorbidity; Cross-Sectional Studies; Cyclosporine; Dermatology; Disease Management; Drug Therapy, Combination; Hepatitis, Viral, Human; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Omalizumab; Practice Guidelines as Topic; Risk Factors; Tertiary Care Centers; Urticaria | 2017 |
[Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].
Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Humans; Omalizumab; Portugal; Quality of Life; Urticaria | 2016 |
Protective effects of FR167653 on chronic allograft nephropathy by inhibiting p38 MAPK in rats.
Topics: Animals; Chronic Disease; Creatinine; Cyclosporine; Immunosuppressive Agents; Kidney Transplantation; Male; p38 Mitogen-Activated Protein Kinases; Proteinuria; Pyrazoles; Pyridines; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 2008 |
C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.
Topics: Administration, Oral; Animals; CD8-Positive T-Lymphocytes; Chronic Disease; Combined Modality Therapy; Cordyceps; Cyclosporine; Drug Synergism; Graft Occlusion, Vascular; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Lymphocyte Culture Test, Mixed; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Rats; Rats, Inbred Lew; Transplantation, Homologous | 2008 |
The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy.
Topics: Animals; Apoptosis; Chronic Disease; Clodronic Acid; Cyclosporine; Immunity, Innate; Immunosuppressive Agents; Kidney; Kidney Diseases; Liposomes; Macrophages; Male; Rats; Rats, Sprague-Dawley | 2008 |
Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Budesonide; Chronic Disease; Cyclosporine; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction; Transplantation, Homologous | 2008 |
Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
Topics: Adult; Biopsy; Blood Pressure; Chronic Disease; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Transplantation, Homologous | 2008 |
Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Glomerulonephritis; Humans; Incidence; Insulin Resistance; Kidney Transplantation; Male; Metabolic Syndrome; Middle Aged; Overweight; Risk Factors; Tacrolimus | 2008 |
Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin.
Topics: Autistic Disorder; Autoimmune Diseases; Child; Chronic Disease; Cyclosporine; Female; Humans; Urticaria | 2009 |
[Effect of anti-ICOS monoclonal antibody combined with low-dose CsA on chronic rejection of heart grafts in rats].
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Inducible T-Cell Co-Stimulator Protein; Random Allocation; Rats; T-Lymphocytes, Regulatory | 2008 |
What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
Topics: Allergens; Autoantibodies; Autoimmunity; Chronic Disease; Cyclosporine; Guidelines as Topic; Histamine Antagonists; Humans; Hydroxyzine; Immunosuppressive Agents; Methotrexate; Urticaria | 2009 |
Toll-like receptor expression in patients with renal allograft dysfunction.
Topics: Acute Disease; Biopsy; Chronic Disease; Cyclosporine; DNA Primers; Gene Expression Regulation; Glomerulonephritis, IGA; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Toll-Like Receptors | 2008 |
Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
Topics: Animals; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Everolimus; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Sphingosine; Transplantation, Homologous | 2008 |
Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts.
Topics: Adult; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Female; Guideline Adherence; Histamine Antagonists; Humans; Immunosuppressive Agents; Leukotriene Antagonists; Male; Middle Aged; Practice Guidelines as Topic; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Urticaria | 2009 |
Chronic kidney disease after heart transplantation.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; Young Adult | 2009 |
The top 10 things nephrologists wish every primary care physician knew.
Topics: Aluminum; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antacids; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Cathartics; Chronic Disease; Contraindications; Creatinine; Cyclosporine; Disease Progression; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Evidence-Based Medicine; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Magnesium; Nephrolithiasis; Nephrology; Phosphates; Primary Health Care; Proteinuria; Recombinant Proteins; Referral and Consultation; Tacrolimus; Urinalysis | 2009 |
Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families.
Topics: Adult; Age of Onset; Chorioretinitis; Chronic Disease; Coloring Agents; Combined Modality Therapy; Cyclosporine; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Histocompatibility Testing; HLA-A Antigens; HLA-B Antigens; HLA-B44 Antigen; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity; White People | 2009 |
Low-dose cyclosporine is a good option for severe chronic urticaria.
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Urticaria | 2009 |
Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis.
Topics: Biopsy; Blood Vessels; Child; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Male; Panniculitis, Nodular Nonsuppurative; Recurrence; Skin; Treatment Outcome; Vasculitis | 2010 |
Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; CCR5 Receptor Antagonists; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; T-Lymphocytes; Transplantation, Homologous | 2009 |
[0.05% cyclosporine a for treatment of chronic severe ocular surface disease].
Topics: Administration, Topical; Adult; Chronic Disease; Conjunctivitis, Allergic; Cyclosporine; Dry Eye Syndromes; Female; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Rosacea; Visual Acuity | 2009 |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus; Treatment Outcome | 2009 |
Cyclosporin treatment in three children with chronic inflammatory demyelinating neuropathy.
Topics: Child, Preschool; Chronic Disease; Cyclosporine; Demyelinating Diseases; Female; Hirsutism; Humans; Immunosuppressive Agents; Infant; Male; Polyneuropathies; Treatment Outcome | 2009 |
Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.
Topics: Chronic Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus | 2009 |
Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Female; Fluorophotometry; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin-6; Interleukin-8; Male; Methylprednisolone; Middle Aged; Ophthalmic Solutions; Tears; Treatment Outcome | 2012 |
Serum indoxyl sulfate as an early marker for detecting chronic cyclosporine nephrotoxicity.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Chronic Disease; Cyclosporine; Early Diagnosis; Female; Humans; Immunosuppressive Agents; Indican; Kidney Diseases; Male; Young Adult | 2010 |
A model of chronic lung allograft rejection in the rat.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bronchiolitis Obliterans; CD3 Complex; Chemokine CCL5; Chronic Disease; Cyclosporine; Disease Models, Animal; Fluorescent Antibody Technique; Forkhead Transcription Factors; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Macrophages, Alveolar; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus; T-Lymphocytes, Helper-Inducer; Transforming Growth Factor beta; Transplantation, Homologous | 2010 |
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Antibodies, Antinuclear; Autoantibodies; Autoimmunity; Basophil Degranulation Test; Chronic Disease; Cohort Studies; Cyclosporine; Female; Histamine Antagonists; Humans; Immunoglobulin E; Male; Middle Aged; Prednisone; Receptors, IgE; Retrospective Studies; Skin Tests; Thyroid Gland; Urticaria; Young Adult | 2009 |
Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast.
Topics: Acetates; Adult; Azathioprine; Chronic Disease; Cyclopropanes; Cyclosporine; Histamine H1 Antagonists; Humans; Male; Quinolines; Sulfides; Urticaria | 2009 |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Baths; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Glucocorticoids; Tacrolimus | 2010 |
Upregulation of hyaluronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy.
Topics: Actins; Animals; Chronic Disease; Cyclosporine; Diet, Sodium-Restricted; Disease Models, Animal; Fibrosis; Hyaluronan Receptors; Hyaluronic Acid; Immunohistochemistry; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Time Factors; Up-Regulation | 2010 |
Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.
Topics: Administration, Oral; Adolescent; Adult; Basophils; C-Reactive Protein; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Middle Aged; Treatment Outcome; Urticaria; Young Adult | 2010 |
Clinical relevance of curcumin-induced immunosuppression in living-related donor renal transplant: an in vitro analysis.
Topics: Acute Disease; Adult; Case-Control Studies; Cells, Cultured; Chronic Disease; Curcumin; Cyclosporine; Dose-Response Relationship, Drug; Female; Flow Cytometry; Graft Rejection; Humans; Immunosuppressive Agents; India; Interferon-gamma; Interleukin-4; Kidney Transplantation; Living Donors; Lymphocytes; Male; Middle Aged; Mitogens; NF-kappa B; Tetradecanoylphorbol Acetate; Time Factors; Young Adult | 2010 |
Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat.
Topics: Acute Disease; Animals; Antigens, CD; CD83 Antigen; Chronic Disease; Cyclosporine; Dendritic Cells; Graft Rejection; Heart Transplantation; Immunoglobulins; Immunosuppressive Agents; Membrane Glycoproteins; Organ Preservation; Rats; Rats, Inbred Strains; Rats, Inbred WF; Reperfusion; RNA, Messenger; Th1 Cells; Th17 Cells; Time Factors; Transplantation, Homologous | 2010 |
Cyclosporine-A in severe chronic urticaria: the option for long-term therapy.
Topics: Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Urticaria | 2010 |
[Association of immunization and thermal latencies in rats with chronic constriction injury].
Topics: Animals; Chronic Disease; Constriction, Pathologic; Cyclosporine; Immunologic Factors; Lipopolysaccharides; Male; Microglia; Neuralgia; Pain Threshold; Random Allocation; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Somatosensory Disorders; Spinal Cord | 2010 |
Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; Chronic Disease; Colonic Diseases; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver Diseases; Mice; Mice, Inbred C3H; Toll-Like Receptors; Transplantation, Isogeneic | 2010 |
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Interactions; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; T-Lymphocytes; Transplantation, Homologous; Young Adult | 2010 |
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Angiotensin II; Animals; Blotting, Western; Chronic Disease; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Glucuronidase; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Klotho Proteins; Male; Mice; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents | 2011 |
Circulating level of chemerin is upregulated in psoriasis.
Topics: Adult; Chemokines; Chronic Disease; Cyclosporine; Dermatitis; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Intercellular Signaling Peptides and Proteins; Leptin; Male; Metabolic Syndrome; Psoriasis; Skin; Up-Regulation | 2010 |
A young male heart transplant recipient who developed CKD due to cyclosporine therapy after a decade.
Topics: Adult; Chronic Disease; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Time Factors; Treatment Outcome | 2010 |
Early and delayed effects of AST-120 on chronic cyclosporine nephropathy.
Topics: Animals; Blotting, Northern; Blotting, Western; Carbon; Chronic Disease; Cyclosporine; Disease Progression; Immunoenzyme Techniques; Immunosuppressive Agents; In Situ Hybridization; Kidney Diseases; Male; Microspheres; Oxidative Stress; Oxides; Rats; Rats, Sprague-Dawley | 2011 |
Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Androstadienes; Chronic Disease; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Pain; Female; Humans; Immunosuppressive Agents; Loteprednol Etabonate; Male; Middle Aged; Retrospective Studies | 2011 |
Cardioprotective effect of calcineurin inhibition in an animal model of renal disease.
Topics: Animals; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Heart Diseases; Hypertrophy, Left Ventricular; Immunosuppressive Agents; Kidney Diseases; Male; Nephrectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus; Ventricular Remodeling | 2011 |
Establishment of a chronic rejection model for orthotopic liver transplantation in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Graft Rejection; Hydrocortisone; Immunosuppressive Agents; Liver Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Sprague-Dawley; Species Specificity; Transplantation, Homologous | 2011 |
Interstitial cystitis: a rare manifestation of primary Sjögren's syndrome, successfully treated with low dose cyclosporine.
Topics: Adult; Biopsy; Chronic Disease; Cyclosporine; Cystitis, Interstitial; Cystoscopy; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Prednisone; Sjogren's Syndrome; Treatment Outcome | 2012 |
Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy.
Topics: Animals; Antineoplastic Agents; Benzamides; Chronic Disease; Cyclosporine; Imatinib Mesylate; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous | 2011 |
[Bullous retinal detachment in chronic central serous chorioretinopathy treated with photodynamic therapy].
Topics: Adult; Blister; Central Serous Chorioretinopathy; Chronic Disease; Cyclosporine; Diagnosis, Differential; Diagnostic Errors; Fluorescein Angiography; Humans; Low-Level Light Therapy; Male; Photochemotherapy; Porphyrins; Prednisone; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Verteporfin; Vitrectomy | 2011 |
[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
Topics: Acute Kidney Injury; Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Encephalitis, Varicella Zoster; Graft vs Host Disease; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Male; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Time Factors; Virus Activation | 2011 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; CD28 Antigens; CD8-Positive T-Lymphocytes; Chronic Disease; Cyclosporine; Female; Forkhead Transcription Factors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; T-Lymphocyte Subsets | 2011 |
Factors that predict the success of cyclosporine treatment for chronic urticaria.
Topics: Administration, Oral; Adult; Chronic Disease; Cohort Studies; Cyclosporine; Dose-Response Relationship, Immunologic; Female; Humans; Immunosuppressive Agents; Male; Retrospective Studies; Urticaria | 2011 |
[Effect of cyclosporine on regulatory T cells and Foxp3 in the peripheral blood of children with chronic aplastic anemia].
Topics: Adolescent; Anemia, Aplastic; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Forkhead Transcription Factors; Humans; Immunosuppressive Agents; Male; RNA, Messenger; T-Lymphocytes, Regulatory | 2011 |
Selected urticaria patients benefit from a referral to tertiary care centres--results of an expert survey.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Dermatology; Female; Germany; Health Care Surveys; Histamine Antagonists; Humans; Incidence; Male; Middle Aged; Patient Selection; Prognosis; Referral and Consultation; Risk Assessment; Surveys and Questionnaires; Tertiary Care Centers; Treatment Outcome; Urticaria | 2013 |
Comparison of early and late conversion of sirolimus in experimental model of chronic cyclosporine nephropathy.
Topics: Animals; Apoptosis; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Intestines; Kidney Diseases; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Sirolimus | 2012 |
Nox2 is a mediator of chronic CsA nephrotoxicity.
Topics: Animals; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Epithelial-Mesenchymal Transition; Humans; Immunosuppressive Agents; Kidney; Liver Transplantation; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tacrolimus; Transforming Growth Factor beta1 | 2012 |
Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclosporine; Disseminated Intravascular Coagulation; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Interferon-gamma; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Plasma Exchange; Prednisolone; Tumor Necrosis Factor-alpha | 2012 |
Risk factors for steroid-resistant T-cell-mediated acute cellular rejection and their effect on kidney graft and patient outcome.
Topics: Acute Disease; Adolescent; Chronic Disease; Creatinine; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Middle Aged; Prevalence; Renal Dialysis; Risk Factors; Steroids; T-Lymphocytes; Treatment Outcome; Young Adult | 2012 |
Ciclosporin no better than infliximab for acute refractory ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab | 2012 |
Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Topics: Adult; Biomarkers; Blood Glucose; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Diabetes Mellitus; Drug Substitution; Female; Graft Rejection; Graft Survival; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lipids; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lymphangiogenesis; Male; Microscopy, Fluorescence; Rats; Rats, Wistar; Renal Insufficiency; Sirolimus; Time Factors; Transplantation, Homologous; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 2013 |
Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease.
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Diagnosis, Differential; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Skin; Skin Diseases; T-Lymphocytes; Young Adult | 2013 |
Expression of apoptosis-related genes in chronic cyclosporine nephrotoxicity in mice.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Pressure; Body Weight; Caspase 1; Caspase 3; Caspases; Chronic Disease; Cyclosporine; Fas Ligand Protein; fas Receptor; Immunohistochemistry; Immunosuppressive Agents; Kidney Diseases; Male; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2002 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome | 2002 |
Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation.
Topics: Adult; Chronic Disease; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Risk Factors | 2002 |
Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Middle Aged; Pathology; Tacrolimus | 2002 |
Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
Topics: Adult; Aged; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Transplantation, Homologous | 2002 |
The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
Topics: Adult; Body Mass Index; Chronic Disease; Control Groups; Cyclosporine; Dose-Response Relationship, Drug; Female; Fibrinolysis; Glucocorticoids; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prednisone; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2002 |
Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Treatment Outcome | 2002 |
Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients.
Topics: Adult; Angiotensinogen; Cadaver; Chronic Disease; Cyclosporine; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; RNA, Messenger; Tissue Donors; Transcription, Genetic; Transforming Growth Factor beta; Transplantation, Homologous | 2002 |
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
Topics: Animals; Blotting, Northern; Chemokine CCL2; Chronic Disease; Collagen; Cyclosporine; Endothelin-1; Immunohistochemistry; Immunosuppressive Agents; Kidney; Magnesium; Male; Osteopontin; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Sialoglycoproteins; Tissue Inhibitor of Metalloproteinase-1 | 2002 |
Use of cyclosporine.
Topics: Animals; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Magnesium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2002 |
Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Topics: ABO Blood-Group System; Adult; Blood Group Incompatibility; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Isoantibodies; Male; Peripheral Blood Stem Cell Transplantation; Red-Cell Aplasia, Pure; Transplantation, Homologous | 2002 |
Recurrent graft pancreatitis in a pancreatico-renal allograft recipient does not affect endocrine function.
Topics: Adult; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Islets of Langerhans; Kidney Transplantation; Male; Pancreas Transplantation; Pancreatitis; Postoperative Complications; Recurrence | 2002 |
CD4+ T cells in lung tissue predict responsiveness to cyclosporin A in interstitial pneumonia.
Topics: Aged; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes; Cell Count; Chronic Disease; Cyclosporine; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Lung Diseases, Interstitial; Lymphocyte Subsets; Male; Middle Aged; Pulmonary Alveoli | 2002 |
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Topics: Acute Disease; Anemia, Sickle Cell; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neutrophils; Survival Rate; Thalassemia; Transplantation, Homologous; Treatment Outcome | 2003 |
Adoptive transfer of regulatory T cells following chronic allograft rejection induces tolerance for secondary allografts.
Topics: Adoptive Transfer; Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Lymphocytes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reoperation; Spleen; T-Lymphocytes; Transplantation, Homologous | 2002 |
Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura.
Topics: Abatacept; Adolescent; Adult; Antigens, Human Platelet; B7-1 Antigen; Blood Platelets; Case-Control Studies; Child; Chronic Disease; Clonal Anergy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immune Tolerance; Immunoconjugates; Lymphocyte Activation; Male; Middle Aged; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; T-Lymphocytes; Treatment Outcome | 2003 |
Latent cerebral hypoperfusion in a boy with persistent nephrotic syndrome.
Topics: Cerebral Cortex; Cerebrovascular Circulation; Child, Preschool; Chronic Disease; Cyclosporine; Developmental Disabilities; Electroencephalography; Humans; Hypoxia-Ischemia, Brain; Magnetic Resonance Imaging; Male; Mood Disorders; Nephrotic Syndrome; Prednisolone; Recovery of Function; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2002 |
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Sulfasalazine; Treatment Outcome | 2002 |
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.
Topics: Aldosterone; Animals; Chronic Disease; Collagen Type I; Collagen Type IV; Cyclosporine; Fibronectins; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Variability of cyclosporine exposure and its relevance to chronic allograft nephropathy: a case-control study.
Topics: Adult; Age Factors; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Prognosis; Transplantation, Homologous | 2002 |
Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
Topics: Animals; Chronic Disease; Cyclosporine; Drug Administration Schedule; Immunosuppressive Agents; Kidney; Kidney Diseases; Macrophages; Male; Osteopontin; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sialoglycoproteins | 2003 |
Diffuse mesenterial sclerosis: a characteristic feature of chronic small-bowel allograft rejection.
Topics: Animals; Blood Vessels; Body Weight; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Immunosuppressive Agents; Intestinal Mucosa; Intestine, Small; Leukocytes, Mononuclear; Male; Mesentery; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Sclerosis; Time Factors; Transplantation, Homologous; Vasculitis | 2003 |
Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Transforming Growth Factor beta | 2003 |
Chronic graft-versus-host disease complicated by acute hepatitis B.
Topics: Acute Disease; Alanine Transaminase; Aspartate Aminotransferases; Bile Ducts; Biopsy; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Liver; Male; Middle Aged | 2003 |
[Experimental study of compound salvia injection in preventing and treating chronic nephrotoxicity induced by cyclosporin A in rats].
Topics: Animals; Chronic Disease; Collagen Type IV; Cyclosporine; Drugs, Chinese Herbal; Male; Nephrosis; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Salvia miltiorrhiza; Transforming Growth Factor beta | 2001 |
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Effect of mycophenolate mofetil on progression of chronic allograft nephropathy.
Topics: Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lymphocyte Activation; Male; Mycophenolic Acid; Regression Analysis; Transplantation, Homologous | 2003 |
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.
Topics: Adult; Chronic Disease; Cyclosporine; Ficusin; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Middle Aged; Photochemotherapy; Prednisone; Ultraviolet Rays | 2003 |
Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity.
Topics: Animals; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Extracellular Matrix Proteins; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Chronic graft versus host disease after allogeneic peripheral blood transplantation.
Topics: Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Incidence; Peripheral Blood Stem Cell Transplantation; Transplantation, Homologous | 2003 |
One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Topics: Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Risk; Risk Factors; Transplantation, Homologous | 2003 |
Infliximab salvage therapy after cyclosporine in an acute flare of chronic ulcerative colitis.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Enzyme Inhibitors; Female; Gastrointestinal Agents; Humans; Infliximab; Treatment Failure | 2003 |
Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Chronic Disease; Cyclosporine; Cytokines; Drug Therapy, Combination; Graft Rejection; Growth Substances; Heart; Heart Transplantation; Immunosuppressive Agents; Male; Morphinans; Myocardium; Rats; Rats, Inbred F344; Transplantation, Homologous; Ventricular Remodeling | 2003 |
FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
Topics: Animals; Chronic Disease; Complement C3; Coronary Vessels; Cyclosporine; Drug Therapy, Combination; Endothelium, Vascular; Fingolimod Hydrochloride; Graft Rejection; Heart Transplantation; Immunoglobulin G; Immunohistochemistry; Immunosuppressive Agents; Lymphocyte Subsets; Lymphocytes; Male; Monocytes; Myocardium; Propylene Glycols; Rats; Sphingosine | 2003 |
Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation.
Topics: Animals; Chronic Disease; Cyclosporine; Electrophoresis; Immunosuppressive Agents; Magnesium; Male; Nephrons; NF-kappa B; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1 | 2003 |
Chronic cholestasis and cardiac mitochondrial function in Wistar rats: a model for cardiovascular alterations in chronic liver disease?
Topics: 1-Naphthylisothiocyanate; Animals; Calcium; Cardiovascular Diseases; Cholestasis; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Fibrosis; Liver Diseases; Mitochondria, Heart; Oxidative Stress; Rats; Rats, Wistar | 2003 |
An immnosuppressive drug, cyclosporine-A acts like anti-depressant for rats under unpredictable chronic stress.
Topics: Adrenal Glands; Analysis of Variance; Animals; Antidepressive Agents; Behavior; Biogenic Monoamines; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Frontal Lobe; Imipramine; Immunosuppressive Agents; Injections, Intraperitoneal; Male; Motor Activity; Organ Size; Rats; Rats, Inbred F344; Reaction Time; Stress, Physiological | 2003 |
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2003 |
CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy.
Topics: Abatacept; Animals; Antibodies, Monoclonal; B7-1 Antigen; Blood Group Incompatibility; CD28 Antigens; CD40 Ligand; Chronic Disease; Coronary Disease; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunoconjugates; Immunosuppressive Agents; Leukocyte Common Antigens; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sirolimus; Transplantation Tolerance; Transplantation, Homologous | 2003 |
Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
Topics: Animals; Benzamides; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Imatinib Mesylate; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; Transplantation, Homologous; Transplantation, Isogeneic | 2003 |
Prolonged cyclosporin-A treatment for severe chronic urticaria.
Topics: Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Recurrence; Severity of Illness Index; Urticaria | 2003 |
Chronic rejection with or without transplant vasculopathy.
Topics: Acute Disease; Adult; Atrophy; Chronic Disease; Cohort Studies; Cyclosporine; Fibrosis; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Kidney Tubules; Logistic Models; Risk Factors; Time Factors; Vascular Diseases | 2003 |
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Thalidomide; Transplantation, Homologous | 2003 |
Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.
Topics: Adult; Chronic Disease; Cyclosporine; Dendritic Cells; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunophenotyping; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Prednisone; Th1 Cells; Uveitis | 2003 |
Early interstitial accumulation of collagen type I discriminates chronic rejection from chronic cyclosporine nephrotoxicity.
Topics: Actins; Adult; Biopsy; Chronic Disease; Collagen Type I; Cyclosporine; Extracellular Matrix; Fibrosis; Graft Rejection; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Laminin; Middle Aged; Muscle, Smooth; ROC Curve; Time Factors | 2003 |
Pancreatitis following heart transplantation: report of a case.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Diagnosis, Differential; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancreatic Pseudocyst; Pancreatitis; Risk Factors | 2003 |
Topical cyclosporin in the treatment of chronic sarcoidosis of the conjunctiva.
Topics: Administration, Topical; Chronic Disease; Conjunctival Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Ophthalmic Solutions; Sarcoidosis | 2003 |
Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chronic Disease; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enterocytes; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Intestinal Absorption; Liver Transplantation; Living Donors; Male; RNA, Messenger; Tacrolimus | 2003 |
Gingival overgrowth in kidney transplant recipients treated with cyclosporine and its relationship with chronic graft nephropathy.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Gingival Hyperplasia; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Survival Analysis; Time Factors | 2003 |
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
Topics: Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies; Treatment Outcome; Uveitis | 2003 |
Long-term immunosuppression after liver transplantation: are steroids necessary?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Chronic Disease; Cyclosporine; Drug Administration Schedule; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Prednisolone; Reproducibility of Results; Risk Factors; Time Factors | 1992 |
Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy.
Topics: Child; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid | 2003 |
Regulation and phenotype of an innate Th1 cell: role of cytokines and the p38 kinase pathway.
Topics: Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; Cell Division; Cell Line; Chronic Disease; Cyclosporine; Cytokines; Enzyme Inhibitors; Epitopes, T-Lymphocyte; Immunity, Innate; Immunophenotyping; Inflammation; Interferon-gamma; Interleukin-12; Interleukin-18; Lectins, C-Type; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; Th1 Cells | 2003 |
The evaluation of the effectiveness and side-effects of a 200-mg/day constant dose of cyclosporin in chronic plaque-type psoriasis: can a constant dose be an alternative?
Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; Chronic Disease; Cyclosporine; Female; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome | 2004 |
Thygeson's superficial punctate keratitis: ten years' experience.
Topics: Adolescent; Adult; Age of Onset; Aged; Child; Child, Preschool; Chronic Disease; Contact Lenses, Extended-Wear; Cornea; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Keratitis; Male; Middle Aged; Retrospective Studies; Visual Acuity | 2004 |
Antagonist: Early surgical intervention in ulcerative colitis.
Topics: Azathioprine; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Mercaptopurine; Patient Selection; Time Factors | 2004 |
Toward calcineurin antagonist minimization.
Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Kidney Transplantation; Transplantation, Homologous | 2004 |
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Combined Modality Therapy; Cyclosporine; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis.
Topics: Animals; Ceruletide; Chronic Disease; Collagen; Cyclosporine; Fibroblasts; Fibrosis; Lipid Peroxidation; Lipoproteins; Male; Myocytes, Smooth Muscle; Pancreas; Pancreatitis; Rats; Rats, Wistar; Vitamin E | 2004 |
Safety of long-term treatment with cyclosporin A in resistant chronic plaque psoriasis: a retrospective case series.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Retrospective Studies | 2004 |
Chronic allograft nephropathy.
Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Survival Rate | 2004 |
Chronic allograft nephropathy.
Topics: Biopsy; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Observer Variation | 2004 |
The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation.
Topics: Acute Disease; Child; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Neoplasms; Retrospective Studies; Survival Analysis | 2004 |
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Topics: Acute Disease; Adult; Australia; Azathioprine; Bronchiolitis Obliterans; Canada; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Forced Expiratory Volume; Graft Rejection; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Incidence; Kidney; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psoriasis; Quality of Life; Recurrence; Severity of Illness Index; Sickness Impact Profile; Treatment Outcome; United Kingdom | 2004 |
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Population Surveillance; Postoperative Care; Retrospective Studies; Risk Assessment; Severity of Illness Index; Siblings; Stem Cell Transplantation | 2004 |
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.
Topics: Adult; Blood Cells; Bone Marrow Transplantation; Chronic Disease; Cohort Studies; Cyclosporine; Drug Therapy, Combination; fas Receptor; Female; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interleukins; Male; Methotrexate; Middle Aged; Polymorphism, Genetic; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2004 |
Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
Topics: Animals; Chronic Disease; Cyclosporine; Drug Synergism; Extracellular Matrix Proteins; Immunosuppressive Agents; Kidney; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sirolimus; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease.
Topics: Alopecia; Animals; Autoimmunity; CD4-Positive T-Lymphocytes; CD8 Antigens; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Immunosuppressive Agents; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Peripheral Blood Stem Cell Transplantation; Skin; Transplantation, Autologous | 2004 |
[Effect of cyclosporine A on myocardial calcineurin activity of the right ventricle and plasma NO, nitric oxide synthase and endothelin-1 levels in rats with chronic hypoxia].
Topics: Animals; Calcineurin; Chronic Disease; Cyclosporine; Endothelin-1; Female; Hypoxia; Immunosuppressive Agents; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Rats | 2004 |
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Jap
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Siblings; Stem Cell Transplantation; Tacrolimus; Time Factors; Tissue Donors; Treatment Outcome | 2004 |
[Chronic active ulcerative colitis. Efficacy of intravenous followed by oral cyclosporine combined with azathioprine].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Attitude of Health Personnel; Attitude to Health; Azathioprine; Chronic Disease; Colitis, Ulcerative; Cyclosporine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Topics: Adolescent; B-Lymphocytes; Cell Line, Transformed; Cell Transformation, Viral; Chronic Disease; Cyclosporine; DNA, Viral; Drug Resistance; Epstein-Barr Virus Infections; Etoposide; Female; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Multiple Organ Failure; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2004 |
Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Topics: Adult; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2004 |
Non-Hodgkin's lymphoma following treatment of atopic eczema with cyclosporin A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Cyclosporine; Dermatitis, Atopic; Disease Progression; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisolone; Severity of Illness Index; Vincristine | 2004 |
Differentiation between chronic rejection and chronic cyclosporine toxicity by analysis of renal cortical mRNA.
Topics: Adult; Chronic Disease; Cyclosporine; Diagnosis, Differential; Extracellular Matrix Proteins; Female; Graft Rejection; Humans; Immunohistochemistry; Kidney; Kidney Cortex; Kidney Transplantation; Laminin; Male; Middle Aged; Poisoning; RNA, Messenger; ROC Curve; Staining and Labeling; Transforming Growth Factor beta | 2004 |
Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
Topics: Chronic Disease; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Tacrolimus; Treatment Failure; Treatment Outcome | 2004 |
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hypercholesterolemia; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity.
Topics: alpha-MSH; Animals; Antigens, Surface; Apoptosis; bcl-2-Associated X Protein; Chronic Disease; Cyclosporine; Fibrosis; Immunosuppressive Agents; In Situ Nick-End Labeling; Kidney Tubules; Male; Nephritis, Interstitial; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Cooling to 10 degrees C and treatment with Cyclosporine A improve cerebral recovery following prolonged hypothermic circulatory arrest in a chronic porcine model.
Topics: Animals; Apoptosis; Brain Injuries; Cell Nucleus; Chronic Disease; Cyclosporine; Disease Models, Animal; Electroencephalography; Evoked Potentials; Female; Heart Arrest; Hemodynamics; Hippocampus; Hypothermia, Induced; Intracranial Pressure; Necrosis; Random Allocation; Swine | 2005 |
KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Topics: Animals; Bradycardia; Chemotaxis, Leukocyte; Chronic Disease; Cyclosporine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Guinea Pigs; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Male; Molecular Structure; Propylene Glycols; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; Skin Transplantation; Sphingosine; Sulfhydryl Compounds; Transplantation, Heterotopic; Transplantation, Homologous | 2005 |
C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria.
Topics: Animals; Chronic Disease; Complement Membrane Attack Complex; Cyclosporine; Diabetes Mellitus, Experimental; Extracellular Matrix Proteins; Female; Immunohistochemistry; Kidney Tubules; Nephritis, Interstitial; Proteinuria; Rats; Streptozocin; Ureteral Obstruction | 2005 |
Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prospective Studies; Tacrolimus | 2005 |
Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.
Topics: Animals; Chronic Disease; Cyclosporine; Enzyme Induction; Graft Rejection; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Kidney; Kidney Transplantation; Protoporphyrins; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 2005 |
Rapamycin in patients with chronic renal allograft dysfunction.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Calcineurin Inhibitors; Case-Control Studies; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Hemoglobins; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Sirolimus; Tacrolimus | 2005 |
Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Interferon-gamma; Middle Aged; Transplantation, Homologous | 2005 |
Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
Topics: Adult; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Magnesium; Male; Middle Aged; Retrospective Studies; Severity of Illness Index | 2005 |
Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
Topics: Animals; Cell Proliferation; Chronic Disease; Cyclosporine; Cytokines; Dendritic Cells; Graft Rejection; Haplotypes; Immunologic Memory; Immunosuppression Therapy; Interferon-gamma; Isoantigens; Kinetics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Skin Transplantation; T-Lymphocytes, Cytotoxic; Time Factors; Tissue Donors; Trachea; Transplantation, Homologous | 2005 |
Long-term outcome of intractable ulcerating enterocolitis of infancy.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Colectomy; Colitis, Ulcerative; Cyclosporine; Enterocolitis; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Steroids; Thalidomide; Time Factors; Treatment Outcome | 2005 |
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Topics: Basophils; Calcineurin Inhibitors; Cells, Cultured; Chronic Disease; Complement C5a; Cyclosporine; Diphenhydramine; Dose-Response Relationship, Immunologic; Histamine H1 Antagonists; Histamine Release; Humans; Hydroxyzine; Immunoglobulin G; Immunosuppressive Agents; Leukocytes; Methotrexate; Recurrence; Tacrolimus; Urticaria | 2005 |
sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil.
Topics: Antigens, CD; Chronic Disease; Cyclosporine; Cytokines; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Ki-1 Antigen; Kidney Transplantation; Mycophenolic Acid; Risk Factors; Tacrolimus | 2005 |
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Topics: Biopsy; Calcineurin Inhibitors; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Sirolimus; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2005 |
Pancreatic fibrosis in rats and its response to antioxidant treatment.
Topics: Animals; Antioxidants; Ceruletide; Chronic Disease; Cyclosporine; Fibrosis; Glutathione Peroxidase; Male; Oxidative Stress; Pancreas; Pancreatitis; Rats; Rats, Wistar | 2005 |
Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.
Topics: Administration, Oral; Adult; Aged; Algorithms; Antirheumatic Agents; Cerebrospinal Fluid Proteins; Child; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Peripheral Nerves; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 2005 |
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Premedication; Retrospective Studies; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Oral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing.
Topics: Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Prednisone; Skin Tests; Urticaria | 2005 |
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine | 2006 |
Late effects of chronic graft-vs.-host disease in minor salivary glands.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biopsy; Bone Marrow Transplantation; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Periodic Acid-Schiff Reaction; Prednisone; Salivary Glands, Minor; Xerostomia | 2005 |
Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients.
Topics: Blood Pressure; Calcineurin Inhibitors; Child; Chronic Disease; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Mycophenolic Acid | 2005 |
Prevention of chronic allograft nephropathy with vitamin D.
Topics: Animals; Blotting, Western; Chronic Disease; Cyclosporine; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Fibrosis; Graft Rejection; Graft Survival; Immunohistochemistry; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Matrix Metalloproteinases; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Sprague-Dawley; Signal Transduction; Smad7 Protein; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transplantation, Homologous; Vitamin D | 2005 |
Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
Topics: Absorbable Implants; Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Female; Immunosuppressive Agents; Male; Polyesters; Rabbits; Uveitis; Vitreous Body | 2006 |
Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis.
Topics: Cell Division; Chronic Disease; Crystallization; Cyclosporine; Graft Rejection; Humans; Hyaluronic Acid; Immunosuppressive Agents; Infant, Newborn; Infant, Premature; Ischemia; Kidney Transplantation; Kidney Tubules, Distal; Nephrocalcinosis; Nephrons; Osteopontin; Sialoglycoproteins | 2005 |
Cyclosporine-induced renal injury induces toll-like receptor and maturation of dendritic cells.
Topics: Animals; Chronic Disease; Cyclosporine; Dendritic Cells; Histocompatibility Antigens Class II; HSP70 Heat-Shock Proteins; Immunosuppressive Agents; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2005 |
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Graft Rejection; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyridones; Sirolimus; Trachea; Transforming Growth Factor beta | 2005 |
Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats.
Topics: Animals; Apoptosis; Caspase 1; Caspase 3; Caspases; Chronic Disease; Cyclosporine; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix; Fibrosis; Glomerulonephritis; Immunosuppressive Agents; Interleukin-1; Male; Mycophenolic Acid; Rats; Rats, Wistar; Reperfusion Injury; Sirolimus; Tacrolimus | 2005 |
The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
Topics: Adult; Aged; Calcitriol; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-10; Interleukins; Male; Middle Aged; Psoriasis; Receptors, Interleukin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin | 2005 |
Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis.
Topics: Animals; Cell Adhesion; Cell Communication; Cell Movement; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Endothelial Cells; Female; Immunosuppressive Agents; Intestinal Mucosa; Leukocyte Rolling; Leukocytes; Mice; Mice, Inbred BALB C; Predictive Value of Tests; Sirolimus | 2006 |
Graft versus host disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Cyclosporine; Developing Countries; Graft vs Host Disease; Humans | 2005 |
Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Inhaled cyclosporine--a breath of fresh air?
Topics: Administration, Inhalation; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Survival Analysis | 2006 |
Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
Topics: Acute Disease; Animals; Biomarkers; Blood Coagulation; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Kidney; Kidney Glomerulus; Kidney Transplantation; Rabbits; Thromboplastin | 2005 |
Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes.
Topics: Adenosine Triphosphate; Animals; Cell Respiration; Chronic Disease; Cyclosporine; Disease Models, Animal; Dogs; Electron Transport Complex IV; Enzyme Inhibitors; Heart Failure; Heart Ventricles; Membrane Potentials; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardium; Myocytes, Cardiac; Ventricular Dysfunction, Left | 2005 |
Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity.
Topics: Aged; Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Treatment Outcome | 2006 |
Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Kidney Diseases; Male; Nephrotic Syndrome; Regression Analysis; Retrospective Studies; Risk Factors | 2006 |
Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure.
Topics: Adrenal Cortex Hormones; Adult; Aged; Chronic Disease; Cyclosporine; Disease-Free Survival; Edema; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Salvage Therapy; Splenectomy | 2006 |
Clinical observation on treatment of chronic aplastic anemia by Shengxuening and cyclosporin A.
Topics: Adult; Aged; Androgens; Anemia, Aplastic; Chronic Disease; Cyclosporine; Drugs, Chinese Herbal; Erythroid Precursor Cells; Follow-Up Studies; Hemoglobins; Humans; Medicine, Chinese Traditional; Middle Aged; Neutrophils; Platelet Count; Reticulocytes; Stanozolol; Tablets | 2006 |
Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity.
Topics: Animals; Chronic Disease; Connective Tissue Growth Factor; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Male; Nephrosis; Rats; Rats, Sprague-Dawley; Sirolimus; Transforming Growth Factor beta1 | 2006 |
[Treating chronic urticaria].
Topics: Adrenal Cortex Hormones; Adult; Child; Chloroquine; Chronic Disease; Cyclosporine; Dapsone; Diagnosis, Differential; Histamine Antagonists; Humans; Pruritus; Urticaria | 2006 |
Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection.
Topics: Animals; bcl-X Protein; Chronic Disease; Cyclosporine; Disease Models, Animal; DNA Primers; Gene Expression Regulation; Graft Rejection; Heme Oxygenase-1; Kidney Transplantation; Male; Mycophenolic Acid; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2006 |
Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dermatitis, Contact; Edema; Erythrocytes; Fumarates; Hypersensitivity, Delayed; Immunosuppressive Agents; Indoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Peritonitis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Toluene 2,4-Diisocyanate; Zymosan | 2006 |
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Topics: Acute Disease; Antifungal Agents; Cause of Death; Chronic Disease; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mycoses; Siblings; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure; Treatment Outcome; Vidarabine | 2006 |
Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
Topics: Administration, Topical; Adult; Chronic Disease; Cyclosporine; Dry Eye Syndromes; Female; Fluorescent Dyes; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Staining and Labeling; Tears; Treatment Outcome | 2007 |
The effect of budesonide mouthwash on oral chronic graft versus host disease.
Topics: Adult; Budesonide; Candidiasis, Oral; Chronic Disease; Cohort Studies; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mouthwashes; Pain Measurement; Peripheral Blood Stem Cell Transplantation; Prednisone; Retrospective Studies; Sodium Chloride; Stomatitis; Transplantation Conditioning; Treatment Outcome | 2007 |
Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Biopsy; Chronic Disease; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Treatment Outcome | 2007 |
NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.
Topics: Actins; Active Transport, Cell Nucleus; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomyopathy, Hypertrophic; Cell Nucleus; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Hypertension, Pulmonary; Hypoxia; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocytes, Smooth Muscle; NFATC Transcription Factors; Polycythemia; Pulmonary Artery; Up-Regulation; Vasoconstriction; Ventricular Remodeling | 2007 |
[Combination therapy with low-dose cyclosporin A, azathiopurine, and prednisolone for a child with refractory chronic idiopathic thrombocytopenic purpura].
Topics: Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Salvage Therapy; Splenectomy; Time Factors; Treatment Outcome | 2007 |
Transplant rejection under the microscope.
Topics: Antibody Formation; BK Virus; Chronic Disease; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Immunosuppressive Agents; Isoantibodies; Kidney Transplantation; Polyomavirus Infections; Transplantation, Homologous | 2007 |
Chronic rejection: an enduring enigma of transplantation biology.
Topics: Chronic Disease; Complement C3; Cyclosporine; Diagnosis, Differential; Glomerular Filtration Rate; Graft Rejection; Humans; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Prevalence; Risk Factors | 2007 |
Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child, Preschool; Chronic Disease; Cyclosporine; Epstein-Barr Virus Infections; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; In Situ Hybridization; Infant; Orbital Diseases; Polymerase Chain Reaction; Prednisolone; RNA, Viral; Skin Diseases; T-Lymphocytes | 2008 |
[Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephrotic Syndrome; Time Factors; Transplantation, Homologous | 2007 |
Cyclosporine in chronic idiopathic urticaria.
Topics: Chronic Disease; Cyclosporine; Dermatologic Agents; Humans; Urticaria | 2007 |
Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Catalase; Chronic Disease; Creatinine; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Glutathione Peroxidase; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Quercetin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E | 2007 |
Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Chemokines; Chronic Disease; Cyclosporine; Cytokines; Drug Therapy, Combination; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Graft Rejection; Heptanoic Acids; Immunosuppressive Agents; Kidney Transplantation; Male; Monocytes; Proteinuria; Pyrroles; Rats; Rats, Inbred F344; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Homologous | 2007 |
Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model.
Topics: Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Heart Failure; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocarditis; Neutrophil Infiltration; Peptide Fragments; Protein Kinase C-epsilon; Protein Kinase Inhibitors; T-Lymphocytes; Transplantation, Heterotopic | 2007 |
Cure for dry eye.
Topics: Administration, Topical; Chronic Disease; Cyclosporine; Dry Eye Syndromes; Humans; Immunosuppressive Agents; Staining and Labeling; Treatment Outcome | 2007 |
[The anti-calcineurins (cyclosporin and tacrolimus)].
Topics: Acute Disease; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Drug Interactions; Graft Rejection; Humans; Immunosuppressive Agents; Patient Selection; Tacrolimus; Transplantation Immunology | 2007 |
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Chronic intestinal pseudo-obstruction caused by an intestinal inflammatory myopathy: case report and review of the literature.
Topics: Adult; Appendectomy; Chronic Disease; Cyclosporine; Eosinophilia; Fasciitis; Female; Humans; Immunosuppressive Agents; Intestinal Pseudo-Obstruction; Intestines; Jejunostomy; Laparoscopy; Myositis; Sterilization, Tubal | 2008 |
A comparison of the effects of fish oil and flaxseed oil on cardiac allograft chronic rejection in rats.
Topics: Animals; Blood Pressure; Body Weight; Cholesterol; Chronic Disease; Cyclosporine; Cytokines; Diet; Fish Oils; Graft Rejection; Graft Survival; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Linseed Oil; Lipid Metabolism; Lipids; Lipoproteins; Myocardium; Rats; Rats, Inbred F344; Rats, Inbred Lew | 2008 |
Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Topics: Adult; Aged; Cell Count; Chronic Disease; Conjunctiva; Cyclosporine; Dry Eye Syndromes; Emulsions; Female; Fluorescent Antibody Technique, Indirect; Goblet Cells; Humans; Immunosuppressive Agents; Male; Middle Aged; Mucin 5AC; Mucins; Ophthalmic Solutions; Transforming Growth Factor beta2 | 2008 |
Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
Topics: Alkynes; Animals; Aorta; Aortic Diseases; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Isoxazoles; Male; Nitriles; Rats; Rats, Inbred ACI; Transplantation, Homologous | 2008 |
[Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Chronic Disease; Corneal Opacity; Cyclosporine; Humans; Immunosuppressive Agents; Keratitis; Keratoconjunctivitis; Ophthalmic Solutions | 2008 |
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
Topics: Acute Disease; Animals; Antibodies; CD3 Complex; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12 Subunit p40; Methotrexate; Mice; Mice, Inbred C57BL | 2008 |
Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Topics: Adult; Age Factors; Aged; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Proportional Hazards Models; Risk; Survivors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
[Effect of urokinase on renal interstitial inflammation in rats with chronic cyclosporine A nephropathy and its possible mechanism].
Topics: Animals; Chronic Disease; Cyclosporine; Fibrosis; Kidney; Macrophages; Male; Nephritis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Urokinase-Type Plasminogen Activator | 2008 |
Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
Topics: Adult; Chronic Disease; Cyclosporine; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prevalence; Retrospective Studies; Survival Rate; Transplantation, Homologous | 1995 |
[The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
Topics: Adult; Chronic Disease; Cyclosporine; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Remission Induction; Time Factors | 1995 |
FK506 conversion for intractable rejection of the liver allograft.
Topics: Acute Disease; Administration, Oral; Adult; Bilirubin; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Injections, Intravenous; Liver Transplantation; Salvage Therapy; Tacrolimus; Transplantation, Homologous | 1993 |
Conversion from cyclosporin to FK 506 after liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Drug Resistance; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Infusions, Intravenous; Liver Transplantation; Middle Aged; Salvage Therapy; Survival Rate; Tacrolimus | 1993 |
Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Intestinal Mucosa; Intestine, Small; Leukocyte Count; Leukocytes, Mononuclear; Lymph Nodes; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocyte Subsets; Tacrolimus; Transplantation, Homologous | 1994 |
[Rejection of a liver allograft. Diagnosis and treatment].
Topics: Acute Disease; Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Liver Transplantation; Postoperative Complications; Tacrolimus; Transplantation, Homologous | 1994 |
[Inhibitory effect of histamine-added mouse gamma-globulin on eosinophil accumulation induced by allergen in BALB/c mice].
Topics: Allergens; Animals; Chronic Disease; Cyclosporine; Drug Combinations; Eosinophils; Female; gamma-Globulins; Histamine; Hypersensitivity; Mice; Mice, Inbred BALB C; Peritoneal Cavity | 1995 |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients.
Topics: Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Randomized Controlled Trials as Topic; Tacrolimus | 1995 |
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy.
Topics: Animals; Arterioles; Chronic Disease; Cyclosporine; Diet, Sodium-Restricted; Kidney Diseases; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1995 |
Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Characteristics; Time Factors; Tissue Donors | 1995 |
Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression.
Topics: Agranulocytosis; Animals; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Chronic Disease; Cyclosporine; Female; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lung; Methylprednisolone; Opportunistic Infections; Rabbits | 1995 |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Topics: Acute Disease; Age Factors; Analysis of Variance; Chronic Disease; Cyclosporine; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Multivariate Analysis; Prognosis; Sex Characteristics; Survival Analysis; Tacrolimus | 1993 |
Rejection: FK 506 for rescue or maintenance.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Middle Aged; Retrospective Studies; Steroids; Tacrolimus; Time Factors | 1993 |
FK 506 treatment of intractable rejection after liver transplantation.
Topics: Acute Disease; Adult; Alanine Transaminase; Bilirubin; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Male; Tacrolimus | 1993 |
Treatment of acute severe exacerbation of chronic hepatitis B with cyclosporin A and interferon-beta: a case report.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Hepatitis B; Humans; Interferon-beta; Male | 1995 |
[The treatment of cyclosporine A-resistant pyoderma gangrenosum with recombinant interferon alfa-2].
Topics: Adult; Chronic Disease; Cyclosporine; Female; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Pyoderma Gangrenosum; Recombinant Proteins; Remission Induction | 1995 |
Natural alpha interferon in chronic actinic dermatitis. Report of a case.
Topics: Aged; Chronic Disease; Cyclosporine; Drug Resistance; Humans; Interferon-alpha; Male; Photosensitivity Disorders | 1995 |
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Middle Aged; Prednisone | 1995 |
Antigen-independent events mimic characteristic changes of chronic allograft rejection.
Topics: Animals; Chronic Disease; Cyclosporine; Cytokines; Gene Expression; Graft Rejection; Ischemia; Isoantigens; Kidney Transplantation; Male; Models, Immunological; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reperfusion Injury; T-Lymphocytes; Transplantation, Homologous; Transplantation, Isogeneic | 1995 |
Treatment of erythropoietin resistance with cyclosporin.
Topics: Adult; Chronic Disease; Cyclosporine; Drug Resistance; Erythropoietin; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male | 1994 |
[Autoimmune chronic active hepatitis].
Topics: Adrenal Cortex Hormones; Antibodies; Chronic Disease; Cyclophosphamide; Cyclosporine; Hepatitis; HLA Antigens; Humans; Liver Transplantation; Penicillamine; Transfer Factor | 1994 |
Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity.
Topics: Chronic Disease; Cyclosporine; Graft Rejection; Histocompatibility Testing; HLA Antigens; Humans; Incidence; Kidney Transplantation; Retrospective Studies; Tissue Donors | 1994 |
Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat.
Topics: Animals; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Drug Administration Schedule; Graft Rejection; Kidney Transplantation; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors | 1994 |
Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients.
Topics: Adult; Cholesterol; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Incidence; Middle Aged; Retrospective Studies; Survival Rate; Time Factors; Triglycerides | 1994 |
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.
Topics: Acute Disease; Adult; Bone Marrow; Bone Marrow Transplantation; Calcineurin; Calmodulin-Binding Proteins; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Phosphoprotein Phosphatases; T-Lymphocytes, Cytotoxic; Time Factors | 1994 |
Myasthenia gravis after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Antigen; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myasthenia Gravis; Prednisolone; Transplantation, Homologous | 1994 |
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Demyelinating Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Polyradiculopathy; Prednisone; Recurrence; Transplantation, Homologous | 1994 |
Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil.
Topics: Animals; Chronic Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Macaca fascicularis; Methylprednisolone; Mycophenolic Acid; Myocardium; Papio; Transplantation, Heterologous | 1994 |
Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Transplantation, Homologous | 1994 |
Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats.
Topics: Animals; Chronic Disease; Cyclosporine; Immunoenzyme Techniques; Injections, Intraperitoneal; Ischemia; Kidney; Male; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley | 1994 |
Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
Topics: Animals; Aorta, Thoracic; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Isoxazoles; Leflunomide; Muscle, Smooth, Vascular; Rats; Rats, Inbred Lew; Rats, Inbred WF; Transplantation, Homologous; Tunica Intima | 1994 |
Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
Topics: Animals; Antibodies, Monoclonal; Aorta; CD4 Antigens; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Endothelium, Vascular; Graft Rejection; Muscle, Smooth, Vascular; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous | 1994 |
Transforming growth factor beta 1 in renal allograft recipients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Creatinine; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Reference Values; Regression Analysis; Transforming Growth Factor beta; Transplantation, Homologous | 1994 |
New issues in therapy after renal transplantation.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Drug Monitoring; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Transplantation | 1994 |
International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts.
Topics: Atrophy; Capillaries; Chronic Disease; Cyclosporine; Endarteritis; Fibrosis; Graft Rejection; Humans; International Cooperation; Kidney Transplantation; Kidney Tubules; Nephritis; Observer Variation; Reference Standards; Reproducibility of Results; Transplantation, Homologous | 1994 |
Evidence for a beneficial effect of increased functional kidney mass upon chronic kidney rejection in rats.
Topics: Animals; Chronic Disease; Cyclosporine; Glomerular Filtration Rate; Graft Rejection; Kidney; Kidney Transplantation; Organ Size; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1994 |
Proteinuria after renal allograft: assessment based on severity and causes.
Topics: Acute Disease; Adult; Analysis of Variance; Biopsy; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Graft Rejection; Humans; Kidney Transplantation; Male; Proteinuria; Retrospective Studies; Time Factors; Transplantation, Homologous | 1994 |
Cyclosporine A nephrotoxicity.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Humans; Kidney Diseases | 1994 |
Bone marrow transplantation in Fanconi anemia using matched sibling donors.
Topics: Abdomen; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Family; Fanconi Anemia; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Male; Prednisone; Thorax; Tissue Donors | 1994 |
Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine.
Topics: Adult; Cell Count; Cells, Cultured; Chronic Disease; Cyclosporine; Extracellular Matrix; Fibroblasts; Gingiva; Gingival Hyperplasia; Glucosamine; Humans; Kidney Transplantation; Male; Nifedipine; Proteoglycans; Tritium | 1994 |
[Cyclosporine and psoriasis: experience with 14 patients].
Topics: Adult; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psoriasis | 1993 |
Acitretin does not prevent psoriasis relapse related to cyclosporin A tapering.
Topics: Acitretin; Chronic Disease; Cyclosporine; Female; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Recurrence; Remission Induction | 1994 |
Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Italy; Leukemia; Male; Registries; Risk Factors; Sex Characteristics; Survival Rate; Tissue Donors; Transplantation, Homologous | 1993 |
Increased susceptibility for CsA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C.
Topics: Chemical and Drug Induced Liver Injury; Chronic Disease; Cyclosporine; Disease Susceptibility; Hepatitis C; Humans; Kidney Transplantation; Liver Function Tests; Retrospective Studies | 1993 |
The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Electrolytes; Glomerular Filtration Rate; Heart Rate; Hypertension; Kidney Diseases; Misoprostol; Osmolar Concentration; Prostaglandins; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin | 1993 |
Cyclosporin A in the treatment of chronic dermatitis of the hands.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Hand Dermatoses; Humans; Male; Middle Aged; Pilot Projects | 1994 |
B-cell lymphoma after cyclosporine for keratosis lichenoides chronica.
Topics: Chronic Disease; Cyclosporine; Humans; Keratosis; Lymphoma, B-Cell; Male; Middle Aged | 1993 |
TNF staining of graft biopsies in renal transplantation.
Topics: Acute Disease; Antibodies, Monoclonal; Biomarkers; Biopsy; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunohistochemistry; Kidney Transplantation; Tumor Necrosis Factor-alpha | 1993 |
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.
Topics: Acute Disease; Base Sequence; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Chronic-Phase; Molecular Sequence Data; Oligonucleotide Probes; Polymerase Chain Reaction; Postoperative Period; Transplantation, Homologous | 1993 |
Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins.
Topics: Adolescent; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Epidermolysis Bullosa Acquisita; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Male; Prednisolone | 1993 |
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.
Topics: Acute Disease; Animals; Chronic Disease; Colitis, Ulcerative; Colon; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Enema; Female; Mice | 1993 |
A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.
Topics: Adrenal Cortex Hormones; Animals; Chronic Disease; Cyclosporine; Dermatitis; Disease Models, Animal; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Mutation; Rodent Diseases; Skin | 1993 |
[Erythroblastopenia: chronic idiopathic or associated with chronic lymphoid leukemia. Value of cultures of erythroblastic progenitors and therapeutic strategy].
Topics: Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Cells, Cultured; Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Erythroid Precursor Cells; Fluoxymesterone; Humans; Immunoglobulins, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Red-Cell Aplasia, Pure; Remission Induction | 1993 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection.
Topics: Acute Disease; Animals; CD4 Antigens; Cell Line; Chronic Disease; Cyclosporine; Graft Rejection; Histocompatibility Antigens Class II; Kidney Transplantation; Lymphocyte Culture Test, Mixed; Rats; T-Lymphocyte Subsets; T-Lymphocytes; Transplantation, Homologous | 1993 |
Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Topics: Animals; Aorta, Thoracic; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Inflammation; Muscle, Smooth, Vascular; Necrosis; Polyenes; Rats; Rats, Inbred Lew; Rats, Inbred WF; Sirolimus; Transplantation, Homologous; Transplantation, Isogeneic | 1993 |
[Cyclosporin in severe bronchial asthma].
Topics: Asthma; Chronic Disease; Cyclosporine; Humans | 1993 |
Chronic superficial keratitis.
Topics: Animals; Chronic Disease; Cyclosporine; Dog Diseases; Dogs; Keratitis; Steroids | 1993 |
The effect of cyclosporin A on disease progression in proliferative immune complex glomerulonephritis.
Topics: Animals; Antigen-Antibody Complex; Chronic Disease; Cyclosporine; Female; Glomerulonephritis; Kidney Glomerulus; Rats; Rats, Inbred Lew; Serum Sickness; T-Lymphocytes | 1993 |
Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
Topics: Arteries; Arterioles; Arteriosclerosis; Chronic Disease; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Muscle, Smooth, Vascular; Renal Circulation | 1993 |
Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Prednisolone; Time Factors | 1993 |
Evaluation of animal models of chronic vascular rejection.
Topics: Animals; Arteriosclerosis; Atrophy; Chronic Disease; Cyclosporine; Disease Models, Animal; Fibrosis; Graft Rejection; Hyperplasia; Ischemia; Kidney Transplantation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; Renal Circulation | 1993 |
Risk factors for chronic rejection in renal allograft recipients.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Regression Analysis; Risk Factors; Transplantation, Homologous | 1993 |
Reactivation of experimental chronic T cruzi infection after immunosuppressive treatment by cyclosporine A and betametasone.
Topics: Animals; Betamethasone; Chagas Disease; Chronic Disease; Cyclosporine; Immunosuppression Therapy; Male; Mice; Mice, Inbred BALB C | 1993 |
Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Guanidines; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Ribonucleosides; Time Factors | 1993 |
Contribution of acute rejection to renal allograft loss from chronic rejection.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Cadaver; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Methylprednisolone; Time Factors; Tissue Donors; Transplantation, Homologous | 1993 |
Therapeutic use of topical cyclosporine.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Prognosis; Recurrence; Risk Factors | 1993 |
Evolution of glomerular basement membrane changes in chronic rejection.
Topics: Animals; Chronic Disease; Cyclosporine; Foam Cells; Graft Rejection; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Rats; Rats, Inbred WF; Time Factors | 1995 |
Chronic rejection after small-bowel transplantation.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Intestine, Small; Male; Rats; Rats, Inbred Strains; Short Bowel Syndrome; Transplantation, Homologous; Transplantation, Isogeneic | 1995 |
Cyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials. Pacific Northwest Gastroenterology Society.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Cyclosporine; Data Collection; Female; Gastroenterology; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Preoperative Care; Prospective Studies; Treatment Outcome; Washington | 1995 |
Cyclosporin-responsive keratoconjunctivitis in the cat and horse.
Topics: Administration, Topical; Animals; Cat Diseases; Cats; Chronic Disease; Cyclosporine; Female; Horse Diseases; Horses; Immunosuppressive Agents; Keratoconjunctivitis; Male; Ophthalmic Solutions | 1995 |
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Ophthalmic Solutions; Prednisone; Retrospective Studies; Uveitis; Visual Acuity | 1996 |
Microemulsion formulation of cyclosporine in pediatric liver transplantation.
Topics: Administration, Oral; Biological Availability; Child; Child, Preschool; Cholestasis; Chronic Disease; Cyclosporine; Diarrhea; Emulsions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Intestinal Absorption; Liver Transplantation; Short Bowel Syndrome | 1996 |
Aerosolized cyclosporine in lung recipients with refractory chronic rejection.
Topics: Adult; Aerosols; Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Respiratory Function Tests | 1996 |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Topics: Acute Disease; Adult; Azathioprine; Biopsy; Blood Glucose; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Prednisone; Tacrolimus; Transplantation, Homologous | 1996 |
Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
Topics: Administration, Oral; Animals; Aorta; Chronic Disease; Cyclosporine; Graft Rejection; Hyperplasia; Immunosuppressive Agents; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima | 1996 |
Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Biopsy; Bronchiolitis Obliterans; Bronchoscopy; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Confidence Intervals; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Lung Transplantation; Multicenter Studies as Topic; Muromonab-CD3; Pneumonia, Viral; Prednisone; Proportional Hazards Models; Retrospective Studies; Spirometry; Syndrome; Time Factors; Transplantation, Homologous | 1996 |
Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis.
Topics: Aged; Anemia; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Humans; Killer Cells, Natural; Leukemia, T-Cell; Lymphocytosis; Male; Middle Aged | 1996 |
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology.
Topics: Atrophy; Biopsy; Chronic Disease; Cyclosporine; Glomerulonephritis; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Transplantation, Homologous | 1996 |
Changes in urinary interleukin-2 in kidney transplant recipients.
Topics: Acute Disease; Adolescent; Adult; Biomarkers; Child; Chronic Disease; Creatinine; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2; Kidney Transplantation; Middle Aged; Monitoring, Physiologic; Reference Values; Regression Analysis | 1996 |
Effects of deoxyspergualine on chronic transplant nephropathy.
Topics: Azathioprine; Biomarkers; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-6; Kidney Transplantation; Male; Proteinuria; Ribonucleosides; Steroids | 1996 |
Causes of hospital admission following successful renal transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Female; Glomerulonephritis; Graft Rejection; Hospitalization; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Medical Records; Middle Aged; Postoperative Complications; Prednisolone; Retrospective Studies; Time Factors | 1996 |
Role of ICAM-1 in chronic rejection in the rat heart transplantation model.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chronic Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Macrophages; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1996 |
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.
Topics: Animals; Body Weight; Chronic Disease; Creatinine; Cyclosporine; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Fluorescent Antibody Technique; Gene Expression; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium; Transforming Growth Factor beta | 1996 |
Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Contrast Media; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Kidney Cortex; Kidney Transplantation; Magnetic Resonance Imaging; Male; Perfusion; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1996 |
Purpura pigmentosa chronica successfully treated with oral cyclosporin A.
Topics: Aged; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Pigmentation Disorders; Purpura; Skin | 1996 |
Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats.
Topics: Acute Disease; Animals; Body Weight; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley | 1995 |
Increased resources are required in patients with low cyclosporine bioavailability.
Topics: Acute Disease; Adolescent; Adult; Aged; Biological Availability; Black or African American; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Patient Readmission; Racial Groups; Retrospective Studies; Time Factors; White People | 1996 |
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.
Topics: Animals; Blood Glucose; Chronic Disease; Cyclosporine; Drug Synergism; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Polyenes; Rats; Rats, Sprague-Dawley; Sirolimus | 1996 |
Chronic renal allograft rejection: immunologic and nonimmunologic risk factors.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cohort Studies; Cyclosporine; Female; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 1996 |
Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression.
Topics: Animals; Chronic Disease; Cyclosporine; Cytomegalovirus Infections; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Kidney Transplantation; Rats; Rats, Inbred WF; Time Factors; Transplantation, Homologous | 1996 |
Causes of long-term graft failure in renal transplantation.
Topics: Adult; Cadaver; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Risk Factors; Survival Analysis; Tissue Donors | 1996 |
The effect of gonadectomy on the clinical course of chronic experimental allergic encephalomyelitis.
Topics: Animals; Brain; Chronic Disease; Cyclosporine; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Gonadal Steroid Hormones; Male; Orchiectomy; Ovary; Rats | 1996 |
Effect of immunosuppressive drug regimens on acute and chronic murine toxoplasmosis.
Topics: Acute Disease; Animals; Azathioprine; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Mice; Toxoplasma; Toxoplasmosis | 1996 |
Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Transplantation, Homologous | 1996 |
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathways.
Topics: Antigen Presentation; Chronic Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Transplantation, Homologous | 1996 |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
Topics: Antilymphocyte Serum; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 1996 |
Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Linear Models; P-Selectin; Rats; Rats, Inbred Strains; Rats, Inbred WF; Vascular Cell Adhesion Molecule-1 | 1997 |
Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation.
Topics: Adult; Alopecia Areata; CD4-CD8 Ratio; Chronic Disease; Cyclosporine; Drug Combinations; Esthetics; Evaluation Studies as Topic; Female; Glucocorticoids; Hair; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Remission Induction; Scalp Dermatoses; T-Lymphocyte Subsets | 1997 |
[Autoimmune hepatitis treated with cyclosporin revealed by acute hepatocellular failure].
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Child, Preschool; Chronic Disease; Cyclosporine; Hepatitis; Humans; Immunosuppressive Agents; Liver Failure, Acute; Male; Prednisolone | 1997 |
T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; B7-2 Antigen; Chronic Disease; CTLA-4 Antigen; Cyclosporine; Graft Rejection; Heart Transplantation; Immunoconjugates; Membrane Glycoproteins; Models, Biological; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1997 |
De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant .
Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic; B-Lymphocytes; Bone Marrow Transplantation; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Count; Lymphocyte Depletion; Male; Retrospective Studies; T-Lymphocytes | 1997 |
Impact of cyclosporin on the incidence and prevalence of chronic rejection in renal transplants.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Period | 1997 |
Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Skin Tests; Urticaria | 1997 |
The effect of diphenyl-dimethyl-dicarboxylate on cyclosporine-A blood level in kidney transplants with chronic hepatitis.
Topics: Chronic Disease; Cyclosporine; Dioxoles; Drug Interactions; Drugs, Chinese Herbal; Female; Graft Rejection; Hepatitis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Radioimmunoassay | 1997 |
Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046.
Topics: Animals; Chronic Disease; Cyclosporine; Drug Evaluation, Preclinical; Enzyme Inhibitors; Kidney Diseases; Male; Methacrylates; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane-A Synthase | 1997 |
Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
Topics: Acute Disease; Adult; Age Factors; Analysis of Variance; Black People; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Ohio; Reoperation; Retrospective Studies; Sex Factors; Survival Rate; Tissue and Organ Procurement; Transplantation, Homologous; White People | 1997 |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era?
Topics: Adult; Blood Transfusion; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Intraoperative Period; Liver Diseases, Alcoholic; Liver Failure; Liver Transplantation; Male; Middle Aged; Tacrolimus; Time Factors | 1997 |
Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
Topics: Animals; Arteriosclerosis; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Heart Transplantation; HLA-B Antigens; Immunosuppressive Agents; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1997 |
Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection.
Topics: Acute Disease; Adult; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Half-Life; Humans; Kidney Transplantation; Methylprednisolone; Middle Aged; Reoperation; Risk Factors; Time Factors; Treatment Outcome | 1997 |
Chronically rejected rat kidney allografts induce donor-specific tolerance.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Immune Tolerance; Intercellular Adhesion Molecule-1; Kidney Transplantation; Male; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reoperation; Time Factors; Transplantation, Homologous | 1997 |
Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis.
Topics: Administration, Topical; Adult; Child; Chronic Disease; Conjunctivitis, Allergic; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Male | 1997 |
Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation.
Topics: Animals; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Immunosuppressive Agents; Male; Myocardial Reperfusion Injury; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Transplantation, Heterotopic; Vascular Diseases | 1997 |
Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat.
Topics: Animals; Azathioprine; Biopsy, Needle; Chronic Disease; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Lymphocytes; Male; Methylprednisolone; Rats; Rats, Inbred BN; Rats, Inbred Strains | 1997 |
[Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Drug Evaluation; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Remission Induction; Time Factors | 1997 |
Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Hematopoiesis; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Recurrence; Transplantation, Homologous | 1997 |
Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients.
Topics: Adult; Amino Acid Sequence; Base Sequence; Case-Control Studies; Chronic Disease; Cyclosporine; Disease Progression; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Male; Middle Aged; Molecular Sequence Data; Multiple Sclerosis; Polymerase Chain Reaction | 1996 |
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease.
Topics: Animals; Antibodies, Monoclonal; Chronic Disease; Coronary Disease; Cyclosporine; Disease Models, Animal; Heart Transplantation; Inflammation; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred ACI; Rats, Inbred Strains; RNA, Messenger; Transplantation, Heterotopic; Up-Regulation | 1997 |
Influence of steroid withdrawal on proteinuria in renal allograft recipients.
Topics: Acute Disease; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Chi-Square Distribution; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prednisone; Proteinuria; Recurrence; Transplantation, Homologous | 1997 |
The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
Topics: Acute Disease; Antibodies; Azathioprine; B-Lymphocytes; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Histocompatibility; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Immunoglobulin G; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Muromonab-CD3; Prednisone; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1997 |
A second native renal allograft of donor origin in a model of chronic rejection demonstrates improved long-term function.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reoperation; Tissue Donors; Transplantation, Homologous | 1997 |
An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat.
Topics: Animals; Azathioprine; Biopsy, Needle; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Methylprednisolone; Rats; Rats, Inbred BN; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
Topics: Angiotensin II; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Chronic Disease; Creatinine; Cyclosporine; Gene Expression Regulation; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Urea | 1997 |
Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells.
Topics: Animals; Antigen-Presenting Cells; Cell Death; Chronic Disease; Cyclosporine; Enterotoxins; Graft vs Host Disease; Immunization; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; T-Lymphocytes, Helper-Inducer | 1997 |
Linear chronic cutaneous graft-versus-host disease.
Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
A novel approach to the treatment of chronic allograft nephropathy.
Topics: Adult; Cadaver; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies | 1997 |
Chronic relapsing thrombotic thrombocytopenic purpura: role of therapy with cyclosporine.
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Splenectomy | 1998 |
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
Topics: Animals; Anterior Eye Segment; Aqueous Humor; CD4-Positive T-Lymphocytes; Chronic Disease; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Electroretinography; Flow Cytometry; Immunosuppressive Agents; Mycobacterium tuberculosis; Panuveitis; Rabbits; Retina; Tuberculin; Vitreous Body | 1998 |
Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura.
Topics: Adolescent; Chronic Disease; Cyclosporine; Humans; Male; Plasma Exchange; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Recurrence | 1998 |
Influence of treatment with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi.
Topics: Animals; Antibodies, Helminth; Azathioprine; Betamethasone; Brain; Chagas Disease; Chronic Disease; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Leukocyte Count; Lymphocyte Count; Mice; Mice, Inbred Strains; Recurrence; Transplantation | 1997 |
Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.
Topics: Adult; Aged; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Time Factors | 1998 |
Are long-term plasma exchanges and ciclosporin useful in the management of severe chronic respiratory failure due to myasthenia gravis?
Topics: Aged; Chronic Disease; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Plasma Exchange; Respiratory Insufficiency; Time Factors | 1997 |
A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Prednisolone | 1998 |
Chronic interstitial cystitis and systemic lupus erythematosus in an 8-year-old girl.
Topics: Brain; Child; Chronic Disease; Cyclosporine; Cystitis, Interstitial; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging | 1998 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
Effects of cyclosporin A on mycelial transformation of Candida albicans cells in human serum.
Topics: Candida albicans; Candidiasis; Chronic Disease; Colony Count, Microbial; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Microbial Sensitivity Tests; Vaginitis | 1998 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |
Do urinary tract infections trigger chronic kidney transplant rejection in man?
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Urinary Tract Infections | 1998 |
[Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
Topics: Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Lumbosacral Region; Multiple Sclerosis; Rats; Rats, Inbred Lew; Rats, Inbred WKY; Recurrence; Spinal Cord | 1997 |
Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
Topics: Anastomosis, Surgical; Animals; Aorta, Abdominal; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Fibrinolytic Agents; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous; Vena Cava, Inferior | 1998 |
Development of tolerance in a chronic rejection model.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Isoantigens; Kidney Transplantation; Lymphocyte Transfusion; Male; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reoperation; Time Factors; Transplantation, Homologous | 1998 |
Role of acute rejection in chronic rejection.
Topics: Acute Disease; Cadaver; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Regression Analysis; Retrospective Studies; Risk Factors; Tissue Donors | 1998 |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Tacrolimus | 1998 |
Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Topics: Adult; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ichthyosis; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Transplantation, Homologous | 1998 |
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Anemia; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Prednisolone | 1998 |
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mass Screening; Methotrexate; Multivariate Analysis; Risk Factors; Transplantation, Homologous | 1998 |
Chronic renal allograft rejection: no response to mycophenolate mofetil.
Topics: Adult; Case-Control Studies; Chronic Disease; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Treatment Failure | 1998 |
Synergistic mechanisms of alloantigen-dependent and independent events in chronic graft rejection.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Ischemia; Isoantigens; Kidney; Kidney Transplantation; Organ Preservation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1998 |
Short-term outcome of chronic immunosuppression on the development of breast lesions in premenopausal heart and lung transplant patients.
Topics: Adolescent; Adult; Azathioprine; Biopsy, Needle; Breast Neoplasms; Child; Chronic Disease; Cyclosporine; Female; Fibroadenoma; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Mammography; Middle Aged; Physical Examination; Premenopause; Preoperative Care; Retrospective Studies; Treatment Outcome | 1998 |
Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy.
Topics: Animals; Cell Division; Chronic Disease; Collagenases; Cyclosporine; Immunohistochemistry; Kidney; Male; Matrix Metalloproteinase 3; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1 | 1998 |
[Long-term follow-up of anatomic heart transplantation. Apropos of 60 patients with a mean follow-up of 36 months].
Topics: Actuarial Analysis; Adult; Aged; Biopsy; Cause of Death; Chronic Disease; Creatinine; Cyclosporine; Death, Sudden, Cardiac; Echocardiography; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Mitral Valve Insufficiency; Neoplasms; Pancreatitis; Survival Analysis; Survival Rate; Tricuspid Valve Insufficiency | 1998 |
Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
Topics: Animals; Chronic Disease; Cricetinae; Cyclosporine; Disease Models, Animal; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mesocricetus; Myocardium; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterologous | 1998 |
Low level of interleukin 10 synthesis during liver allograft rejection.
Topics: Acute Disease; Azathioprine; Cells, Cultured; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-10; Liver Transplantation; Lymphocyte Culture Test, Mixed; Lymphocytes; Methylprednisolone; Tacrolimus; Transplantation, Homologous | 1998 |
A puzzling case: conjunctivitis lignosa?
Topics: Anti-Bacterial Agents; Child, Preschool; Chronic Disease; Chymotrypsin; Conjunctivitis; Cyclosporine; Diagnosis, Differential; Heparin; Humans; Hyaluronoglucosaminidase; Male | 1998 |
Ganglioside changes in brain in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat.
Topics: Animals; Brain; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Gangliosides; Immunosuppressive Agents; Myelin Sheath; Rats; Rats, Inbred Lew; Recurrence | 1998 |
Chronic rejection and chronic cyclosporin toxicity in renal allografts.
Topics: Animals; Blotting, Northern; Cell Line; Chronic Disease; Cyclosporine; Dactinomycin; Graft Rejection; Growth Substances; Humans; Immunosuppressive Agents; Kidney Transplantation; Nucleic Acid Synthesis Inhibitors; Rats; RNA, Messenger; Transforming Growth Factor beta | 1998 |
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Sex Factors; Transplantation, Homologous | 1998 |
[Effects of immunosuppressor and cytostatic agents on the extracellular matrix production during experimental neuropathies].
Topics: Animals; Antineoplastic Agents; Chronic Disease; Cyclophosphamide; Cyclosporine; Extracellular Matrix; Glomerulonephritis; Immunosuppressive Agents; Methylprednisolone; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Wistar | 1998 |
Cyclosporin A therapy in refractory non-infectious childhood uveitis.
Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity | 1998 |
[Liver transplantation: experiences and results of a program at the University of Liege].
Topics: Actuarial Analysis; Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Belgium; Chronic Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Liver Transplantation; Myocardial Infarction; Postoperative Complications; Reoperation; Survival Rate; Tacrolimus; Time Factors; Waiting Lists | 1998 |
The detection of chronic heart graft rejection by 31P NMR spectroscopy.
Topics: Adenosine Triphosphate; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Magnetic Resonance Spectroscopy; Myocardium; Phosphocreatine; Phosphorus; Phosphorus Isotopes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1999 |
Short-term oral cyclosporine for chronic idiopathic urticaria.
Topics: Administration, Oral; Adult; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Fatigue; Female; Headache; Humans; Immunosuppressive Agents; Male; Nausea; Treatment Outcome; Urticaria | 1999 |
Differential role of TNF-alpha and IFN-gamma in the brain of rats with chronic relapsing autoimmune encephalomyelitis.
Topics: Animals; Brain; Chronic Disease; Cyclosporine; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Guinea Pigs; Immunosuppressive Agents; Injections, Intraventricular; Interferon-gamma; Interleukin-10; Male; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; Recurrence; RNA, Messenger; Spinal Cord; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1999 |
Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Infant; Liver Function Tests; Liver Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome; Tumor Virus Infections | 1999 |
In vivo migration of lymphocytes in chronically rejecting rat kidney allografts.
Topics: Animals; CD18 Antigens; Cell Movement; Chronic Disease; Cyclosporine; Graft Rejection; Kidney Transplantation; Kinetics; Lymphocytes; Male; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Tritium; Uridine | 1999 |
Increased expression of interleukin-4 during liver allograft rejection.
Topics: Acute Disease; Adult; Cholestasis; Chronic Disease; Cyclosporine; Female; Gene Expression Regulation; Graft Rejection; Humans; Immunohistochemistry; Immunosuppression Therapy; Interleukin-2; Interleukin-4; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Receptors, Interleukin-2; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Transplantation, Homologous | 1999 |
Cyclosporin and chronic pancreatitis: a supermodel?
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Pancreatitis; Transforming Growth Factor beta | 1999 |
Optimization of the immunosuppressive protocol after lung transplantation.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Rabbits; Retrospective Studies; Tacrolimus | 1999 |
Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis.
Topics: Adult; Affect; Analysis of Variance; Case-Control Studies; Chronic Disease; Clinical Trials as Topic; Cognition; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Neuropsychological Tests; Somatostatin; Time Factors | 1999 |
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies | 1999 |
Usefulness of the switch to tacrolimus in liver transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Retrospective Studies; Tacrolimus | 1999 |
Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat.
Topics: Animals; Bronchiolitis Obliterans; Cell Division; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Male; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Respiratory Mucosa; Trachea; Transplantation, Homologous; Transplantation, Isogeneic | 1999 |
[A case of chronic iridocyclitis in young girls--surgery for complicated cataract and effect of cyclosporin A].
Topics: Cataract Extraction; Child; Chronic Disease; Cyclosporine; Female; Humans; Iridocyclitis | 1999 |
Correlation between salt-depleted diet and chronic ciclosporin-induced nephropathy in living-related donor renal transplant recipients.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft Survival; Humans; Hyponatremia; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Proteinuria; Sodium, Dietary | 1999 |
The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection.
Topics: Acute Disease; Animals; Aorta; Chronic Disease; Cyclosporine; Disease Progression; Graft Rejection; Heart Transplantation; Isoantigens; Rats; Transplantation, Homologous | 1999 |
Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model.
Topics: Animals; Cell Division; Chronic Disease; Coronary Disease; Cyclosporine; Graft vs Host Disease; Heart Transplantation; Male; ortho-Aminobenzoates; Platelet Aggregation Inhibitors; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 1999 |
Dose- and time-related acceleration of chronic graft vascular disease caused by cyclosporine in a rat cardiac isograft model.
Topics: Administration, Oral; Animals; Chronic Disease; Coronary Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Transplantation; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred ACI; Time Factors; Transplantation, Isogeneic | 1999 |
Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
Topics: ABO Blood-Group System; Adult; Azathioprine; Blood Group Incompatibility; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Tacrolimus; Treatment Failure; Treatment Outcome | 1999 |
Short-term cyclosporin monotherapy for chronic severe plaque-type psoriasis.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Psoriasis | 1999 |
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Northern; Blotting, Western; Caspase 3; Caspases; Chronic Disease; Creatinine; Cyclosporine; Fas Ligand Protein; Fibrosis; Fluorescent Antibody Technique; Gene Expression Regulation, Enzymologic; Immunosuppressive Agents; In Situ Nick-End Labeling; Kidney Diseases; Male; Membrane Glycoproteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Suppressor Protein p53; Weight Gain | 1999 |
Successful use of cyclosporine in the treatment of glucocorticoid- resistant nongranulomatous chronic idiopathic enterocolitis.
Topics: Chronic Disease; Cyclosporine; Enterocolitis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Retreatment | 1999 |
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR1; Receptors, Chemokine; RNA, Messenger; Transplantation, Homologous | 2000 |
Functional, histological, and inflammatory changes in chronically rejecting small bowel transplants.
Topics: Animals; Body Weight; Chronic Disease; Cyclosporine; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Intestine, Small; Male; Rats; Rats, Inbred Strains; Serum Albumin; Transplantation, Homologous; Transplantation, Isogeneic | 2000 |
Electron microscopic peritubular capillary lesions: a new criterion for chronic rejection.
Topics: Basement Membrane; Biopsy; Capillaries; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Microscopy, Electron; Time Factors | 1999 |
Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection.
Topics: Animals; Azathioprine; Chronic Disease; Cyclosporine; Glomerulosclerosis, Focal Segmental; Graft Rejection; Immunosuppressive Agents; Kidney; Kidney Transplantation; Leukocytes; Male; Polymerase Chain Reaction; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Interleukin-2; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Two cases of chronic graft-versus-host disease with elevated levels of soluble Fas ligand in serum.
Topics: Adolescent; Chronic Disease; Cyclosporine; Fas Ligand Protein; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Liver; Male; Membrane Glycoproteins; Middle Aged; Prednisolone; Solubility | 2000 |
The relationship between acute rejection and chronic rejection is highly dependent on specific MHC matching: a multi-strain rat heterotopic heart transplant study.
Topics: Acute Disease; Animals; Chronic Disease; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Major Histocompatibility Complex; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Inbred WF; Transplantation, Homologous; Viral Plaque Assay | 2000 |
Beneficial effect of low dose G-CSF and cyclosporin-A in a case of chronic neutropenia.
Topics: Autoimmune Diseases; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia | 2000 |
[Index of histopathological changes in rapidly progressive glomerulonephritis: a preliminary report].
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Azathioprine; Biopsy; Child; Chronic Disease; Cyclosporine; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glomerulonephritis; Humans; Kidney; Prednisone; Prognosis; Remission, Spontaneous; Severity of Illness Index | 2000 |
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis.
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nephritis, Interstitial; Panuveitis; Retrospective Studies; Secondary Prevention; Uveitis, Anterior; Visual Acuity | 2000 |
Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness.
Topics: Animals; Cell Adhesion Molecules; Chemotaxis, Leukocyte; Chronic Disease; Creatinine; Cyclosporine; Disease Models, Animal; Gene Expression Regulation; Histocompatibility Antigens; Immune Complex Diseases; Immunization; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interferon-gamma; Kidney; Kidney Glomerulus; Male; Microscopy, Fluorescence; Nephritis; Ovalbumin; Proteinuria; Rats; Rats, Sprague-Dawley; Serum Sickness; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2000 |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.
Topics: Acute Disease; Adult; Base Sequence; Case-Control Studies; CD4-Positive T-Lymphocytes; CD40 Antigens; CD40 Ligand; Chronic Disease; Cyclosporine; DNA Primers; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; In Vitro Techniques; Kidney Transplantation; Ligands; Membrane Glycoproteins; Middle Aged; Tacrolimus | 2000 |
Association between a positive flow cytometry crossmatch and the development of chronic rejection in primary renal transplantation.
Topics: Acute Disease; Adult; Analysis of Variance; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Retrospective Studies; Sex Factors; Time Factors | 2000 |
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Arterioles; Biglycan; Blood Pressure; Blotting, Northern; Chronic Disease; Collagen; Cyclosporine; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Gene Expression; Glomerular Filtration Rate; Hyalin; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Proteoglycans; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basement Membrane; Capillaries; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Sensitivity and Specificity; Transplantation, Homologous | 2000 |
Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Recurrence; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2000 |
Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Prednisone; Treatment Outcome | 2000 |
Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
Topics: Adolescent; Arterioles; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Humans; Immunohistochemistry; Infant; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Male; Nephrotic Syndrome; Renal Circulation; Renin | 2000 |
LF 08-0299 in the prophylaxis and treatment of chronic rejection in a rat aortic allograft model.
Topics: Animals; Aorta; Carbamates; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Immunosuppressive Agents; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 2000 |
Strategy for chronic rejection in recipient of living-related liver transplantation.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Liver Transplantation; Living Donors; Lymphocytes; Male; Methylprednisolone; Reoperation; Tacrolimus | 2000 |
More effective immunosuppression with the use of FK506 after liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Liver Transplantation; Middle Aged; Retrospective Studies; Tacrolimus | 2000 |
Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras.
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancreas Transplantation; Pancreatitis; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2000 |
[Therapy of chronic inflammatory intestinal disease].
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Combinations; Gastrointestinal Agents; Glucosamine; Humans; Immunosuppressive Agents; Infliximab; Sulfasalazine | 2000 |
Chronic cyclosporin-induced nephropathy.
Topics: Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Prognosis; Retrospective Studies | 2001 |
[Treatment of chronic aplastic anemia with triolandren and cyclosporin A].
Topics: Adolescent; Adult; Anemia, Aplastic; Cell Division; Cells, Cultured; Child; Chronic Disease; Cyclosporine; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Male; Middle Aged; Testosterone | 1998 |
Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
Topics: Adrenal Cortex Hormones; Adult; Calcineurin; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Time Factors | 2001 |
[Immunology-related chronic progressive cicatricial conjunctival diseases: diagnosis, therapy and prognosis].
Topics: Aged; Aged, 80 and over; Chronic Disease; Conjunctival Diseases; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunoglobulin A; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pemphigoid, Bullous; Prognosis | 2001 |
Cyclosporin A withdrawal in live related renal transplantation: long-term results.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Risk Factors; Time Factors | 2001 |
Host leukocytes and their products in chronic kidney allograft rejection in rats.
Topics: Animals; CD4-Positive T-Lymphocytes; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Kidney Transplantation; Lymphocytes; Macrophages; Monocytes; Neutrophils; Rats; Rats, Inbred F344; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
FK 506 rescue therapy for intractable liver allograft rejection.
Topics: Acute Disease; Adult; Bilirubin; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1994 |
Chronic rejection in pediatric renal transplantation: where are we?
Topics: Acute Disease; Animals; Calcineurin Inhibitors; Child; Chronic Disease; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Nephritis, Interstitial; Primates; Risk Factors; T-Lymphocytes, Cytotoxic | 2000 |
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.
Topics: Animals; Antibodies; Bile Ducts; Biomarkers; Cell Division; Cellular Senescence; Chronic Disease; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclosporine; Epithelial Cells; Graft Rejection; Humans; Immunosuppressive Agents; Intracellular Membranes; Liver Transplantation; Male; Mice; RNA, Messenger; Signal Transduction; Tacrolimus; Time Factors; Transforming Growth Factor beta | 2001 |
Hyperuricemia exacerbates chronic cyclosporine nephropathy.
Topics: Animals; Chronic Disease; Collagen; Crystallization; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Kidney; Kidney Diseases; Macrophages; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Osteopontin; Oxonic Acid; Rats; Rats, Sprague-Dawley; Reference Values; Sialoglycoproteins; Urate Oxidase; Uric Acid | 2001 |
Involvement of platelet-derived growth factor and histocompatibility of DRB 1 in chronic renal allograft nephropathy.
Topics: Adult; Cell Division; Cells, Cultured; Chronic Disease; Culture Media, Conditioned; Cyclosporine; DNA; Female; Histocompatibility; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; T-Lymphocytes; Transplantation, Homologous | 2001 |
[A case of tongue neoplasm in a 15-year old patient treated with immunosuppressants for renal insufficiency].
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisone; Pyelonephritis; Tongue Neoplasms | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
Involvement of interleukin-2 and growth factors in chronic kidney allograft rejection in rats.
Topics: Animals; Blood Pressure; Chronic Disease; Cyclosporine; Graft Rejection; Interleukin-2; Kidney Transplantation; Macrophages; Male; Platelet-Derived Growth Factor; Rats; Rats, Inbred F344; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Transcription, Genetic; Transforming Growth Factor beta; Transplantation, Homologous | 2001 |
The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
Topics: Animals; Chronic Disease; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Mycophenolic Acid; Rats; Rats, Inbred F344; Rats, Inbred Lew; Renal Circulation; Tacrolimus; Transplantation, Homologous | 2001 |
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Prednisolone; Receptors, Interleukin-2; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2001 |
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Circadian Rhythm; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2001 |
Microemulsion cyclosporin formulation, in contrast to the old formulation, widens the T lymphocyte subsets differences between stable and acute rejection of kidney transplants.
Topics: Antigens, CD; Biopsy, Needle; Chronic Disease; Cyclosporine; Emulsions; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Receptor-CD3 Complex, Antigen, T-Cell; Retrospective Studies; T-Lymphocyte Subsets | 2001 |
Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study.
Topics: Administration, Oral; Animals; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Immunosuppressive Agents; Pilot Projects; Pruritus | 2001 |
Polymyositis--an unusual manifestation of chronic graft-versus-host disease.
Topics: Adolescent; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Diagnosis, Differential; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, B-Cell; Polymyositis; Recurrence; Steroids; Treatment Outcome | 2001 |
Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Topics: Acute Disease; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Middle Aged; Monocytes; Reference Values; Tissue Donors; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2001 |
Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephrotoxicity.
Topics: Animals; Chronic Disease; Cyclosporine; Diet, Sodium-Restricted; Endothelial Growth Factors; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphokines; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2001 |
Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
Topics: Animals; Anticoagulants; Chronic Disease; Cyclosporine; Graft Rejection; Heparin, Low-Molecular-Weight; Histocompatibility Antigens Class II; Kidney Transplantation; Male; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Systole; T-Lymphocytes; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 2001 |
The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.
Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Chronic Disease; Cyclosporine; Disease Models, Animal; Everolimus; Graft Rejection; Immunosuppressive Agents; Isoantigens; Male; Mycophenolic Acid; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Tacrolimus | 2001 |
Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Hemodynamics; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Transplantation; Losartan; Mycophenolic Acid; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renal Circulation; Transplantation, Homologous; Transplantation, Isogeneic | 2001 |
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Topics: Adolescent; Adult; Cause of Death; Child; Child, Preschool; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Odds Ratio; Prednisone; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2001 |
Severe oral manifestations of chronic graft-vs.-host disease.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Betamethasone; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Methotrexate; Mouth Diseases; Mouthwashes; Mycophenolic Acid; Oral Hygiene; Prednisone; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis.
Topics: Administration, Oral; Adolescent; Adult; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Psoriasis; Treatment Outcome | 2001 |
Allochimeric class I MHC molecules prevent chronic rejection and attenuate alloantibody responses.
Topics: Amino Acid Sequence; Animals; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Histocompatibility Antigens; Immunoglobulin G; Immunohistochemistry; Isoantibodies; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Inbred ACI; Rats, Inbred WF; Recombinant Fusion Proteins | 2001 |
The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
Topics: Adolescent; Adult; Capillaries; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Microscopy, Electron; Middle Aged; Transplantation, Homologous | 2001 |
The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
Topics: Animals; Becaplermin; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Kidney Transplantation; Male; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Receptors, Platelet-Derived Growth Factor; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 2002 |
Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy.
Topics: Calcineurin Inhibitors; Chronic Disease; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Transplantation, Homologous | 2002 |
A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; CD40 Ligand; Chronic Disease; Cricetinae; Cyclosporine; Cytokines; Gene Expression; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Immunotherapy; Male; Rats; Rats, Inbred Lew; Rats, Inbred WF; Ribonucleases; Transplantation, Homologous | 2002 |
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.1 Differential diagnosis of chronic graft dysfunction.
Topics: Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Renal Artery Obstruction; Transplantation, Homologous; Ureteral Obstruction | 2002 |
Nocardiosis in tropical renal transplant recipients.
Topics: Adult; Chronic Disease; Cohort Studies; Cyclosporine; Female; Humans; India; Kidney Transplantation; Liver Diseases; Male; Nocardia Infections; Retrospective Studies; Risk Factors; Time Factors; Tropical Climate; Tuberculosis | 2002 |
Urticaria and cyclosporine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Hypersensitivity; Female; Humans; Middle Aged; Treatment Outcome; Urticaria | 2002 |
Effects of cyclosporine A on the hypothalamic-pituitary-adrenal axis and anterior pituitary interleukin-6 mRNA expression during chronic inflammatory stress in the rat.
Topics: Adrenocorticotropic Hormone; Animals; Arthritis, Experimental; Chronic Disease; Cyclosporine; Hypothalamo-Hypophyseal System; Interleukin-6; Lymphocyte Activation; Male; Pituitary Gland, Anterior; Pituitary-Adrenal System; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1992 |
Cyclosporin A responsive chronic severe vesicular hand eczema.
Topics: Administration, Oral; Aged; Chronic Disease; Cyclosporine; Eczema; Hand Dermatoses; Humans; Male; Severity of Illness Index; Skin Diseases, Vesiculobullous | 1992 |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft Rejection; Hepatic Artery; Hepatitis; Humans; Immunity, Cellular; Infant; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Tacrolimus | 1992 |
Stereoscopic analysis of focal interstitial infiltrate in a model of chronic rejection.
Topics: Animals; Blood Transfusion; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Immunoenzyme Techniques; Kidney Transplantation; Leukocyte Common Antigens; Rats; Rats, Inbred Strains | 1992 |
Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats.
Topics: Animals; Chromatography, High Pressure Liquid; Chronic Disease; Colitis; Colon; Cyclosporine; Disease Models, Animal; Indomethacin; Male; Prostaglandins; Rats; Rats, Wistar; Thromboxane B2; Trinitrobenzenesulfonic Acid | 1992 |
The use of lithium clearance studies in the early detection of cyclosporin A (CsA) nephrotoxicity: a protocol of renal function assessment with CsA therapy.
Topics: Chronic Disease; Creatinine; Cyclosporine; Humans; Kidney Diseases; Kidney Function Tests; Lithium; Uveitis, Posterior | 1992 |
Systemic therapy with cyclosporine.
Topics: Angioedema; Chronic Disease; Cyclosporine; Humans; Urticaria | 1992 |
[Alternative approaches to the treatment of aplastic anemia patients].
Topics: Adolescent; Adult; Anemia, Aplastic; Blood Transfusion; Chronic Disease; Combined Modality Therapy; Cyclosporine; Erythrocyte Transfusion; Female; Humans; Leukapheresis; Male; Middle Aged; Remission Induction; Splenectomy | 1992 |
Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
Topics: Actuarial Analysis; Antibodies, Anti-Idiotypic; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Isoantibodies; Kidney Transplantation; Postoperative Complications; Survival Rate | 1992 |
Successful treatment of musk ketone-induced chronic actinic dermatitis with cyclosporine and PUVA.
Topics: Chronic Disease; Cyclosporine; Dinitrobenzenes; Drug Therapy, Combination; Humans; Ketones; Male; Middle Aged; Perfume; Photosensitivity Disorders; PUVA Therapy | 1992 |
Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency of chronic infection in adult woodchucks.
Topics: Animals; Chronic Disease; Cyclosporine; Hepadnaviridae; Hepatitis, Animal; Immunosuppression Therapy; Marmota | 1992 |
Renal transplant recipients and chronic liver disease: statistical evaluation of predisposing factors.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Female; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Liver Diseases; Male; Methylprednisolone; Middle Aged; Risk Factors | 1992 |
Treatment of chronic neutropenia of childhood responsive to cyclosporin A in vitro and in vivo.
Topics: Adolescent; Autoimmune Diseases; Bone Marrow; Cell Differentiation; Cells, Cultured; Chemotaxis, Leukocyte; Chronic Disease; Colony-Forming Units Assay; Cyclosporine; Female; Hematopoietic Stem Cells; Humans; Killer Cells, Natural; Neutropenia; Neutrophils; Prednisolone; Respiratory Burst; Stimulation, Chemical; T-Lymphocytes | 1992 |
Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A.
Topics: Anesthesia; Animals; Chronic Disease; Cyclosporine; Demyelinating Diseases; Female; Male; Myelin Sheath; Neuritis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Recurrence | 1992 |
SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in
Topics: Animals; Cell Movement; Central Nervous System; Chronic Disease; Cyclosporine; Cyclosporins; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Immunosuppressive Agents; Lymph Nodes; Lymphocytes; Multiple Sclerosis; Phospholipid Ethers; Rats; Rats, Inbred Lew; Recurrence; Remission Induction | 1992 |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Middle Aged; Tacrolimus; Treatment Outcome | 1991 |
Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
Topics: Administration, Topical; Animals; Breeding; Chronic Disease; Cyclosporine; Dog Diseases; Dogs; Female; Follow-Up Studies; Keratoconjunctivitis Sicca; Male; Ophthalmic Solutions; Tears; Treatment Outcome | 1991 |
FK 506 used as rescue therapy for human liver allograft recipients.
Topics: Acute Disease; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Steroids; Transplantation, Homologous; Treatment Outcome | 1991 |
[Infantile dermatomyositis. Clinical aspects and prospective treatments].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Male | 1991 |
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema.
Topics: Administration, Oral; Adult; Angioedema; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Hydroxyzine; Middle Aged; Prednisone; Urticaria | 1991 |
[Functional reversibility of chronic cyclosporine nephrotoxicity in patients after kidney transplantation].
Topics: Chronic Disease; Cyclosporine; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Time Factors | 1991 |
Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months.
Topics: Adolescent; Adult; Cholangitis; Chronic Disease; Cyclosporine; Female; Heart Transplantation; Hepatitis B; Hepatitis C; Hepatitis E; Humans; Liver; Liver Diseases; Male; Middle Aged; Retrospective Studies | 1991 |
Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.
Topics: Adult; Asthma; Cell Division; Cells, Cultured; Chronic Disease; Cyclosporine; Depression, Chemical; Dose-Response Relationship, Drug; Drug Resistance; Flow Cytometry; Fluorescent Antibody Technique; Glucocorticoids; Humans; Interferon-gamma; Interleukin-2; Lymphocyte Activation; T-Lymphocytes | 1991 |